{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "\n",
    "# ============= 设置 OpenAI 与 PubMed API 密钥 =============\n",
    "OpenAI_key=''\n",
    "\n",
    "os.environ['OPENAI_API_KEY'] = OpenAI_key\n",
    "\n",
    "# PubMed e-utilities 基础 URL\n",
    "PUBMED_URL = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi\"\n",
    "PUBMED_FETCH_URL = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi\"\n",
    "# PubMed API Key\n",
    "PubMed_api_key = \"\"\n",
    "os.environ[\"PUBMED_API_KEY\"] = PubMed_api_key\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "sys.path.insert(0, r\"D:\\DFKI\\SciAgentsDiscovery-openai\\SciAgentsDiscovery-main\")\n",
    "\n",
    "# 假设你将改写后的文件命名为 agents_new_langroid.py\n",
    "from ScienceDiscovery.agents_langroid import run_chat\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "WARNING:langroid.cachedb.redis_cachedb:REDIS_PASSWORD, REDIS_HOST, REDIS_PORT not set in .env file,\n",
      "                        using fake redis client\n",
      "2025-03-13 19:18:27 - WARNING - REDIS_PASSWORD, REDIS_HOST, REDIS_PORT not set in .env file,\n",
      "                        using fake redis client\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "**Execution Plan for Generating Hypotheses about 'BRCA1'**\n",
      "\n",
      "**Step 1: Retrieve a KG summary from Neo4j (via DiseaseExplorerAgent)**\n",
      "- Task: Query the Neo4j database to obtain a knowledge graph (KG) summary specifically related to BRCA1, which may include information on its biological functions, associated diseases, related genes, and known interactions.\n",
      "- Action: Initiate a request to the DiseaseExplorerAgent to fetch the relevant KG summary.\n",
      "\n",
      "**Step 2: Generate 2 initial hypotheses in the 'Entity–Relation–Entity' format (via ScientistAgent)**\n",
      "- Task: Based on the retrieved KG summary, formulate two hypotheses that express potential relationships involving BRCA1.\n",
      "- Hypothesis Format: \n",
      "  - Hypothesis 1: \"BRCA1 – is associated with – Breast Cancer\"\n",
      "  - Hypothesis 2: \"BRCA1 – regulates – DNA Repair Mechanisms\"\n",
      "- Action: Use the ScientistAgent to generate these initial hypotheses based on the data from the KG.\n",
      "\n",
      "**Step 3: Perform individual iterative refinement for each hypothesis**\n",
      "- For Hypothesis 1: \"BRCA1 – is associated with – Breast Cancer\"\n",
      "  - a. Utilize KGAgent to explore existing evidence in the knowledge graph backing this association.\n",
      "  - b. Use PubMedAgent to search for recent literature and studies relating BRCA1 to Breast Cancer.\n",
      "  - c. Employ CriticAgent to assess the validity and relevance of the gathered data.\n",
      "  - d. Use RevisionAgent to make necessary adjustments to the hypothesis based on the critique.\n",
      "  - e. RefineAgent will finalize the hypothesis by consolidating all the information and insights gained.\n",
      "  \n",
      "- For Hypothesis 2: \"BRCA1 – regulates – DNA Repair Mechanisms\"\n",
      "  - a. Initiate a query with KGAgent to confirm how BRCA1 is involved in DNA repair within the knowledge graph.\n",
      "  - b. Use PubMedAgent to find relevant publications detailing the role of BRCA1 in DNA repair mechanisms.\n",
      "  - c. Analyze the findings with CriticAgent to ensure credibility and relevance.\n",
      "  - d. Collaborate with RevisionAgent to reformulate the hypothesis if needed.\n",
      "  - e. End with RefineAgent to finalize this hypothesis based on the collected evidence.\n",
      "\n",
      "**Step 4: Output a final decision (via DecisionAgent)**\n",
      "- Task: Collect all the refined hypotheses and their supporting evidence, and provide a synthesized decision on the validity and significance of each hypothesis.\n",
      "- Action: Use DecisionAgent to analyze the final refined hypotheses and present a coherent conclusion regarding their potential impact on understanding BRCA1-related research.\n",
      "\n",
      "This structured plan ensures a thorough investigation into BRCA1, enabling the generation of valid and meaningful hypotheses rooted in the latest scientific evidence."
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">2</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">219</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">566</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0004</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0004</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0004</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m2\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m219\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m566\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0004\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0004\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0004\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Planner Output]\n",
      "**Execution Plan for Generating Hypotheses about 'BRCA1'**\n",
      "\n",
      "**Step 1: Retrieve a KG summary from Neo4j (via DiseaseExplorerAgent)**\n",
      "- Task: Query the Neo4j database to obtain a knowledge graph (KG) summary specifically related to BRCA1, which may include information on its biological functions, associated diseases, related genes, and known interactions.\n",
      "- Action: Initiate a request to the DiseaseExplorerAgent to fetch the relevant KG summary.\n",
      "\n",
      "**Step 2: Generate 2 initial hypotheses in the 'Entity–Relation–Entity' format (via ScientistAgent)**\n",
      "- Task: Based on the retrieved KG summary, formulate two hypotheses that express potential relationships involving BRCA1.\n",
      "- Hypothesis Format: \n",
      "  - Hypothesis 1: \"BRCA1 – is associated with – Breast Cancer\"\n",
      "  - Hypothesis 2: \"BRCA1 – regulates – DNA Repair Mechanisms\"\n",
      "- Action: Use the ScientistAgent to generate these initial hypotheses based on the data from the KG.\n",
      "\n",
      "**Step 3: Perform individual iterative refinement for each hypothesis**\n",
      "- For Hypothesis 1: \"BRCA1 – is associated with – Breast Cancer\"\n",
      "  - a. Utilize KGAgent to explore existing evidence in the knowledge graph backing this association.\n",
      "  - b. Use PubMedAgent to search for recent literature and studies relating BRCA1 to Breast Cancer.\n",
      "  - c. Employ CriticAgent to assess the validity and relevance of the gathered data.\n",
      "  - d. Use RevisionAgent to make necessary adjustments to the hypothesis based on the critique.\n",
      "  - e. RefineAgent will finalize the hypothesis by consolidating all the information and insights gained.\n",
      "  \n",
      "- For Hypothesis 2: \"BRCA1 – regulates – DNA Repair Mechanisms\"\n",
      "  - a. Initiate a query with KGAgent to confirm how BRCA1 is involved in DNA repair within the knowledge graph.\n",
      "  - b. Use PubMedAgent to find relevant publications detailing the role of BRCA1 in DNA repair mechanisms.\n",
      "  - c. Analyze the findings with CriticAgent to ensure credibility and relevance.\n",
      "  - d. Collaborate with RevisionAgent to reformulate the hypothesis if needed.\n",
      "  - e. End with RefineAgent to finalize this hypothesis based on the collected evidence.\n",
      "\n",
      "**Step 4: Output a final decision (via DecisionAgent)**\n",
      "- Task: Collect all the refined hypotheses and their supporting evidence, and provide a synthesized decision on the validity and significance of each hypothesis.\n",
      "- Action: Use DecisionAgent to analyze the final refined hypotheses and present a coherent conclusion regarding their potential impact on understanding BRCA1-related research.\n",
      "\n",
      "This structured plan ensures a thorough investigation into BRCA1, enabling the generation of valid and meaningful hypotheses rooted in the latest scientific evidence.\n",
      "\n",
      "[Neo4j Call] Querying Neo4j with keyword: 'BRCA1'\n",
      "[Neo4j Output] Aggregated KG Summary:\n",
      "BRCA1 --[disease_disease | parent-child]--> BTC\n",
      "BTC --[disease_disease | parent-child]--> BRCA1\n",
      "BRCA1 --[phenotype_protein | associated with]--> Abnormality of chromosome stability, Chromosome breakage\n",
      "Chromosome breakage --[phenotype_protein | associated with]--> BRCA1\n",
      "Abnormality of chromosome stability --[phenotype_protein | associated with]--> BRCA1\n",
      "BRCA1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, ITGAM, IVL, LAGE3, NOS1, PPP2CA, Pseudoaneurysm, RNA binding, RNA polymerase binding, enzyme binding, tubulin binding\n",
      "PPP2CA --[molfunc_protein | interacts with]--> BRCA1\n",
      "IVL --[molfunc_protein | interacts with]--> BRCA1\n",
      "ADGRE5 --[molfunc_protein | interacts with]--> BRCA1\n",
      "ITGAM --[molfunc_protein | interacts with]--> BRCA1\n",
      "LAGE3 --[molfunc_protein | interacts with]--> BRCA1\n",
      "NOS1 --[molfunc_protein | interacts with]--> BRCA1\n",
      "RNA binding --[molfunc_protein | interacts with]--> BRCA1\n",
      "enzyme binding --[molfunc_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[cellcomp_protein | interacts with]--> ADRA2B, Abnormal pulmonary fissure morphology, BRCA1-A complex, CALD1, HTRA1, Increased pitch variability of speech, MS4A1, PRPS2, PSMB6, PTGFR, RAD23A, dysraphism-cleft lip/palate-limb reduction defects syndrome, ribonucleoprotein complex\n",
      "ADRA2B --[cellcomp_protein | interacts with]--> BRCA1\n",
      "HTRA1 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "RAD23A --[cellcomp_protein | interacts with]--> BRCA1\n",
      "PRPS2 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "CALD1 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "PSMB6 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "MS4A1 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[pathway_protein | interacts with]--> Defective DNA double strand break response due to BARD1 loss of function, Defective DNA double strand break response due to BRCA1 loss of function, G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Meiotic recombination, Meiotic synapsis, Metalloprotease DUBs, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA), SUMOylation of DNA damage response and repair proteins, TP53 Regulates Transcription of DNA Repair Genes, Transcriptional Regulation by E2F6\n",
      "Meiotic synapsis --[pathway_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[exposure_protein | interacts with]--> DDT\n",
      "DDT --[exposure_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "NDUFS2 --[anatomy_protein_absent | expression absent]--> BRCA1\n",
      "BRCA1 --[protein_protein | ppi]--> AURKA, BRCA2, CCNB1, CDK2, CHEK1, E2F1, EGR1, ETS2, HNRNPA2B1, INPP1, KAT5, MYC, PIK3R1, PRPF3, SF1, SKP2, SP1, SUMO1, TERF2, TUBGCP5\n",
      "BRCA1 --[disease_protein | associated with]--> AHCYL1, BAG2, BRAP, CLASP2, CSH1, ETS1, GLUL, KHK, MAPK9, OPRM1, PDCL, PDGFRB, PEX10, PGAM1, PGAM2, PMS2P1, PRL, RNF2, SEMG1, SLC14A2\n",
      "BRCA1 --[bioprocess_protein | interacts with]--> C6, CCL13, CCT4, CYRIB, DDX39A, DNAJB11, HSD17B6, LARP7, SARS1, SAT1, SEC62, SNRPD2, THBS3, TLR3, TXNIP, cellular response to tumor necrosis factor, negative regulation of centriole replication, positive regulation of histone H4-K20 methylation, protein K6-linked ubiquitination, protein autoubiquitination\n",
      "BRCA1 --[anatomy_protein_present | expression present]--> A2M, ACTN4, ATF3, CD33, CD36, CDC27, CDK2, CDX1, CISH, COL8A1, COL8A2, E2F3, E2F4, E2F5, EPB42, ERN1, ETS1, ETS2, KRT83, PTK2B\n",
      "\n",
      "[DiseaseExplorer Output]\n",
      "BRCA1 --[disease_disease | parent-child]--> BTC\n",
      "BTC --[disease_disease | parent-child]--> BRCA1\n",
      "BRCA1 --[phenotype_protein | associated with]--> Abnormality of chromosome stability, Chromosome breakage\n",
      "Chromosome breakage --[phenotype_protein | associated with]--> BRCA1\n",
      "Abnormality of chromosome stability --[phenotype_protein | associated with]--> BRCA1\n",
      "BRCA1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, ITGAM, IVL, LAGE3, NOS1, PPP2CA, Pseudoaneurysm, RNA binding, RNA polymerase binding, enzyme binding, tubulin binding\n",
      "PPP2CA --[molfunc_protein | interacts with]--> BRCA1\n",
      "IVL --[molfunc_protein | interacts with]--> BRCA1\n",
      "ADGRE5 --[molfunc_protein | interacts with]--> BRCA1\n",
      "ITGAM --[molfunc_protein | interacts with]--> BRCA1\n",
      "LAGE3 --[molfunc_protein | interacts with]--> BRCA1\n",
      "NOS1 --[molfunc_protein | interacts with]--> BRCA1\n",
      "RNA binding --[molfunc_protein | interacts with]--> BRCA1\n",
      "enzyme binding --[molfunc_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[cellcomp_protein | interacts with]--> ADRA2B, Abnormal pulmonary fissure morphology, BRCA1-A complex, CALD1, HTRA1, Increased pitch variability of speech, MS4A1, PRPS2, PSMB6, PTGFR, RAD23A, dysraphism-cleft lip/palate-limb reduction defects syndrome, ribonucleoprotein complex\n",
      "ADRA2B --[cellcomp_protein | interacts with]--> BRCA1\n",
      "HTRA1 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "RAD23A --[cellcomp_protein | interacts with]--> BRCA1\n",
      "PRPS2 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "CALD1 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "PSMB6 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "MS4A1 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[pathway_protein | interacts with]--> Defective DNA double strand break response due to BARD1 loss of function, Defective DNA double strand break response due to BRCA1 loss of function, G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Meiotic recombination, Meiotic synapsis, Metalloprotease DUBs, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA), SUMOylation of DNA damage response and repair proteins, TP53 Regulates Transcription of DNA Repair Genes, Transcriptional Regulation by E2F6\n",
      "Meiotic synapsis --[pathway_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[exposure_protein | interacts with]--> DDT\n",
      "DDT --[exposure_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "NDUFS2 --[anatomy_protein_absent | expression absent]--> BRCA1\n",
      "BRCA1 --[protein_protein | ppi]--> AURKA, BRCA2, CCNB1, CDK2, CHEK1, E2F1, EGR1, ETS2, HNRNPA2B1, INPP1, KAT5, MYC, PIK3R1, PRPF3, SF1, SKP2, SP1, SUMO1, TERF2, TUBGCP5\n",
      "BRCA1 --[disease_protein | associated with]--> AHCYL1, BAG2, BRAP, CLASP2, CSH1, ETS1, GLUL, KHK, MAPK9, OPRM1, PDCL, PDGFRB, PEX10, PGAM1, PGAM2, PMS2P1, PRL, RNF2, SEMG1, SLC14A2\n",
      "BRCA1 --[bioprocess_protein | interacts with]--> C6, CCL13, CCT4, CYRIB, DDX39A, DNAJB11, HSD17B6, LARP7, SARS1, SAT1, SEC62, SNRPD2, THBS3, TLR3, TXNIP, cellular response to tumor necrosis factor, negative regulation of centriole replication, positive regulation of histone H4-K20 methylation, protein K6-linked ubiquitination, protein autoubiquitination\n",
      "BRCA1 --[anatomy_protein_present | expression present]--> A2M, ACTN4, ATF3, CD33, CD36, CDC27, CDK2, CDX1, CISH, COL8A1, COL8A2, E2F3, E2F4, E2F5, EPB42, ERN1, ETS1, ETS2, KRT83, PTK2B\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "- 'BRCA1 may affect chromosome stability through interaction with PPP2CA'\n",
      "- 'DDT exposure may influence BRCA1 expression through its interaction with BRCA1'"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">2</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">1403</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">35</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0002</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0002</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0006</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m2\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m1403\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m35\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0002\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0002\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0006\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Scientist Output]\n",
      "- 'BRCA1 may affect chromosome stability through interaction with PPP2CA'\n",
      "- 'DDT exposure may influence BRCA1 expression through its interaction with BRCA1'\n",
      "\n",
      "--- Processing Hypothesis: - 'BRCA1 may affect chromosome stability through interaction with PPP2CA' ---\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BRCA1, chromosome stability, interaction, PPP2CA"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">2</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">158</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">13</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0000</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0000</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0006</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m2\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m158\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m13\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0000\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0000\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0006\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[KeywordExtractor Output]\n",
      "BRCA1, chromosome stability, interaction, PPP2CA\n",
      "\n",
      "[Neo4j Call] Querying Neo4j with keyword: 'BRCA1'\n",
      "[Neo4j Output] Aggregated KG Summary:\n",
      "BRCA1 --[disease_disease | parent-child]--> BTC\n",
      "BTC --[disease_disease | parent-child]--> BRCA1\n",
      "BRCA1 --[phenotype_protein | associated with]--> Abnormality of chromosome stability, Chromosome breakage\n",
      "Chromosome breakage --[phenotype_protein | associated with]--> BRCA1\n",
      "Abnormality of chromosome stability --[phenotype_protein | associated with]--> BRCA1\n",
      "BRCA1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, ITGAM, IVL, LAGE3, NOS1, PPP2CA, Pseudoaneurysm, RNA binding, RNA polymerase binding, enzyme binding, tubulin binding\n",
      "PPP2CA --[molfunc_protein | interacts with]--> BRCA1\n",
      "IVL --[molfunc_protein | interacts with]--> BRCA1\n",
      "ADGRE5 --[molfunc_protein | interacts with]--> BRCA1\n",
      "ITGAM --[molfunc_protein | interacts with]--> BRCA1\n",
      "LAGE3 --[molfunc_protein | interacts with]--> BRCA1\n",
      "NOS1 --[molfunc_protein | interacts with]--> BRCA1\n",
      "RNA binding --[molfunc_protein | interacts with]--> BRCA1\n",
      "enzyme binding --[molfunc_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[cellcomp_protein | interacts with]--> ADRA2B, Abnormal pulmonary fissure morphology, BRCA1-A complex, CALD1, HTRA1, Increased pitch variability of speech, MS4A1, PRPS2, PSMB6, PTGFR, RAD23A, dysraphism-cleft lip/palate-limb reduction defects syndrome, ribonucleoprotein complex\n",
      "ADRA2B --[cellcomp_protein | interacts with]--> BRCA1\n",
      "HTRA1 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "RAD23A --[cellcomp_protein | interacts with]--> BRCA1\n",
      "PRPS2 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "CALD1 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "PSMB6 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "MS4A1 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[pathway_protein | interacts with]--> Defective DNA double strand break response due to BARD1 loss of function, Defective DNA double strand break response due to BRCA1 loss of function, G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Meiotic recombination, Meiotic synapsis, Metalloprotease DUBs, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA), SUMOylation of DNA damage response and repair proteins, TP53 Regulates Transcription of DNA Repair Genes, Transcriptional Regulation by E2F6\n",
      "Meiotic synapsis --[pathway_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[exposure_protein | interacts with]--> DDT\n",
      "DDT --[exposure_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "NDUFS2 --[anatomy_protein_absent | expression absent]--> BRCA1\n",
      "BRCA1 --[protein_protein | ppi]--> AURKA, BRCA2, CCNB1, CDK2, CHEK1, E2F1, EGR1, ETS2, HNRNPA2B1, INPP1, KAT5, MYC, PIK3R1, PRPF3, SF1, SKP2, SP1, SUMO1, TERF2, TUBGCP5\n",
      "BRCA1 --[disease_protein | associated with]--> AHCYL1, BAG2, BRAP, CLASP2, CSH1, ETS1, GLUL, KHK, MAPK9, OPRM1, PDCL, PDGFRB, PEX10, PGAM1, PGAM2, PMS2P1, PRL, RNF2, SEMG1, SLC14A2\n",
      "BRCA1 --[bioprocess_protein | interacts with]--> C6, CCL13, CCT4, CYRIB, DDX39A, DNAJB11, HSD17B6, LARP7, SARS1, SAT1, SEC62, SNRPD2, THBS3, TLR3, TXNIP, cellular response to tumor necrosis factor, negative regulation of centriole replication, positive regulation of histone H4-K20 methylation, protein K6-linked ubiquitination, protein autoubiquitination\n",
      "BRCA1 --[anatomy_protein_present | expression present]--> A2M, ACTN4, ATF3, CD33, CD36, CDC27, CDK2, CDX1, CISH, COL8A1, COL8A2, E2F3, E2F4, E2F5, EPB42, ERN1, ETS1, ETS2, KRT83, PTK2B\n",
      "\n",
      "[KGAgent Output] Extended KG info for hypothesis:\n",
      "BRCA1 --[disease_disease | parent-child]--> BTC\n",
      "BTC --[disease_disease | parent-child]--> BRCA1\n",
      "BRCA1 --[phenotype_protein | associated with]--> Abnormality of chromosome stability, Chromosome breakage\n",
      "Chromosome breakage --[phenotype_protein | associated with]--> BRCA1\n",
      "Abnormality of chromosome stability --[phenotype_protein | associated with]--> BRCA1\n",
      "BRCA1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, ITGAM, IVL, LAGE3, NOS1, PPP2CA, Pseudoaneurysm, RNA binding, RNA polymerase binding, enzyme binding, tubulin binding\n",
      "PPP2CA --[molfunc_protein | interacts with]--> BRCA1\n",
      "IVL --[molfunc_protein | interacts with]--> BRCA1\n",
      "ADGRE5 --[molfunc_protein | interacts with]--> BRCA1\n",
      "ITGAM --[molfunc_protein | interacts with]--> BRCA1\n",
      "LAGE3 --[molfunc_protein | interacts with]--> BRCA1\n",
      "NOS1 --[molfunc_protein | interacts with]--> BRCA1\n",
      "RNA binding --[molfunc_protein | interacts with]--> BRCA1\n",
      "enzyme binding --[molfunc_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[cellcomp_protein | interacts with]--> ADRA2B, Abnormal pulmonary fissure morphology, BRCA1-A complex, CALD1, HTRA1, Increased pitch variability of speech, MS4A1, PRPS2, PSMB6, PTGFR, RAD23A, dysraphism-cleft lip/palate-limb reduction defects syndrome, ribonucleoprotein complex\n",
      "ADRA2B --[cellcomp_protein | interacts with]--> BRCA1\n",
      "HTRA1 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "RAD23A --[cellcomp_protein | interacts with]--> BRCA1\n",
      "PRPS2 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "CALD1 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "PSMB6 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "MS4A1 --[cellcomp_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[pathway_protein | interacts with]--> Defective DNA double strand break response due to BARD1 loss of function, Defective DNA double strand break response due to BRCA1 loss of function, G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Meiotic recombination, Meiotic synapsis, Metalloprotease DUBs, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA), SUMOylation of DNA damage response and repair proteins, TP53 Regulates Transcription of DNA Repair Genes, Transcriptional Regulation by E2F6\n",
      "Meiotic synapsis --[pathway_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[exposure_protein | interacts with]--> DDT\n",
      "DDT --[exposure_protein | interacts with]--> BRCA1\n",
      "BRCA1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "NDUFS2 --[anatomy_protein_absent | expression absent]--> BRCA1\n",
      "BRCA1 --[protein_protein | ppi]--> AURKA, BRCA2, CCNB1, CDK2, CHEK1, E2F1, EGR1, ETS2, HNRNPA2B1, INPP1, KAT5, MYC, PIK3R1, PRPF3, SF1, SKP2, SP1, SUMO1, TERF2, TUBGCP5\n",
      "BRCA1 --[disease_protein | associated with]--> AHCYL1, BAG2, BRAP, CLASP2, CSH1, ETS1, GLUL, KHK, MAPK9, OPRM1, PDCL, PDGFRB, PEX10, PGAM1, PGAM2, PMS2P1, PRL, RNF2, SEMG1, SLC14A2\n",
      "BRCA1 --[bioprocess_protein | interacts with]--> C6, CCL13, CCT4, CYRIB, DDX39A, DNAJB11, HSD17B6, LARP7, SARS1, SAT1, SEC62, SNRPD2, THBS3, TLR3, TXNIP, cellular response to tumor necrosis factor, negative regulation of centriole replication, positive regulation of histone H4-K20 methylation, protein K6-linked ubiquitination, protein autoubiquitination\n",
      "BRCA1 --[anatomy_protein_present | expression present]--> A2M, ACTN4, ATF3, CD33, CD36, CDC27, CDK2, CDX1, CISH, COL8A1, COL8A2, E2F3, E2F4, E2F5, EPB42, ERN1, ETS1, ETS2, KRT83, PTK2B\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BRCA1, chromosome stability, PPP2CA"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">2</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">158</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">11</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0000</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0000</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0007</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m2\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m158\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m11\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0000\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0000\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0007\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[KeywordExtractor Output]\n",
      "BRCA1, chromosome stability, PPP2CA\n",
      "\n",
      "[PubMed] For hypothesis, extracted keywords: ['BRCA1', 'chromosome stability', 'PPP2CA']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['BRCA1', 'chromosome stability']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['BRCA1', 'PPP2CA']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['chromosome stability', 'PPP2CA']\n",
      "[PubMed Output] Aggregated Literature Evidence:\n",
      "{\"id\": \"39955949\", \"title\": \"TIPIN is essential for chromosome stability and cell viability in BRCA1-deficient cells.\", \"abstract\": \"The mutations of breast cancer type 1 susceptibility gene (BRCA1) cause hereditary breast cancer. One of the medical revolutions of cancer therapy for BRCA1-mutated breast cancer is the drug approval of Poly (ADP-ribose) polymerase (PARP) inhibitors because of the synthetic lethal interaction between BRCA1 mutation and PARP inhibition. Here, we report another synthetic lethal interaction between BRCA1 and TIMELESS interacting protein (TIPIN), the latter of which encodes a protein involved in DNA replication, DNA damage checkpoint and sister chromatid cohesion. Cells deficient for both BRCA1 and TIPIN die due to elevated chromosomal aberrations including chromosomal breaks and radial chromosomes. The synthetic lethality of TIPIN/BRCA1-deficient cells is restored by the depletion of Tumor protein p53 binding protein 1 (53BP1), which prevents homologous recombination (HR) by its restricting DNA processing. Thus, spontaneous DNA lesions in TIPIN deficient cells could be preferentially repaired by BRCA1-mediated HR pathway. The viability of TIPIN/53BP1/BRCA1 triple mutant is lost by the depletion of Ring finger protein 8 (RNF8) E3-ubiquitin ligase, implicating that RNF8-mediated sub-HR pathway may work in a complementary manner of BRCA1 and 53BP1 pathway.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39955949/\"}\n",
      "{\"id\": \"39500552\", \"title\": \"TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality.\", \"abstract\": \"PARP inhibitors (PARPi) have been licensed for the maintenance therapy of patients with metastatic pancreatic cancer carrying pathogenic germline BRCA1/2 mutations. However, mutations in BRCA1/2 are notably rare in pancreatic cancer. There is a significant unmet clinical need to broaden the utility of PARPi. RNA sequencing was performed to screen potential targets for PARPi sensitivity. The synthetic lethal effects were verified in patient-derived xenograft (PDX), xenograft and patient-derived organoid models. Mechanisms were explored via LC‒MS/MS, coimmunoprecipitation, laser microirradiation, immunofluorescence, the homologous recombination (HR) or non-homologous end joining (NHEJ) reporter system, in situ proximity ligation assay and live-cell time-lapse imaging analyses. Targeting protein for Xenopus kinesin-like protein 2 (TPX2) is an exploitable vulnerability. TPX2 was downregulated in PDX models sensitive to PARPi, and TPX2 inhibition conferred synthetic lethality to PARPi both  Our findings revealed the dual-functional significance of TPX2 in controlling DNA DSB repair pathway choice and mitotic progression, suggesting a potential therapeutic strategy involving PARPi for patients with pancreatic cancer.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39500552/\"}\n",
      "{\"id\": \"39705313\", \"title\": \"Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1.\", \"abstract\": \"Taxanes are frequently used anticancer drugs known to kill tumor cells by inducing mitotic aberrations and segregation defects. A defining feature of specific cancers, notably triple-negative breast cancer (TNBC) and particularly those deficient in BRCA1, is chromosomal instability (CIN). Here, we focused on understanding the mechanisms of docetaxel-induced cytotoxicity, especially in the context of BRCA1-deficient TNBC. Using functional genetic screens in CIN+ cells, we identified genes that mediate docetaxel response and found an interaction between Huntingtin (HTT) and BRCA1-associated protein-1 (BAP1). We employed \", \"pub_date\": \"2024\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39705313/\"}\n",
      "{\"id\": \"39484366\", \"title\": \"Deletions Rate-Limit Breast and Ovarian Cancer Initiation.\", \"abstract\": \"Optimizing prevention and early detection of cancer requires understanding the number, types and timing of driver mutations. To quantify this, we exploited the elevated cancer incidence and mutation rates in germline \", \"pub_date\": \"2024\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39484366/\"}\n",
      "{\"id\": \"39112709\", \"title\": \"The genomic landscape of 2,023 colorectal cancers.\", \"abstract\": \"Colorectal carcinoma (CRC) is a common cause of mortality\", \"pub_date\": \"2024\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39112709/\"}\n",
      "{\"id\": \"38838792\", \"title\": \"Pre-pubertal obesity compromises ovarian oxidative stress, DNA repair and chemical biotransformation.\", \"abstract\": \"Obesity in adult females impairs fertility by altering oxidative stress, DNA repair and chemical biotransformation. Whether prepubertal obesity results in similar ovarian impacts is under-explored. The objective of this study was to induce obesity in prepubertal female mice and assess puberty onset, follicle number, and abundance of oxidative stress, DNA repair and chemical biotransformation proteins basally and in response to 7,12-dimethylbenz(a)anthracene (DMBA) exposure. DMBA is a polycyclic aromatic hydrocarbon that has been shown to be ovotoxic. Lactating dams (C57BL6J) were fed either a normal rodent containing 3.5% kCal from fat (lean), or a high fat diet comprised of 60% kCal from fat, and 9% kCal from sucrose. The offspring were weaned onto the diet of their dam and exposed at postnatal day 35 to either corn oil or DMBA (1 mg/kg) for 7 d via intraperitoneal injection. Mice on the HFD had reduced (P < 0.05) age at puberty onset as measured by vaginal opening but DMBA did not impact puberty onset. Heart, spleen, kidney, uterus and ovary weight were increased (P < 0.05) by obesity and liver weight was increased (P < 0.05) by DMBA exposure in obese mice. Follicle number was largely unaffected by obesity or DMBA exposure, with the exception of primary follicle number, which were higher (P < 0.05) in lean DMBA exposed and obese control relative to lean control mice. There were also greater numbers (P < 0.05) of corpora lutea in obese relative to lean mice. In lean mice, DMBA exposure reduced (P < 0.05) the level of CYP2E1, EPHX1, GSTP1, BRCA1, and CAT but this DMBA-induced reduction was absent in obese mice. Basally, obesity reduced (P < 0.05) the abundance of CYP2E1, EPHX1, GSTP1, BRCA1, SOD1 and CAT. There was greater (P < 0.05) fibrotic staining in obese DMBA-exposed ovaries and PPP2CA was decreased (P < 0.05) in growing follicles by both obesity and DMBA exposure. Thus, prepubertal obesity alters the capacity of the ovary to respond to DNA damage, ovotoxicant exposure and oxidative stress.\", \"pub_date\": \"2024\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/38838792/\"}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. Scientific Plausibility: The hypothesis that BRCA1 may affect chromosome stability through interaction with PPP2CA is scientifically plausible. BRCA1 is known to be involved in DNA repair mechanisms and maintaining chromosome stability, while PPP2CA is a protein phosphatase that can influence various cellular processes, including those related to DNA damage response. Their interaction suggests a potential pathway for BRCA1's role in chromosome stability.\n",
      "\n",
      "2. Novelty: The hypothesis introduces a new dimension by highlighting the interaction between BRCA1 and PPP2CA, which, while both proteins are known to be involved in cellular processes related to DNA repair, has not been extensively explored in the context of chromosome stability. This aspect lends it a degree of novelty.\n",
      "\n",
      "3. Testability: The hypothesis is testable as it can be verified through experimental approaches such as co-immunoprecipitation to confirm the interaction between BRCA1 and PPP2CA, and functional assays to assess chromosome stability in cell lines with manipulated levels of these proteins.\n",
      "\n",
      "4. Clinical/Biological Relevance: The potential implications of this hypothesis are significant, as understanding the role of BRCA1 and its interactions could lead to better diagnostic markers for cancer susceptibility and novel therapeutic targets, particularly in BRCA1-associated cancers.\n",
      "\n",
      "5. Confidence & Reliability: The supporting literature provides a solid foundation, with evidence linking BRCA1 mutations to chromosome instability and highlighting interactions with various proteins, including PPP2CA. However, the specific interaction between BRCA1 and PPP2CA requires more direct evidence.\n",
      "\n",
      "6. Technical Clarity & Completeness: The hypothesis is presented clearly and logically connects previous findings about BRCA1 and PPP2CA. However, more context about the specific mechanisms or pathways involved would enhance the overall clarity and completeness.\n",
      "\n",
      "Overall Score: 8\n",
      "\n",
      "Feedback: This hypothesis is well-founded and presents an interesting avenue for exploration that could yield important insights into the roles of BRCA1 and PPP2CA in chromosome stability and cancer biology. Further research is necessary to validate the interaction and its implications for chromosome stability and cancer susceptibility."
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">2</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">3184</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">418</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0007</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0007</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0014</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m2\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m3184\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m418\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0007\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0007\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0014\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Critic Output]\n",
      "1. Scientific Plausibility: The hypothesis that BRCA1 may affect chromosome stability through interaction with PPP2CA is scientifically plausible. BRCA1 is known to be involved in DNA repair mechanisms and maintaining chromosome stability, while PPP2CA is a protein phosphatase that can influence various cellular processes, including those related to DNA damage response. Their interaction suggests a potential pathway for BRCA1's role in chromosome stability.\n",
      "\n",
      "2. Novelty: The hypothesis introduces a new dimension by highlighting the interaction between BRCA1 and PPP2CA, which, while both proteins are known to be involved in cellular processes related to DNA repair, has not been extensively explored in the context of chromosome stability. This aspect lends it a degree of novelty.\n",
      "\n",
      "3. Testability: The hypothesis is testable as it can be verified through experimental approaches such as co-immunoprecipitation to confirm the interaction between BRCA1 and PPP2CA, and functional assays to assess chromosome stability in cell lines with manipulated levels of these proteins.\n",
      "\n",
      "4. Clinical/Biological Relevance: The potential implications of this hypothesis are significant, as understanding the role of BRCA1 and its interactions could lead to better diagnostic markers for cancer susceptibility and novel therapeutic targets, particularly in BRCA1-associated cancers.\n",
      "\n",
      "5. Confidence & Reliability: The supporting literature provides a solid foundation, with evidence linking BRCA1 mutations to chromosome instability and highlighting interactions with various proteins, including PPP2CA. However, the specific interaction between BRCA1 and PPP2CA requires more direct evidence.\n",
      "\n",
      "6. Technical Clarity & Completeness: The hypothesis is presented clearly and logically connects previous findings about BRCA1 and PPP2CA. However, more context about the specific mechanisms or pathways involved would enhance the overall clarity and completeness.\n",
      "\n",
      "Overall Score: 8\n",
      "\n",
      "Feedback: This hypothesis is well-founded and presents an interesting avenue for exploration that could yield important insights into the roles of BRCA1 and PPP2CA in chromosome stability and cancer biology. Further research is necessary to validate the interaction and its implications for chromosome stability and cancer susceptibility.\n",
      "\n",
      "[Critic] Extracted Overall Score: 8.0\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "neo4j:BRCA1,PPP2CA,chromosome stability,pathways,mechanisms"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">2</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">692</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">21</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0001</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0001</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0015</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m2\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m692\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m21\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0001\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0001\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0015\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Revision Decision Output]\n",
      "neo4j:BRCA1,PPP2CA,chromosome stability,pathways,mechanisms\n",
      "\n",
      "[Neo4j Call] Querying Neo4j with keyword: 'BRCA1 --[disease_disease | parent-child]--> BTC\n",
      "BRCA1 --[phenotype_protein | associated with]--> Abnormality of chromosome stability, Chromosome breakage\n",
      "BRCA1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, ITGAM, IVL, LAGE3, NOS1, PPP2CA, Pseudoaneurysm, RNA binding, RNA polymerase binding, enzyme binding, tubulin binding\n",
      "BRCA1 --[cellcomp_protein | interacts with]--> ADRA2B, Abnormal pulmonary fissure morphology, BRCA1-A complex, CALD1, HTRA1, Increased pitch variability of speech, MS4A1, PRPS2, PSMB6, PTGFR, RAD23A, dysraphism-cleft lip/palate-limb reduction defects syndrome, ribonucleoprotein complex\n",
      "BRCA1 --[pathway_protein | interacts with]--> Defective DNA double strand break response due to BARD1 loss of function, Defective DNA double strand break response due to BRCA1 loss of function, G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Meiotic recombination, Meiotic synapsis, Metalloprotease DUBs, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA), SUMOylation of DNA damage response and repair proteins, TP53 Regulates Transcription of DNA Repair Genes, Transcriptional Regulation by E2F6\n",
      "BRCA1 --[exposure_protein | interacts with]--> DDT\n",
      "BRCA1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "BRCA1 --[protein_protein | ppi]--> AURKA, BARD1, BRAP, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, HNRNPA2B1, INPP1, JUN, JUND, KAT5, MAPK14, MYC, PCNA, PIK3R1, PLK1, PPP1CA, PRPF3, RPS2, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "BRCA1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "BRCA1 --[disease_protein | associated with]--> BRAP, ETS1\n",
      "PPP2CA --[cellcomp_protein | interacts with]--> PRPS2, RAD23A\n",
      "PPP2CA --[protein_protein | ppi]--> CDK2, CSNK2B, EGR1, EP300, ETS1, JUN, MAPK14, MYC, SMAD3, UBC\n",
      "PPP2CA --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PPP2CA --[molfunc_molfunc | parent-child]--> enzyme binding\n",
      "PPP2CA --[molfunc_protein | interacts with]--> ADGRE5, ADRA2B, AURKA, BARD1, BRAP, BRCA1, BRCA2, BTC, CALD1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, IVL, JUN, JUND, KAT5, LAGE3, MAPK14, MS4A1, MYC, NDUFS2, NOS1, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, RPS2, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "BTC --[protein_protein | ppi]--> GATA1\n",
      "BTC --[disease_disease | parent-child]--> BRCA1\n",
      "BTC --[molfunc_protein | interacts with]--> PPP2CA\n",
      "BTC --[cellcomp_protein | interacts with]--> RAD23A\n",
      "BTC --[disease_phenotype_positive | phenotype present]--> KAT5\n",
      "BTC --[anatomy_protein_present | expression present]--> ETS1, ETS2\n",
      "Chromosome breakage --[phenotype_protein | associated with]--> BRCA1, MYC\n",
      "Chromosome breakage --[phenotype_phenotype | parent-child]--> Abnormality of chromosome stability\n",
      "Abnormality of chromosome stability --[phenotype_protein | associated with]--> BRCA1, MYC\n",
      "Abnormality of chromosome stability --[phenotype_phenotype | parent-child]--> Chromosome breakage\n",
      "IVL --[cellcomp_protein | interacts with]--> PTGFR, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "IVL --[molfunc_protein | interacts with]--> BRCA1, EP300, KAT5, PPP2CA\n",
      "IVL --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "ADGRE5 --[cellcomp_protein | interacts with]--> RAD23A\n",
      "ADGRE5 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "ADGRE5 --[anatomy_protein_present | expression present]--> CDK2, E2F3, ETS1, ETS2\n",
      "ADGRE5 --[molfunc_protein | interacts with]--> BRCA1, CCNT1, EGR1, ETS1, GATA1, HNF4A, JUN, JUND, PPP2CA, SMAD3, SP1, SPI1\n",
      "ITGAM --[cellcomp_protein | interacts with]--> RAD23A\n",
      "ITGAM --[molfunc_molfunc | parent-child]--> DNA binding\n",
      "ITGAM --[protein_protein | ppi]--> SP1, SPI1\n",
      "ITGAM --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "ITGAM --[molfunc_protein | interacts with]--> BRCA1, EP300, PCNA, PPP2CA, RAD23A\n",
      "LAGE3 --[protein_protein | ppi]--> UBC\n",
      "LAGE3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "LAGE3 --[molfunc_protein | interacts with]--> BRAP, BRCA1, EGR1, EP300, GATA1, HNF4A, PPP2CA, SF1, SMAD3\n",
      "LAGE3 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "NOS1 --[protein_protein | ppi]--> EGR1, SUMO1, UBC\n",
      "NOS1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1\n",
      "NOS1 --[molfunc_protein | interacts with]--> BARD1, BRAP, BRCA1, PPP2CA\n",
      "NOS1 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2, PTGFR, RAD23A\n",
      "RNA binding --[disease_disease | parent-child]--> JUN\n",
      "RNA binding --[molfunc_molfunc | parent-child]--> JUN, JUND\n",
      "RNA binding --[molfunc_protein | interacts with]--> BARD1, BRCA1, CDKN2A, CSTF1, EIF3B, HNRNPA2B1, JUN, PRPF3, RPS2, SF1, SPI1, SUMO1, SUMO2, UBC, UBE2I\n",
      "enzyme binding --[molfunc_molfunc | parent-child]--> PPP2CA, RNA polymerase binding\n",
      "enzyme binding --[molfunc_protein | interacts with]--> BRCA1, JUN, JUND, MAPK14, PCNA, RPS2, SUMO1, TERF2, UBE2I\n",
      "RNA polymerase binding --[molfunc_protein | interacts with]--> BRCA1, CCNT1\n",
      "RNA polymerase binding --[molfunc_molfunc | parent-child]--> enzyme binding\n",
      "DNA binding --[molfunc_molfunc | parent-child]--> ITGAM\n",
      "DNA binding --[molfunc_protein | interacts with]--> BRCA1, CCNT1, E2F1, E2F4, EGR1, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, JUN, MYC, SP1, TERF1\n",
      "tubulin binding --[molfunc_protein | interacts with]--> BRCA1\n",
      "Pseudoaneurysm --[molfunc_protein | interacts with]--> AURKA, BRCA1, JUN, NDUFS2, SMAD3, SUMO1, SUMO2, UBC\n",
      "ADRA2B --[molfunc_protein | interacts with]--> PPP2CA\n",
      "ADRA2B --[anatomy_protein_present | expression present]--> E2F3, ETS1\n",
      "ADRA2B --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "ADRA2B --[cellcomp_protein | interacts with]--> BARD1, BRAP, BRCA1, RAD23A\n",
      "HTRA1 --[protein_protein | ppi]--> CSNK2B\n",
      "HTRA1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "HTRA1 --[cellcomp_protein | interacts with]--> AURKA, BARD1, BRAP, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EP300, ETS1, ETS2, GATA1, HNF4A, HNRNPA2B1, JUN, JUND, KAT5, LAGE3, MAPK14, MS4A1, MYC, NDUFS2, NOS1, PCNA, PLK1, PPP1CA, PRPF3, PSMB6, RAD23A, RPS2, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, UBC, UBE2I\n",
      "HTRA1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "RAD23A --[molfunc_protein | interacts with]--> ITGAM, PPP2CA\n",
      "RAD23A --[protein_protein | ppi]--> CCNA2, CCNB1, CHEK1, EP300, GATA1, MYC, UBC\n",
      "RAD23A --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "RAD23A --[cellcomp_protein | interacts with]--> ADGRE5, ADRA2B, Abnormal pulmonary fissure morphology, BRCA1, BTC, CALD1, CSNK2A1, CSNK2B, ETS2, HTRA1, ITGAM, JUN, MS4A1, NOS1, PIK3R1, PPP1CA, PPP2CA, PRPS2, PTGFR, SMAD3, STAT2, SUMO1, UBC\n",
      "PRPS2 --[protein_protein | ppi]--> UBC\n",
      "PRPS2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PRPS2 --[cellcomp_protein | interacts with]--> AURKA, BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, E2F1, E2F3, EGR1, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, HNRNPA2B1, JUN, KAT5, LAGE3, MAPK14, MYC, NOS1, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PSMB6, PTGFR, RAD23A, RPS2, SF1, SKP2, SMAD3, SP1, SPI1, SUMO1, SUMO2, TERF1, TERF2, UBC, UBE2I\n",
      "PRPS2 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "CALD1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CALD1 --[protein_protein | ppi]--> CDK2, TERF1\n",
      "CALD1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CALD1 --[cellcomp_protein | interacts with]--> BRCA1, BRCA2, RAD23A\n",
      "PSMB6 --[disease_disease | parent-child]--> EP300\n",
      "PSMB6 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PSMB6 --[protein_protein | ppi]--> PLK1, UBC\n",
      "PSMB6 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PSMB6 --[cellcomp_protein | interacts with]--> BRCA1, EP300, HTRA1, PRPS2, PTGFR\n",
      "MS4A1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "MS4A1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "MS4A1 --[protein_protein | ppi]--> SPI1\n",
      "MS4A1 --[anatomy_protein_present | expression present]--> ETS2\n",
      "MS4A1 --[cellcomp_protein | interacts with]--> BRCA1, HTRA1, RAD23A, TUBGCP5\n",
      "PTGFR --[anatomy_protein_present | expression present]--> ETS1\n",
      "PTGFR --[cellcomp_protein | interacts with]--> BARD1, BRAP, BRCA1, CCNA2, CCNB1, CDK2, CDKN2A, CHEK1, CSNK2B, E2F4, EGR1, ETS1, HNF4A, HNRNPA2B1, IVL, LAGE3, MAPK14, NOS1, PIK3R1, PLK1, PPP1CA, PRPS2, PSMB6, PTGFR, RAD23A, SMAD3, SP1, TERF1, UBC, UBE2I\n",
      "BRCA1-A complex --[cellcomp_protein | interacts with]--> BARD1, BRCA1\n",
      "Abnormal pulmonary fissure morphology --[cellcomp_cellcomp | parent-child]--> ribonucleoprotein complex\n",
      "Abnormal pulmonary fissure morphology --[cellcomp_protein | interacts with]--> BRCA1, BRCA2, CHEK1, E2F1, MYC, NOS1, RAD23A\n",
      "dysraphism-cleft lip/palate-limb reduction defects syndrome --[cellcomp_protein | interacts with]--> BRCA1, IVL, LAGE3, PCNA, SF1, SUMO1, TERF1, TERF2\n",
      "ribonucleoprotein complex --[cellcomp_cellcomp | parent-child]--> Abnormal pulmonary fissure morphology\n",
      "ribonucleoprotein complex --[cellcomp_protein | interacts with]--> BRCA1, HNRNPA2B1\n",
      "Increased pitch variability of speech --[cellcomp_protein | interacts with]--> BARD1, BRCA1\n",
      "Meiotic synapsis --[pathway_protein | interacts with]--> BRCA1, H2AC4, TERF1, TERF2, UBE2I\n",
      "Meiotic recombination --[pathway_protein | interacts with]--> BRCA1, BRCA2, CDK2, H2AC4\n",
      "Transcriptional Regulation by E2F6 --[pathway_protein | interacts with]--> BRCA1, CHEK1, E2F1\n",
      "SUMOylation of DNA damage response and repair proteins --[pathway_protein | interacts with]--> BRCA1, CDKN2A, SUMO1, SUMO2, UBE2I\n",
      "TP53 Regulates Transcription of DNA Repair Genes --[pathway_protein | interacts with]--> BRCA1, CCNT1, CHEK1, JUN\n",
      "Regulation of TP53 Activity through Phosphorylation --[pathway_protein | interacts with]--> AURKA, BARD1, BRCA1, CCNA2, CDK2, CHEK1, CSNK2A1, CSNK2B, KAT5, MAPK14, UBC\n",
      "Metalloprotease DUBs --[pathway_protein | interacts with]--> BARD1, BRCA1, EP300, H2AC4, UBC\n",
      "Nonhomologous End-Joining (NHEJ) --[pathway_protein | interacts with]--> BARD1, BRCA1, KAT5, SUMO1\n",
      "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5\n",
      "Resolution of D-loop Structures through Holliday Junction Intermediates --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5\n",
      "HDR through Single Strand Annealing (SSA) --[pathway_protein | interacts with]--> BARD1, BRCA1, KAT5\n",
      "Processing of DNA double-strand break ends --[pathway_protein | interacts with]--> BARD1, BRCA1, CCNA2, CDK2, CHEK1, KAT5, SUMO1, SUMO2, UBC, UBE2I\n",
      "Presynaptic phase of homologous DNA pairing and strand exchange --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, CHEK1, KAT5\n",
      "Presynaptic phase of homologous DNA pairing and strand exchange --[pathway_pathway | parent-child]--> Homologous DNA Pairing and Strand Exchange\n",
      "Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks --[pathway_protein | interacts with]--> BARD1, BRCA1, KAT5, SUMO1, UBC, UBE2I\n",
      "Defective DNA double strand break response due to BRCA1 loss of function --[pathway_protein | interacts with]--> BARD1, BRCA1\n",
      "Defective DNA double strand break response due to BARD1 loss of function --[pathway_protein | interacts with]--> BARD1, BRCA1\n",
      "HDR through Homologous Recombination (HRR) --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5, PCNA, UBC\n",
      "HDR through Homologous Recombination (HRR) --[pathway_pathway | parent-child]--> Homologous DNA Pairing and Strand Exchange\n",
      "Homologous DNA Pairing and Strand Exchange --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5\n",
      "Homologous DNA Pairing and Strand Exchange --[pathway_pathway | parent-child]--> HDR through Homologous Recombination (HRR), Presynaptic phase of homologous DNA pairing and strand exchange\n",
      "G2/M DNA damage checkpoint --[pathway_protein | interacts with]--> BARD1, BRCA1, CHEK1, KAT5, SUMO1\n",
      "DDT --[exposure_protein | interacts with]--> BRCA1\n",
      "NDUFS2 --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm\n",
      "NDUFS2 --[cellcomp_protein | interacts with]--> HTRA1\n",
      "NDUFS2 --[protein_protein | ppi]--> MYC\n",
      "NDUFS2 --[anatomy_protein_absent | expression absent]--> ADGRE5, ADRA2B, AURKA, BARD1, BRCA1, CCNB1, CDK2, CHEK1, E2F1, E2F3, GATA1, IVL, MS4A1, SPI1\n",
      "NDUFS2 --[anatomy_protein_present | expression present]--> BRAP, CALD1, CDK2, CSNK2A1, E2F3, E2F4, EIF3B, EP300, ETS1, ETS2, HNRNPA2B1, HTRA1, INPP1, JUN, JUND, MAPK14, NDUFS2, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PSMB6, RAD23A, SF1, SKP2, SP1, STAT2, TERF1, TERF2, UBC, UBE2I\n",
      "EGR1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, LAGE3, PPP2CA\n",
      "EGR1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "EGR1 --[protein_protein | ppi]--> BRCA1, CCNT1, CDK2, CDKN2A, EP300, ETS1, ETS2, JUN, JUND, NOS1, PPP2CA, RPS2, SMAD3, SP1, SUMO1, UBC\n",
      "EGR1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "EGR1 --[disease_protein | associated with]--> BRAP\n",
      "MYC --[phenotype_protein | associated with]--> Abnormality of chromosome stability, Chromosome breakage\n",
      "MYC --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2\n",
      "MYC --[protein_protein | ppi]--> AURKA, BRCA1, BRCA2, CCNB1, CCNT1, CDKN2A, CSNK2A1, CSTF1, E2F1, E2F4, EIF3B, EP300, GATA1, HNF4A, JUN, KAT5, MAPK14, NDUFS2, PLK1, PPP2CA, RAD23A, RPS2, SKP2, SMAD3, SP1, UBC\n",
      "MYC --[anatomy_protein_present | expression present]--> CDK2, E2F3, ETS1, ETS2\n",
      "MYC --[disease_protein | associated with]--> BRAP\n",
      "MYC --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "TUBGCP5 --[protein_protein | ppi]--> BRCA1, ETS1, UBC\n",
      "TUBGCP5 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "TUBGCP5 --[cellcomp_protein | interacts with]--> MS4A1\n",
      "TUBGCP5 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "CCNB1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CCNB1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "CCNB1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "CCNB1 --[protein_protein | ppi]--> BRCA1, CCNA2, CDK2, E2F4, EP300, ETS1, MYC, PCNA, PLK1, RAD23A, SKP2, SP1, UBC\n",
      "CCNB1 --[anatomy_protein_present | expression present]--> ETS1, ETS2\n",
      "CDK2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CDK2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "CDK2 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "CDK2 --[protein_protein | ppi]--> BARD1, BRCA1, BRCA2, CALD1, CCNA2, CCNB1, CHEK1, E2F1, E2F4, EGR1, EP300, H2AC4, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, SKP2, SMAD3, SP1, TERF2, UBC\n",
      "CDK2 --[pathway_protein | interacts with]--> Meiotic recombination, Processing of DNA double-strand break ends, Regulation of TP53 Activity through Phosphorylation\n",
      "CDK2 --[anatomy_protein_present | expression present]--> ADGRE5, BARD1, BRAP, BRCA1, CALD1, CCNT1, CSNK2A1, E2F1, E2F3, E2F4, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NDUFS2, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SMAD3, STAT2, TERF1, TERF2, UBC, UBE2I\n",
      "PIK3R1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PIK3R1 --[cellcomp_protein | interacts with]--> PRPS2, PTGFR, RAD23A\n",
      "PIK3R1 --[protein_protein | ppi]--> AURKA, BRCA1, CDK2, CHEK1, CSNK2A1, E2F4, EP300, ETS1, GATA1, UBC\n",
      "PIK3R1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PIK3R1 --[disease_protein | associated with]--> BRAP\n",
      "ETS2 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "ETS2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A\n",
      "ETS2 --[protein_protein | ppi]--> BRCA1, EGR1, EP300, ETS1, JUN, SPI1, UBC\n",
      "ETS2 --[anatomy_protein_present | expression present]--> ADGRE5, AURKA, BARD1, BRAP, BRCA1, BRCA2, BTC, CALD1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSTF1, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, MS4A1, MYC, NDUFS2, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "SP1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "SP1 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNA2, CCNB1, CDK2, CDKN2A, E2F1, E2F3, EGR1, EP300, ETS1, GATA1, H2AC4, HNF4A, ITGAM, JUN, MAPK14, MYC, SKP2, SMAD3, SUMO1, UBC\n",
      "SP1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA\n",
      "SP1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "AURKA --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm\n",
      "AURKA --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "AURKA --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "AURKA --[protein_protein | ppi]--> BARD1, BRCA1, E2F4, EP300, HNF4A, MYC, PIK3R1, PLK1, PPP1CA, SUMO1, UBC, UBE2I\n",
      "AURKA --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "AURKA --[disease_protein | associated with]--> BRAP\n",
      "AURKA --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "KAT5 --[disease_phenotype_positive | phenotype present]--> BTC\n",
      "KAT5 --[molfunc_protein | interacts with]--> IVL, PPP2CA\n",
      "KAT5 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "KAT5 --[protein_protein | ppi]--> BARD1, BRCA1, CDKN2A, E2F1, E2F4, EP300, ETS1, MAPK14, MYC, SUMO1, UBC, UBE2I\n",
      "KAT5 --[pathway_protein | interacts with]--> G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\n",
      "KAT5 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "INPP1 --[protein_protein | ppi]--> BRCA1\n",
      "INPP1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "INPP1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PRPF3 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "PRPF3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "PRPF3 --[protein_protein | ppi]--> BRCA1, CDK2, CHEK1, CSNK2A1, SUMO2, UBC\n",
      "PRPF3 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "SF1 --[molfunc_protein | interacts with]--> LAGE3, PPP2CA, RNA binding\n",
      "SF1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "SF1 --[protein_protein | ppi]--> BRCA1, UBC\n",
      "SF1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "E2F1 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "E2F1 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2\n",
      "E2F1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "E2F1 --[protein_protein | ppi]--> BRCA1, CCNA2, CDK2, CDKN2A, CSTF1, E2F3, E2F4, EP300, JUND, KAT5, MYC, SKP2, SP1, UBC\n",
      "E2F1 --[pathway_protein | interacts with]--> Transcriptional Regulation by E2F6\n",
      "E2F1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "BRCA2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "BRCA2 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, CALD1, HTRA1, PRPS2\n",
      "BRCA2 --[pathway_protein | interacts with]--> HDR through Homologous Recombination (HRR), Homologous DNA Pairing and Strand Exchange, Meiotic recombination, Presynaptic phase of homologous DNA pairing and strand exchange, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\n",
      "BRCA2 --[protein_protein | ppi]--> BARD1, BRCA1, CCNA2, CDK2, E2F4, ETS1, MYC, PCNA, PLK1, SKP2, SMAD3, SP1, UBC\n",
      "BRCA2 --[anatomy_protein_present | expression present]--> ETS2\n",
      "BRCA2 --[disease_protein | associated with]--> BRAP\n",
      "SKP2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "SKP2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "SKP2 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNA2, CCNB1, CDK2, E2F1, E2F4, EP300, MAPK14, MYC, PPP1CA, SP1, UBC\n",
      "SKP2 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "HNRNPA2B1 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "HNRNPA2B1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, ribonucleoprotein complex\n",
      "HNRNPA2B1 --[protein_protein | ppi]--> BRCA1, CHEK1, CSNK2A1, CSNK2B, SUMO1, SUMO2, UBC\n",
      "HNRNPA2B1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "SUMO1 --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm, RNA binding, enzyme binding\n",
      "SUMO1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "SUMO1 --[protein_protein | ppi]--> AURKA, BRCA1, E2F4, EGR1, ETS1, GATA1, H2AC4, HNRNPA2B1, JUN, KAT5, NOS1, PCNA, SP1, SUMO2, UBC, UBE2I\n",
      "SUMO1 --[pathway_protein | interacts with]--> G2/M DNA damage checkpoint, Nonhomologous End-Joining (NHEJ), Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, SUMOylation of DNA damage response and repair proteins\n",
      "SUMO1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "CHEK1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CHEK1 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2, PTGFR\n",
      "CHEK1 --[pathway_protein | interacts with]--> G2/M DNA damage checkpoint, Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Regulation of TP53 Activity through Phosphorylation, TP53 Regulates Transcription of DNA Repair Genes, Transcriptional Regulation by E2F6\n",
      "CHEK1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "CHEK1 --[protein_protein | ppi]--> BRCA1, CDK2, CSNK2A1, CSNK2B, E2F3, E2F4, ETS1, HNRNPA2B1, PCNA, PIK3R1, PRPF3, RAD23A, UBC\n",
      "CHEK1 --[anatomy_protein_present | expression present]--> ETS1, ETS2\n",
      "TERF2 --[molfunc_protein | interacts with]--> PPP2CA, enzyme binding\n",
      "TERF2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "TERF2 --[pathway_protein | interacts with]--> Meiotic synapsis\n",
      "TERF2 --[protein_protein | ppi]--> BRCA1, CDK2, EP300, TERF1, UBC, UBE2I\n",
      "TERF2 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "ETS1 --[disease_protein | associated with]--> BRCA1\n",
      "ETS1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA\n",
      "ETS1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "ETS1 --[protein_protein | ppi]--> BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F4, EGR1, EP300, ETS2, HNF4A, JUN, JUND, KAT5, MAPK14, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, RPS2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TUBGCP5, UBC, UBE2I\n",
      "ETS1 --[anatomy_protein_present | expression present]--> ADGRE5, ADRA2B, AURKA, BARD1, BRAP, BRCA1, BTC, CALD1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NDUFS2, NOS1, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, PTGFR, RAD23A, RPS2, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "TERF1 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "TERF1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "TERF1 --[pathway_protein | interacts with]--> Meiotic synapsis\n",
      "TERF1 --[protein_protein | ppi]--> BRCA1, CALD1, CSNK2A1, EP300, PLK1, TERF2, UBC\n",
      "TERF1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "H2AC4 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "H2AC4 --[cellcomp_protein | interacts with]--> PRPS2\n",
      "H2AC4 --[pathway_protein | interacts with]--> Meiotic recombination, Meiotic synapsis, Metalloprotease DUBs\n",
      "H2AC4 --[protein_protein | ppi]--> BRCA1, CDK2, EP300, GATA1, JUN, JUND, SP1, SUMO1, UBC\n",
      "GATA1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "GATA1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "GATA1 --[protein_protein | ppi]--> BRCA1, BTC, CSTF1, EP300, H2AC4, JUN, MYC, PIK3R1, PLK1, RAD23A, SMAD3, SP1, SPI1, SUMO1, UBC\n",
      "GATA1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, LAGE3, PPP2CA\n",
      "CSNK2B --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CSNK2B --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "CSNK2B --[protein_protein | ppi]--> BRCA1, CHEK1, CSNK2A1, E2F4, ETS1, HNRNPA2B1, HTRA1, JUN, MAPK14, PPP1CA, PPP2CA, SPI1, SUMO2, UBC\n",
      "CSNK2B --[anatomy_protein_present | expression present]--> E2F3, ETS1\n",
      "CSNK2B --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "PPP1CA --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PPP1CA --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "PPP1CA --[protein_protein | ppi]--> AURKA, BRCA1, CDK2, CSNK2B, ETS1, SKP2, UBC\n",
      "PPP1CA --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PCNA --[molfunc_protein | interacts with]--> ITGAM, PPP2CA, enzyme binding\n",
      "PCNA --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "PCNA --[protein_protein | ppi]--> BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CDK2, CHEK1, CSTF1, E2F4, EP300, ETS1, SUMO1, SUMO2, UBC\n",
      "PCNA --[pathway_protein | interacts with]--> HDR through Homologous Recombination (HRR)\n",
      "PCNA --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "SUMO2 --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm, RNA binding\n",
      "SUMO2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "SUMO2 --[pathway_protein | interacts with]--> Processing of DNA double-strand break ends, SUMOylation of DNA damage response and repair proteins\n",
      "SUMO2 --[protein_protein | ppi]--> BRCA1, CSNK2B, EP300, ETS1, HNRNPA2B1, JUN, JUND, PCNA, PRPF3, SUMO1, UBC, UBE2I\n",
      "SUMO2 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "SMAD3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "SMAD3 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNT1, CDK2, E2F4, EGR1, EP300, ETS1, GATA1, HNF4A, JUN, JUND, MYC, PPP2CA, SP1, UBC\n",
      "SMAD3 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "SMAD3 --[molfunc_protein | interacts with]--> ADGRE5, LAGE3, PPP2CA, Pseudoaneurysm\n",
      "E2F4 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "E2F4 --[cellcomp_protein | interacts with]--> HTRA1, PTGFR\n",
      "E2F4 --[protein_protein | ppi]--> AURKA, BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CHEK1, CSNK2B, CSTF1, E2F1, E2F3, EP300, ETS1, KAT5, MYC, PCNA, PIK3R1, PLK1, SKP2, SMAD3, STAT2, SUMO1, UBC\n",
      "E2F4 --[anatomy_protein_present | expression present]--> AURKA, BARD1, BRAP, BRCA1, CALD1, CCNA2, CCNT1, CDK2, CDKN2A, CSNK2A1, CSTF1, E2F1, E2F3, EGR1, EIF3B, EP300, ETS1, ETS2, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, NDUFS2, NOS1, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "UBE2I --[molfunc_protein | interacts with]--> PPP2CA, RNA binding, enzyme binding\n",
      "UBE2I --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "UBE2I --[protein_protein | ppi]--> AURKA, BRCA1, CDKN2A, EP300, ETS1, HNF4A, JUN, KAT5, SUMO1, SUMO2, TERF2, UBC\n",
      "UBE2I --[pathway_protein | interacts with]--> Meiotic synapsis, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, SUMOylation of DNA damage response and repair proteins\n",
      "UBE2I --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "E2F3 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "E2F3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "E2F3 --[protein_protein | ppi]--> BRCA1, CHEK1, E2F1, E2F4, SP1\n",
      "E2F3 --[anatomy_protein_present | expression present]--> ADGRE5, ADRA2B, AURKA, BARD1, BRAP, BRCA1, CALD1, CCNT1, CDK2, CDKN2A, CSNK2A1, CSNK2B, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NDUFS2, NOS1, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, RPS2, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "E2F3 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "SPI1 --[molfunc_protein | interacts with]--> ADGRE5, PPP2CA, RNA binding\n",
      "SPI1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "SPI1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "SPI1 --[protein_protein | ppi]--> BRCA1, CSNK2A1, CSNK2B, ETS1, ETS2, GATA1, ITGAM, JUN, MS4A1\n",
      "SPI1 --[anatomy_protein_present | expression present]--> E2F3, ETS1\n",
      "EP300 --[disease_disease | parent-child]--> PSMB6\n",
      "EP300 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PSMB6\n",
      "EP300 --[protein_protein | ppi]--> AURKA, BRCA1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, E2F1, E2F4, EGR1, EIF3B, ETS1, ETS2, GATA1, H2AC4, HNF4A, JUN, JUND, KAT5, MAPK14, MYC, PCNA, PIK3R1, PLK1, PPP2CA, RAD23A, SKP2, SMAD3, SP1, STAT2, SUMO2, TERF1, TERF2, UBC, UBE2I\n",
      "EP300 --[pathway_protein | interacts with]--> Metalloprotease DUBs\n",
      "EP300 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "EP300 --[molfunc_protein | interacts with]--> DNA binding, ITGAM, IVL, LAGE3, PPP2CA\n",
      "STAT2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "STAT2 --[cellcomp_protein | interacts with]--> HTRA1, RAD23A\n",
      "STAT2 --[protein_protein | ppi]--> BRCA1, E2F4, EP300, ETS1, UBC\n",
      "STAT2 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CSTF1 --[protein_protein | ppi]--> BARD1, BRCA1, E2F1, E2F4, ETS1, GATA1, HNF4A, MYC, PCNA, UBC\n",
      "CSTF1 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "CSTF1 --[cellcomp_protein | interacts with]--> HTRA1\n",
      "CSTF1 --[anatomy_protein_present | expression present]--> E2F4, ETS1, ETS2\n",
      "UBC --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm, RNA binding\n",
      "UBC --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "UBC --[protein_protein | ppi]--> AURKA, BARD1, BRAP, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, GATA1, H2AC4, HNRNPA2B1, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NOS1, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, RPS2, SF1, SKP2, SMAD3, SP1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBE2I\n",
      "UBC --[pathway_protein | interacts with]--> HDR through Homologous Recombination (HRR), Metalloprotease DUBs, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation\n",
      "UBC --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "MAPK14 --[molfunc_protein | interacts with]--> PPP2CA, enzyme binding\n",
      "MAPK14 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "MAPK14 --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "MAPK14 --[protein_protein | ppi]--> BRCA1, CDKN2A, CSNK2A1, CSNK2B, EP300, ETS1, HNF4A, JUN, KAT5, MYC, PPP2CA, SKP2, SP1, UBC\n",
      "MAPK14 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CDKN2A --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "CDKN2A --[cellcomp_protein | interacts with]--> PRPS2, PTGFR\n",
      "CDKN2A --[pathway_protein | interacts with]--> SUMOylation of DNA damage response and repair proteins\n",
      "CDKN2A --[protein_protein | ppi]--> BRCA1, E2F1, EGR1, EP300, KAT5, MAPK14, MYC, SP1, UBC, UBE2I\n",
      "CDKN2A --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "JUND --[cellcomp_protein | interacts with]--> HTRA1\n",
      "JUND --[molfunc_molfunc | parent-child]--> RNA binding\n",
      "JUND --[protein_protein | ppi]--> BRCA1, E2F1, EGR1, EP300, ETS1, H2AC4, HNF4A, JUN, SMAD3, SUMO2, UBC\n",
      "JUND --[molfunc_protein | interacts with]--> ADGRE5, PPP2CA, enzyme binding\n",
      "JUND --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CCNA2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CCNA2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "CCNA2 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNB1, CDK2, E2F1, E2F4, EP300, ETS1, PCNA, RAD23A, SKP2, SP1, UBC\n",
      "CCNA2 --[pathway_protein | interacts with]--> Processing of DNA double-strand break ends, Regulation of TP53 Activity through Phosphorylation\n",
      "CCNA2 --[anatomy_protein_present | expression present]--> E2F4, ETS1, ETS2\n",
      "PLK1 --[protein_protein | ppi]--> AURKA, BRCA1, BRCA2, CCNB1, CCNT1, E2F4, EP300, ETS1, GATA1, MYC, PSMB6, TERF1, UBC\n",
      "PLK1 --[anatomy_protein_present | expression present]--> CDK2, ETS2\n",
      "PLK1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PLK1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "EIF3B --[disease_phenotype_positive | phenotype present]--> BARD1\n",
      "EIF3B --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "EIF3B --[protein_protein | ppi]--> BRCA1, EP300, MYC, UBC\n",
      "EIF3B --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CCNT1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA, RNA polymerase binding\n",
      "CCNT1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "CCNT1 --[pathway_protein | interacts with]--> TP53 Regulates Transcription of DNA Repair Genes\n",
      "CCNT1 --[protein_protein | ppi]--> BRCA1, E2F4, EGR1, EP300, ETS1, MYC, PLK1, SMAD3, UBC\n",
      "CCNT1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "HNF4A --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, LAGE3, PPP2CA\n",
      "HNF4A --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "HNF4A --[protein_protein | ppi]--> AURKA, BRCA1, CSTF1, EP300, ETS1, JUND, MAPK14, MYC, SMAD3, SP1, UBE2I\n",
      "HNF4A --[anatomy_protein_present | expression present]--> CDK2, E2F3, ETS1, ETS2\n",
      "BRAP --[molfunc_protein | interacts with]--> LAGE3, NOS1, PPP2CA\n",
      "BRAP --[cellcomp_protein | interacts with]--> ADRA2B, HTRA1, PTGFR\n",
      "BRAP --[protein_protein | ppi]--> BRCA1, UBC\n",
      "BRAP --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "BRAP --[disease_protein | associated with]--> AURKA, BRCA1, BRCA2, EGR1, MYC, PIK3R1\n",
      "CSNK2A1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CSNK2A1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A\n",
      "CSNK2A1 --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "CSNK2A1 --[protein_protein | ppi]--> BRCA1, CHEK1, CSNK2B, ETS1, HNRNPA2B1, JUN, MAPK14, MYC, PIK3R1, PRPF3, SPI1, TERF1, UBC\n",
      "CSNK2A1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "BARD1 --[molfunc_protein | interacts with]--> NOS1, PPP2CA, RNA binding\n",
      "BARD1 --[cellcomp_protein | interacts with]--> ADRA2B, BRCA1-A complex, HTRA1, Increased pitch variability of speech, PRPS2, PTGFR\n",
      "BARD1 --[pathway_protein | interacts with]--> Defective DNA double strand break response due to BARD1 loss of function, Defective DNA double strand break response due to BRCA1 loss of function, G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Metalloprotease DUBs, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\n",
      "BARD1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "BARD1 --[protein_protein | ppi]--> AURKA, BRCA1, BRCA2, CDK2, CSTF1, E2F4, ETS1, KAT5, PCNA, UBC\n",
      "BARD1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "BARD1 --[disease_phenotype_positive | phenotype present]--> EIF3B\n",
      "JUN --[disease_disease | parent-child]--> RNA binding\n",
      "JUN --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A\n",
      "JUN --[pathway_protein | interacts with]--> TP53 Regulates Transcription of DNA Repair Genes\n",
      "JUN --[molfunc_molfunc | parent-child]--> RNA binding\n",
      "JUN --[protein_protein | ppi]--> BRCA1, CSNK2A1, CSNK2B, EGR1, EP300, ETS1, ETS2, GATA1, H2AC4, JUND, MAPK14, MYC, PPP2CA, SMAD3, SP1, SPI1, SUMO1, SUMO2, UBC, UBE2I\n",
      "JUN --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "JUN --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA, Pseudoaneurysm, RNA binding, enzyme binding\n",
      "RPS2 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding, enzyme binding\n",
      "RPS2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "RPS2 --[protein_protein | ppi]--> BRCA1, EGR1, ETS1, MYC, UBC\n",
      "RPS2 --[anatomy_protein_present | expression present]--> E2F3, ETS1'\n",
      "[Neo4j Output] Aggregated KG Summary:\n",
      "\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Refined Hypothesis:\n",
      "- 'BRCA1 affects chromosome stability through its interaction with PPP2CA, which is involved in multiple pathways related to DNA damage response, including G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ). Furthermore, mutations or dysfunctions in BRCA1 can lead to abnormalities in chromosome stability and breakage, thereby implicating a direct relationship between BRCA1, PPP2CA, and chromosome integrity.'"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">2</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">15051</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">93</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0023</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0023</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0038</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m2\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m15051\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m93\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0023\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0023\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0038\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Refine Output]\n",
      "Refined Hypothesis:\n",
      "- 'BRCA1 affects chromosome stability through its interaction with PPP2CA, which is involved in multiple pathways related to DNA damage response, including G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ). Furthermore, mutations or dysfunctions in BRCA1 can lead to abnormalities in chromosome stability and breakage, thereby implicating a direct relationship between BRCA1, PPP2CA, and chromosome integrity.'\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. Scientific Plausibility: The refined hypothesis is scientifically plausible, as it aligns well with existing knowledge that BRCA1 is critical for DNA repair mechanisms and chromosome stability. The involvement of PPP2CA in pathways related to DNA damage response, including G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ), further supports the plausibility of this interaction.\n",
      "\n",
      "2. Novelty: While interactions between BRCA1 and DNA repair pathways are documented, the specific focus on PPP2CA as a mediator of chromosome stability through BRCA1 presents a novel angle that has not been thoroughly explored in current literature. This adds a degree of innovation to the hypothesis.\n",
      "\n",
      "3. Testability: The hypothesis is testable through various experimental methods. Specifically, co-immunoprecipitation experiments can be designed to confirm the interaction between BRCA1 and PPP2CA. Additionally, functional assays can assess the effects of BRCA1 and PPP2CA manipulation on chromosome stability.\n",
      "\n",
      "4. Clinical/Biological Relevance: The potential implications for cancer therapy and diagnostics are significant. Given the known role of BRCA1 mutations in hereditary cancers, understanding its interactions with PPP2CA could enhance targeted therapies and improve patient outcomes in cancers associated with BRCA1 mutations.\n",
      "\n",
      "5. Confidence & Reliability: The supporting evidence from the literature is robust, indicating that BRCA1 is associated with chromosome stability and that PPP2CA is involved in DNA damage response pathways. However, empirical evidence directly linking BRCA1 and PPP2CA in this context would strengthen confidence in the hypothesis.\n",
      "\n",
      "6. Technical Clarity & Completeness: The revised hypothesis is articulated clearly and logically outlines the proposed relationships. It effectively connects the roles of BRCA1 and PPP2CA in maintaining chromosome integrity, although it could benefit from additional details on the mechanisms of interaction.\n",
      "\n",
      "Overall Score: 9\n",
      "\n",
      "Feedback: The refined hypothesis presents a compelling and well-supported proposition about the role of BRCA1 and its interaction with PPP2CA in regulating chromosome stability. It opens avenues for further exploration into the mechanisms behind DNA damage response, especially in the context of BRCA1-related cancers. Further experimental verification is necessary to establish the interactions and their implications fully."
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">4</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">6746</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">446</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0013</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0020</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0051</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m4\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m6746\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m446\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0013\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0020\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0051\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Critic Output]\n",
      "1. Scientific Plausibility: The refined hypothesis is scientifically plausible, as it aligns well with existing knowledge that BRCA1 is critical for DNA repair mechanisms and chromosome stability. The involvement of PPP2CA in pathways related to DNA damage response, including G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ), further supports the plausibility of this interaction.\n",
      "\n",
      "2. Novelty: While interactions between BRCA1 and DNA repair pathways are documented, the specific focus on PPP2CA as a mediator of chromosome stability through BRCA1 presents a novel angle that has not been thoroughly explored in current literature. This adds a degree of innovation to the hypothesis.\n",
      "\n",
      "3. Testability: The hypothesis is testable through various experimental methods. Specifically, co-immunoprecipitation experiments can be designed to confirm the interaction between BRCA1 and PPP2CA. Additionally, functional assays can assess the effects of BRCA1 and PPP2CA manipulation on chromosome stability.\n",
      "\n",
      "4. Clinical/Biological Relevance: The potential implications for cancer therapy and diagnostics are significant. Given the known role of BRCA1 mutations in hereditary cancers, understanding its interactions with PPP2CA could enhance targeted therapies and improve patient outcomes in cancers associated with BRCA1 mutations.\n",
      "\n",
      "5. Confidence & Reliability: The supporting evidence from the literature is robust, indicating that BRCA1 is associated with chromosome stability and that PPP2CA is involved in DNA damage response pathways. However, empirical evidence directly linking BRCA1 and PPP2CA in this context would strengthen confidence in the hypothesis.\n",
      "\n",
      "6. Technical Clarity & Completeness: The revised hypothesis is articulated clearly and logically outlines the proposed relationships. It effectively connects the roles of BRCA1 and PPP2CA in maintaining chromosome integrity, although it could benefit from additional details on the mechanisms of interaction.\n",
      "\n",
      "Overall Score: 9\n",
      "\n",
      "Feedback: The refined hypothesis presents a compelling and well-supported proposition about the role of BRCA1 and its interaction with PPP2CA in regulating chromosome stability. It opens avenues for further exploration into the mechanisms behind DNA damage response, especially in the context of BRCA1-related cancers. Further experimental verification is necessary to establish the interactions and their implications fully.\n",
      "\n",
      "[Critic] Extracted Overall Score: 9.0\n",
      "[Critic] Hypothesis accepted: Refined Hypothesis:\n",
      "- 'BRCA1 affects chromosome stability through its interaction with PPP2CA, which is involved in multiple pathways related to DNA damage response, including G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ). Furthermore, mutations or dysfunctions in BRCA1 can lead to abnormalities in chromosome stability and breakage, thereby implicating a direct relationship between BRCA1, PPP2CA, and chromosome integrity.'\n",
      "--- Processing Hypothesis: - 'DDT exposure may influence BRCA1 expression through its interaction with BRCA1' ---\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DDT, exposure, BRCA1, expression, interaction"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">2</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">161</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">13</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0000</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0000</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0051</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m2\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m161\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m13\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0000\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0000\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0051\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[KeywordExtractor Output]\n",
      "DDT, exposure, BRCA1, expression, interaction\n",
      "\n",
      "[Neo4j Call] Querying Neo4j with keyword: 'DDT'\n",
      "[Neo4j Output] Aggregated KG Summary:\n",
      "DDT --[protein_protein | ppi]--> UBC\n",
      "UBC --[protein_protein | ppi]--> DDT\n",
      "DDT --[disease_disease | parent-child]--> Abnormality of the cervical spine, melanoma\n",
      "Abnormality of the cervical spine --[disease_disease | parent-child]--> DDT\n",
      "melanoma --[disease_disease | parent-child]--> DDT\n",
      "DDT --[cellcomp_cellcomp | parent-child]--> cellular anatomical entity\n",
      "cellular anatomical entity --[cellcomp_cellcomp | parent-child]--> DDT\n",
      "DDT --[molfunc_protein | interacts with]--> D-dopachrome decarboxylase activity, PCSK2, orbitofrontal cortex, phenylpyruvate tautomerase activity\n",
      "PCSK2 --[molfunc_protein | interacts with]--> DDT\n",
      "D-dopachrome decarboxylase activity --[molfunc_protein | interacts with]--> DDT\n",
      "phenylpyruvate tautomerase activity --[molfunc_protein | interacts with]--> DDT\n",
      "orbitofrontal cortex --[molfunc_protein | interacts with]--> DDT\n",
      "DDT --[cellcomp_protein | interacts with]--> CARF, CDKN2AIP, CLEC3B, FBL, NPM1, PTGFR, RRP1B, SURF6, extracellular exosome, plasmacytoma\n",
      "NPM1 --[cellcomp_protein | interacts with]--> DDT\n",
      "FBL --[cellcomp_protein | interacts with]--> DDT\n",
      "SURF6 --[cellcomp_protein | interacts with]--> DDT\n",
      "CDKN2AIP --[cellcomp_protein | interacts with]--> DDT\n",
      "PTGFR --[cellcomp_protein | interacts with]--> DDT\n",
      "CLEC3B --[cellcomp_protein | interacts with]--> DDT\n",
      "RRP1B --[cellcomp_protein | interacts with]--> DDT\n",
      "extracellular exosome --[cellcomp_protein | interacts with]--> DDT\n",
      "plasmacytoma --[cellcomp_protein | interacts with]--> DDT\n",
      "CARF --[cellcomp_protein | interacts with]--> DDT\n",
      "DDT --[bioprocess_protein | interacts with]--> Absent toe, Focal sensory seizure with hot-cold sensations, melanin biosynthetic process, positive regulation of ERK1 and ERK2 cascade, positive regulation of inflammatory response\n",
      "Absent toe --[bioprocess_protein | interacts with]--> DDT\n",
      "Focal sensory seizure with hot-cold sensations --[bioprocess_protein | interacts with]--> DDT\n",
      "positive regulation of inflammatory response --[bioprocess_protein | interacts with]--> DDT\n",
      "melanin biosynthetic process --[bioprocess_protein | interacts with]--> DDT\n",
      "positive regulation of ERK1 and ERK2 cascade --[bioprocess_protein | interacts with]--> DDT\n",
      "DDT --[anatomy_anatomy | parent-child]--> Abnormal myocardium morphology\n",
      "Abnormal myocardium morphology --[anatomy_anatomy | parent-child]--> DDT\n",
      "DDT --[anatomy_protein_present | expression present]--> A2M, ACTN4, ATF3, CD33, CD36, CDC27, CDK2, CISH, COL8A1, E2F3, E2F4, E2F5, E2F6, EDA, EGF, EPB42, ETS1, ETS2, KRT83, PTK2B\n",
      "BRCA1 --[exposure_protein | interacts with]--> DDT\n",
      "IGF2 --[exposure_protein | interacts with]--> DDT\n",
      "IGF1 --[exposure_protein | interacts with]--> DDT\n",
      "ZFPM2 --[exposure_protein | interacts with]--> DDT\n",
      "DDT --[exposure_protein | interacts with]--> BRCA1, IGF1, IGF2, ZFPM2\n",
      "PLCG1 --[exposure_disease | linked to]--> DDT\n",
      "OTX2 --[exposure_disease | linked to]--> DDT\n",
      "SH2D2A --[exposure_disease | linked to]--> DDT\n",
      "PTPRT --[exposure_disease | linked to]--> DDT\n",
      "SERPINF2 --[exposure_disease | linked to]--> DDT\n",
      "TCEA3 --[exposure_disease | linked to]--> DDT\n",
      "Metaphyseal sclerosis --[exposure_disease | linked to]--> DDT\n",
      "amyotrophic lateral sclerosis --[exposure_disease | linked to]--> DDT\n",
      "neoplasm (disease) --[exposure_disease | linked to]--> DDT\n",
      "non-Hodgkin lymphoma --[exposure_disease | linked to]--> DDT\n",
      "breast neoplasm --[exposure_disease | linked to]--> DDT\n",
      "glioma --[exposure_disease | linked to]--> DDT\n",
      "hyperthyroidism --[exposure_disease | linked to]--> DDT\n",
      "fatty liver disease --[exposure_disease | linked to]--> DDT\n",
      "hypothyroidism --[exposure_disease | linked to]--> DDT\n",
      "colonic neoplasm --[exposure_disease | linked to]--> DDT\n",
      "bronchitis --[exposure_disease | linked to]--> DDT\n",
      "pancreatic neoplasm --[exposure_disease | linked to]--> DDT\n",
      "DDT --[exposure_disease | linked to]--> OTX2, PLCG1\n",
      "Thyroxine --[exposure_exposure | parent-child]--> DDT\n",
      "25-hydroxyvitamin D --[exposure_exposure | parent-child]--> DDT\n",
      "DDT --[exposure_exposure | parent-child]--> 25-hydroxyvitamin D, Dichlorodiphenyl Dichloroethylene, Endocrine Disruptors, Environmental Pollutants, Hydrocarbons, Chlorinated, Insecticides, Organic Chemicals, Pesticides, Polychlorinated Biphenyls, Thyroxine\n",
      "Dichlorodiphenyl Dichloroethylene --[exposure_exposure | parent-child]--> DDT\n",
      "Endocrine Disruptors --[exposure_exposure | parent-child]--> DDT\n",
      "Environmental Pollutants --[exposure_exposure | parent-child]--> DDT\n",
      "Insecticides --[exposure_exposure | parent-child]--> DDT\n",
      "Pesticides --[exposure_exposure | parent-child]--> DDT\n",
      "Polychlorinated Biphenyls --[exposure_exposure | parent-child]--> DDT\n",
      "Hydrocarbons, Chlorinated --[exposure_exposure | parent-child]--> DDT\n",
      "Organic Chemicals --[exposure_exposure | parent-child]--> DDT\n",
      "PGRMC2 --[exposure_bioprocess | interacts with]--> DDT\n",
      "ZNHIT1 --[exposure_bioprocess | interacts with]--> DDT\n",
      "menarche --[exposure_bioprocess | interacts with]--> DDT\n",
      "mixed lobular and ductal breast carcinoma --[exposure_bioprocess | interacts with]--> DDT\n",
      "stutter disorder --[exposure_bioprocess | interacts with]--> DDT\n",
      "ovulation cycle process --[exposure_bioprocess | interacts with]--> DDT\n",
      "insulin metabolic process --[exposure_bioprocess | interacts with]--> DDT\n",
      "cognition --[exposure_bioprocess | interacts with]--> DDT\n",
      "changes to DNA methylation involved in embryo development --[exposure_bioprocess | interacts with]--> DDT\n",
      "genetic imprinting --[exposure_bioprocess | interacts with]--> DDT\n",
      "motor behavior --[exposure_bioprocess | interacts with]--> DDT\n",
      "memory --[exposure_bioprocess | interacts with]--> DDT\n",
      "adipose tissue development --[exposure_bioprocess | interacts with]--> DDT\n",
      "DDT --[exposure_bioprocess | interacts with]--> PGRMC2, ZNHIT1, insulin metabolic process, menarche, mixed lobular and ductal breast carcinoma, ovulation cycle process, stutter disorder\n",
      "\n",
      "[KGAgent Output] Extended KG info for hypothesis:\n",
      "DDT --[protein_protein | ppi]--> UBC\n",
      "UBC --[protein_protein | ppi]--> DDT\n",
      "DDT --[disease_disease | parent-child]--> Abnormality of the cervical spine, melanoma\n",
      "Abnormality of the cervical spine --[disease_disease | parent-child]--> DDT\n",
      "melanoma --[disease_disease | parent-child]--> DDT\n",
      "DDT --[cellcomp_cellcomp | parent-child]--> cellular anatomical entity\n",
      "cellular anatomical entity --[cellcomp_cellcomp | parent-child]--> DDT\n",
      "DDT --[molfunc_protein | interacts with]--> D-dopachrome decarboxylase activity, PCSK2, orbitofrontal cortex, phenylpyruvate tautomerase activity\n",
      "PCSK2 --[molfunc_protein | interacts with]--> DDT\n",
      "D-dopachrome decarboxylase activity --[molfunc_protein | interacts with]--> DDT\n",
      "phenylpyruvate tautomerase activity --[molfunc_protein | interacts with]--> DDT\n",
      "orbitofrontal cortex --[molfunc_protein | interacts with]--> DDT\n",
      "DDT --[cellcomp_protein | interacts with]--> CARF, CDKN2AIP, CLEC3B, FBL, NPM1, PTGFR, RRP1B, SURF6, extracellular exosome, plasmacytoma\n",
      "NPM1 --[cellcomp_protein | interacts with]--> DDT\n",
      "FBL --[cellcomp_protein | interacts with]--> DDT\n",
      "SURF6 --[cellcomp_protein | interacts with]--> DDT\n",
      "CDKN2AIP --[cellcomp_protein | interacts with]--> DDT\n",
      "PTGFR --[cellcomp_protein | interacts with]--> DDT\n",
      "CLEC3B --[cellcomp_protein | interacts with]--> DDT\n",
      "RRP1B --[cellcomp_protein | interacts with]--> DDT\n",
      "extracellular exosome --[cellcomp_protein | interacts with]--> DDT\n",
      "plasmacytoma --[cellcomp_protein | interacts with]--> DDT\n",
      "CARF --[cellcomp_protein | interacts with]--> DDT\n",
      "DDT --[bioprocess_protein | interacts with]--> Absent toe, Focal sensory seizure with hot-cold sensations, melanin biosynthetic process, positive regulation of ERK1 and ERK2 cascade, positive regulation of inflammatory response\n",
      "Absent toe --[bioprocess_protein | interacts with]--> DDT\n",
      "Focal sensory seizure with hot-cold sensations --[bioprocess_protein | interacts with]--> DDT\n",
      "positive regulation of inflammatory response --[bioprocess_protein | interacts with]--> DDT\n",
      "melanin biosynthetic process --[bioprocess_protein | interacts with]--> DDT\n",
      "positive regulation of ERK1 and ERK2 cascade --[bioprocess_protein | interacts with]--> DDT\n",
      "DDT --[anatomy_anatomy | parent-child]--> Abnormal myocardium morphology\n",
      "Abnormal myocardium morphology --[anatomy_anatomy | parent-child]--> DDT\n",
      "DDT --[anatomy_protein_present | expression present]--> A2M, ACTN4, ATF3, CD33, CD36, CDC27, CDK2, CISH, COL8A1, E2F3, E2F4, E2F5, E2F6, EDA, EGF, EPB42, ETS1, ETS2, KRT83, PTK2B\n",
      "BRCA1 --[exposure_protein | interacts with]--> DDT\n",
      "IGF2 --[exposure_protein | interacts with]--> DDT\n",
      "IGF1 --[exposure_protein | interacts with]--> DDT\n",
      "ZFPM2 --[exposure_protein | interacts with]--> DDT\n",
      "DDT --[exposure_protein | interacts with]--> BRCA1, IGF1, IGF2, ZFPM2\n",
      "PLCG1 --[exposure_disease | linked to]--> DDT\n",
      "OTX2 --[exposure_disease | linked to]--> DDT\n",
      "SH2D2A --[exposure_disease | linked to]--> DDT\n",
      "PTPRT --[exposure_disease | linked to]--> DDT\n",
      "SERPINF2 --[exposure_disease | linked to]--> DDT\n",
      "TCEA3 --[exposure_disease | linked to]--> DDT\n",
      "Metaphyseal sclerosis --[exposure_disease | linked to]--> DDT\n",
      "amyotrophic lateral sclerosis --[exposure_disease | linked to]--> DDT\n",
      "neoplasm (disease) --[exposure_disease | linked to]--> DDT\n",
      "non-Hodgkin lymphoma --[exposure_disease | linked to]--> DDT\n",
      "breast neoplasm --[exposure_disease | linked to]--> DDT\n",
      "glioma --[exposure_disease | linked to]--> DDT\n",
      "hyperthyroidism --[exposure_disease | linked to]--> DDT\n",
      "fatty liver disease --[exposure_disease | linked to]--> DDT\n",
      "hypothyroidism --[exposure_disease | linked to]--> DDT\n",
      "colonic neoplasm --[exposure_disease | linked to]--> DDT\n",
      "bronchitis --[exposure_disease | linked to]--> DDT\n",
      "pancreatic neoplasm --[exposure_disease | linked to]--> DDT\n",
      "DDT --[exposure_disease | linked to]--> OTX2, PLCG1\n",
      "Thyroxine --[exposure_exposure | parent-child]--> DDT\n",
      "25-hydroxyvitamin D --[exposure_exposure | parent-child]--> DDT\n",
      "DDT --[exposure_exposure | parent-child]--> 25-hydroxyvitamin D, Dichlorodiphenyl Dichloroethylene, Endocrine Disruptors, Environmental Pollutants, Hydrocarbons, Chlorinated, Insecticides, Organic Chemicals, Pesticides, Polychlorinated Biphenyls, Thyroxine\n",
      "Dichlorodiphenyl Dichloroethylene --[exposure_exposure | parent-child]--> DDT\n",
      "Endocrine Disruptors --[exposure_exposure | parent-child]--> DDT\n",
      "Environmental Pollutants --[exposure_exposure | parent-child]--> DDT\n",
      "Insecticides --[exposure_exposure | parent-child]--> DDT\n",
      "Pesticides --[exposure_exposure | parent-child]--> DDT\n",
      "Polychlorinated Biphenyls --[exposure_exposure | parent-child]--> DDT\n",
      "Hydrocarbons, Chlorinated --[exposure_exposure | parent-child]--> DDT\n",
      "Organic Chemicals --[exposure_exposure | parent-child]--> DDT\n",
      "PGRMC2 --[exposure_bioprocess | interacts with]--> DDT\n",
      "ZNHIT1 --[exposure_bioprocess | interacts with]--> DDT\n",
      "menarche --[exposure_bioprocess | interacts with]--> DDT\n",
      "mixed lobular and ductal breast carcinoma --[exposure_bioprocess | interacts with]--> DDT\n",
      "stutter disorder --[exposure_bioprocess | interacts with]--> DDT\n",
      "ovulation cycle process --[exposure_bioprocess | interacts with]--> DDT\n",
      "insulin metabolic process --[exposure_bioprocess | interacts with]--> DDT\n",
      "cognition --[exposure_bioprocess | interacts with]--> DDT\n",
      "changes to DNA methylation involved in embryo development --[exposure_bioprocess | interacts with]--> DDT\n",
      "genetic imprinting --[exposure_bioprocess | interacts with]--> DDT\n",
      "motor behavior --[exposure_bioprocess | interacts with]--> DDT\n",
      "memory --[exposure_bioprocess | interacts with]--> DDT\n",
      "adipose tissue development --[exposure_bioprocess | interacts with]--> DDT\n",
      "DDT --[exposure_bioprocess | interacts with]--> PGRMC2, ZNHIT1, insulin metabolic process, menarche, mixed lobular and ductal breast carcinoma, ovulation cycle process, stutter disorder\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DDT, exposure, BRCA1, expression, interaction"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">2</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">161</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">13</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0000</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0000</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0052</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m2\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m161\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m13\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0000\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0000\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0052\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[KeywordExtractor Output]\n",
      "DDT, exposure, BRCA1, expression, interaction\n",
      "\n",
      "[PubMed] For hypothesis, extracted keywords: ['DDT', 'exposure', 'BRCA1', 'expression', 'interaction']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['DDT', 'exposure']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['DDT', 'BRCA1']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['DDT', 'expression']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['DDT', 'interaction']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['exposure', 'BRCA1']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['exposure', 'expression']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['exposure', 'interaction']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['BRCA1', 'expression']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['BRCA1', 'interaction']\n",
      "[PubMed Call] Searching PubMed with keyword pair: ['expression', 'interaction']\n",
      "[PubMed Output] Aggregated Literature Evidence:\n",
      "{\"id\": \"40073390\", \"title\": \"Central Auditory Processing in Children is Affected by Perinatal HIV Exposure.\", \"abstract\": \"Children living with HIV are at higher risk for hearing loss compared to children with HIV-unexposed, uninfected (HUU). There is little known regarding the effects of children living with perinatally-acquired HIV (PHIV) and those living with perinatal HIV exposure but uninfected (PHEU) on central auditory function. Children aged 11-14 years who were participating in the Auditory Research in Children with HIV study. Children were administered the dichotic digits test (DDT) to evaluate binaural integration as a part of a comprehensive hearing protocol. Scores were recorded as percent correct for each ear. Data were collected on 268 children (102 HUU, 80 with PHEU and 86 with PHIV). Children with PHIV had the lowest median DDT for the right and left ears. After adjusting for age and grade level, children with PHIV had statistically significant 8-point lower DDT right ear percent correct (95% confidence interval [CI]: -13.69 to -1.86) and a 15-point lower DDT left ear percent correct (95% CI: -23.03 to -7.45) compared to HUU children. Children with PHEU did have slightly lower DDT scores bilaterally. In children living with PHIV, no HIV disease variables were significantly associated with DDT outcomes. Both peripheral hearing loss and central auditory function should be evaluated in children living with HIV. Children living with PHIV have poorer DDT outcomes compared with HUU children, while children living with PHEU had similar DDT outcomes to HUU children. Poorer binaural integration can have a significant impact on functional auditory performance and academic achievement.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40073390/\"}\n",
      "{\"id\": \"40034592\", \"title\": \"Bisphenol A and DDT disrupt adipocyte function in the mammary gland: implications for breast cancer risk and progression.\", \"abstract\": \"As breast cancer incidence continues to rise worldwide, there is a pressing need to understand the environmental factors that contribute to its development. Obesogens, including Bisphenol A (BPA) and Dichlorodiphenyltrichloroethane (DDT), are highly prevalent in the environment, and have been associated with obesity and metabolic dysregulation. BPA and DDT, known to disrupt hormone signaling in breast epithelial cells, also promote adipogenesis, lipogenesis, and adipokine secretion in adipose tissue, directly contributing to the pathogenesis of obesity. While the adipose-rich mammary gland may be particularly vulnerable to environmental obesogens, there is a scarcity of research investigating obesogen-mediated changes in adipocytes that drive oncogenic transformation of breast epithelial cells. Here, we review the preclinical and clinical evidence linking BPA and DDT to impaired mammary gland development and breast cancer risk. We discuss how the obesogen-driven mechanisms that contribute to obesity, including changes in adipogenesis, lipogenesis, and adipokine secretion, could provide a pro-inflammatory, nutrient-rich environment that promotes activation of oncogenic pathways in breast epithelial cells. Understanding the role of obesogens in breast cancer risk and progression is essential for informing public health guidelines aimed at minimizing obesogen exposure, to ultimately reduce breast cancer incidence and improve outcomes for women.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40034592/\"}\n",
      "{\"id\": \"40027678\", \"title\": \"Effects of Pesticide Exposure on Neuroinflammation and Microglial Gene Expression: Relevance to Mechanisms of Alzheimer's Disease Risk.\", \"abstract\": \"Alzheimer's disease (AD) is characterized by the presence of amyloid-β plaques, neurofibrillary tangles, and neuroinflammation. Previously, we reported serum levels of dichlorodiphenyldichloroethylene (DDE), the primary metabolite of the pesticide dichlorodiphenyltrichloroethane (DDT), were significantly higher in AD patients compared to age-matched controls and that DDT exposure worsened AD pathology in animal models. Here, we investigated the effect of DDT on neuroinflammation in primary mouse microglia (PMG) and C57BL/6J mice. Effects of DDT on inflammation and disease-associated microglia were determined in primary mouse microglia and C57BL/6J mice. PMG exposed to DDT (0.5-5.0 µM) elicited a ∼2-3-fold increase in  These data indicate that DDT increases neuroinflammation, which may result from direct actions of DDT on microglia, providing a novel pathway by which DDT may contribute to AD risk.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40027678/\"}\n",
      "{\"id\": \"40015485\", \"title\": \"Environmental basis for early onset breast cancer.\", \"abstract\": \"Pregnancy provokes a heightened amino acid requirement, especially in the third trimester. Alterations to late pregnancy amino acid metabolism have been associated with environmental breast carcinogen exposures, including DDT and PFAS. This project examined whether maternal serum amino acids in late pregnancy are associated with subsequent breast cancer risk. Archival third-trimester serum samples from 172 women who were later diagnosed with breast cancer were compared to samples from 351 women without known breast cancer. A prospective metabolome-wide association study (MWAS) for breast cancer cases showed that associated amino acid pathways included lysine, arginine, proline, aspartate, asparagine, alanine, tyrosine, tryptophan, histidine and branched-chain amino acids. Lower mean concentrations of individual amino acids, including histidine, threonine, lysine, and proline, were associated with an increased risk of breast cancer, and network analyses showed that these amino acids were negatively associated with protective breast cancer risk factors. Prospective MWAS for breast cancer cases diagnosed within 15 years of sample collection showed pathway associations for tryptophan, histidine, lysine methionine, and cysteine metabolism. Nutrient stresses caused by low amino acid levels impair immunosurveillance and activate oncogenic mechanisms of cell survival, thereby providing mechanisms by which environmental exposures in late pregnancy can contribute to breast cancer risk.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40015485/\"}\n",
      "{\"id\": \"39983969\", \"title\": \"Alterations of early-life gut microbiome in hospitalized infants with chemical pollutants exposure.\", \"abstract\": \"Exposure to chemical pollutants and their effects on the gut microbiome during early life are scarce, especially the effects of mixed exposures. Plasma pollutants levels were measured using gas chromatography -triple quadrupole mass spectrometer (GC-MS/MS) among 304 infants in the neonatal ward at Hunan Children's hospital, China, and gut microbiota was derived from 16S rRNA sequencing. We assessed exposure and alpha diversity using generalized linear models, and variation in beta diversity (Bray-Curtis), taxa abundance (MaAsLin2), and employed Bayesian kernel machine regression (BKMR) to investigate the association of pollutants mixture with alpha diversity and taxa. PBDE-99 was positively associated with the Chao1 index (β = 4.29, 95%CI:1.54,7.03). Exposure to the pesticides trifluralin, γ-BHC, and methidathion significantly affected beta diversity (all P\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39983969/\"}\n",
      "{\"id\": \"34680945\", \"title\": \"Non-Recombinogenic Functions of Rad51, BRCA2, and Rad52 in DNA Damage Tolerance.\", \"abstract\": \"The DNA damage tolerance (DDT) response is aimed to timely and safely complete DNA replication by facilitating the advance of replication forks through blocking lesions. This process is associated with an accumulation of single-strand DNA (ssDNA), both at the fork and behind the fork. Lesion bypass and ssDNA filling can be performed by translation synthesis (TLS) and template switching mechanisms. TLS uses low-fidelity polymerases to incorporate a dNTP opposite the blocking lesion, whereas template switching uses a Rad51/ssDNA nucleofilament and the sister chromatid to bypass the lesion. Rad51 is loaded at this nucleofilament by two mediator proteins, BRCA2 and Rad52, and these three factors are critical for homologous recombination (HR). Here, we review recent advances showing that Rad51, BRCA2, and Rad52 perform some of these functions through mechanisms that do not require the strand exchange activity of Rad51: the formation and protection of reversed fork structures aimed to bypass blocking lesions, and the promotion of TLS. These findings point to the central HR proteins as potential molecular switches in the choice of the mechanism of DDT.\", \"pub_date\": \"2021\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/34680945/\"}\n",
      "{\"id\": \"32432041\", \"title\": \"Replication Fork Remodeling and Therapy Escape in DNA Damage Response-Deficient Cancers.\", \"abstract\": \"Most cancers have lost a critical DNA damage response (DDR) pathway during tumor evolution. These alterations provide a useful explanation for the initial sensitivity of tumors to DNA-targeting chemotherapy. A striking example is dysfunctional homology-directed repair (HDR), e.g., due to inactivating mutations in \", \"pub_date\": \"2020\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/32432041/\"}\n",
      "{\"id\": \"29551577\", \"title\": \"Association of prenatal organochlorine pesticide-dichlorodiphenyltrichloroethane exposure with fetal genome-wide DNA methylation.\", \"abstract\": \"To investigate whether intrauterine organochlorine pesticide (OCP)-dichlorodiphenyltrichloroethane (DDT) exposure could lead to epigenetic alterations by DNA methylation with possible important lifetime health consequences for offspring. We used Illumina Infinium HumanMethylation 450 K BeadChip to explore the pattern of genome-wide DNA methylation containing >485,000 gene sites in cord blood of 24 subjects in a 12 mother-newborn pairs birth cohort. Based on the genome-wide DNA methylation data, we chose one potential gene, BRCA1, to verify the results in another group comprising 126 subjects. We identified 1,131 significantly different CpG sites which included 690 hypermethylation sites and 441 hypomethylation sites in the DNA methylation level between case and control group. The identified sites were located in 598 unique genes. In subsequent validation studies, we found that the DNA methylation level of the identified CpGs of BRCA1 increased with increased exposure to dichlorodiphenyltrichloroethane (DDT) and the level of gene expression in the identified CpGs of BRCA1 decreased with increased exposure to dichlorodiphenyltrichloroethane (DDT). The results indicated that epigenetic processes played a possible role in the development of fetuses affected by maternal OCP-DDT exposure. Early prenatal exposure to DDT may affect fetal BRCA1 gene methylation, and increased exposure leads to a higher DNA methylation level and lower gene expression level.\", \"pub_date\": \"2018\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/29551577/\"}\n",
      "{\"id\": \"22402442\", \"title\": \"A UVR-induced G2-phase checkpoint response to ssDNA gaps produced by replication fork bypass of unrepaired lesions is defective in melanoma.\", \"abstract\": \"UVR is a major environmental risk factor for the development of melanoma. Here we describe a coupled DNA-damage tolerance (DDT) mechanism and G2-phase cell cycle checkpoint induced in response to suberythemal doses of UVR that is commonly defective in melanomas. This coupled response is triggered by a small number of UVR-induced DNA lesions incurred during G1 phase that are not repaired by nucleotide excision repair (NER). These lesions are detected during S phase, but rather than stalling replication, they trigger the DDT-dependent formation of single-stranded DNA (ssDNA) gaps. The ssDNA attracts replication protein A (RPA), which initiates ATR-Chk1 (ataxia telangiectasia and Rad3-related/checkpoint kinase 1) G2-phase checkpoint signaling, and colocalizes with components of the RAD18 and RAD51 postreplication repair pathways. We demonstrate that depletion of RAD18 delays both the resolution of RPA foci and exit from the G2-phase arrest, indicating the involvement of RAD18-dependent postreplication repair in ssDNA gap repair during G2 phase. Moreover, the presence of RAD51 and BRCA1 suggests that an error-free mechanism may also contribute to repair. Loss of the UVR-induced G2-phase checkpoint results in increased UVR signature mutations after exposure to suberythemal UVR. We propose that defects in the UVR-induced G2-phase checkpoint and repair mechanism are likely to contribute to melanoma development.\", \"pub_date\": \"2012\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/22402442/\"}\n",
      "{\"id\": \"20206645\", \"title\": \"Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens.\", \"abstract\": \"Estrogen receptor (ER) transcriptional cross-talk after activation by 17beta-estradiol (E2) has been studied in considerable detail, but comparatively little is known about the ways in which synthetic estrogen-like chemicals, so-called xenoestrogens, interfere with these signalling pathways. E2 can stimulate rapid, non-genomic signalling events, such as activation of the Src/Ras/Erk signalling pathway. We investigated how activation of this pathway by E2, the estrogenic environmental contaminants o,p'-DDT, beta-HCH and p,p'-DDE, and epidermal growth factor (EGF) influences the expression of ER target genes, such as TFF1, ER, PR, BRCA1 and CCND1, and the proliferation of breast cancer cells. Despite commonalities in their estrogenicity as judged by cell proliferation assays, the environmental contaminants exhibited striking differences in their non-genomic and genomic signalling. The gene expression profiles of o,p'-DDT and beta-HCH resembled the effects observed with E2. In the case of beta-HCH this is surprising, considering its reported lack of affinity to the \\\"classical\\\" ER. The expression profiles seen with p,p'-DDE showed some similarities with E2, but overall, p,p'-DDE was a fairly weak transcriptional inducer of TFF1, ER, PR, BRCA1 and CCND1. We observed distinct differences in the non-genomic signalling of the tested compounds. p,p'-DDE was unable to stimulate Src and Erk1/Erk2 activations. The effects of E2 on Src and Erk1/Erk2 phosphorylation were transient and weak when compared to EGF, but beta-HCH induced strong and sustained activation of all tested kinases. Transcription of TFF1, ER, PR and BRCA1 by E2, o,p'-DDT and beta-HCH could be suppressed partially by inhibiting the Src/Ras/Erk pathway with PD 98059. However, this was not seen with p,p'-DDE. Our investigations show that the cellular activities of estrogens and xenoestrogens are the result of a combination of extranuclear (non-genomic) and nuclear (genomic) events and highlight the need to take non-genomic effects and signalling cross-talk into consideration, when screening for environmental estrogens. Otherwise, chemicals devoid of ER affinity, such as beta-HCH, but with an effect profile otherwise similar to estrogens might be overlooked in safety testing.\", \"pub_date\": \"2010\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/20206645/\"}\n",
      "{\"id\": \"40032530\", \"title\": \"Cocaine self-administration increases impulsive decision-making in low-impulsive rats associated with impaired functional connectivity in the mesocorticolimbic system.\", \"abstract\": \"Impulsivity is often considered a risk factor for drug addiction; however, not all evidence supports this view. In the present study, we used a food reward delay-discounting task (DDT) to categorize rats as low-, middle-, and high-impulsive but failed to find any difference among these groups in the acquisition and maintenance of cocaine self-administration, regardless of electrical foot-shock punishment. Additionally, there were no group differences in locomotor responses to acute cocaine in rats with or without a history of cocaine self-administration. Unexpectedly, chronic cocaine self-administration selectively increased impulsive choice in low-impulsive rats. Resting-state fMRI analysis revealed a positive correlation between impulsivity and cerebral blood volume in the midbrain, thalamus, and auditory cortex. Using these three regions as seeds, we observed a negative correlation between impulsivity and functional connectivity between the midbrain and frontal cortex, as well as between the thalamus and frontal cortex (including the orbitofrontal, primary, and parietal cortices) in low-impulsive rats. These correlations were attenuated following chronic cocaine self-administration. RNAscope in situ hybridization assays revealed a significant reduction in DA D1, D2, and D3 receptor mRNA expression in the corticostriatal regions of low-impulsive rats after cocaine self-administration. Our findings challenge the widely held view that impulsivity is a vulnerability factor for cocaine addiction. Instead, chronic cocaine use appears to selectively increase impulsive choice decision-making in low-impulsive rats, associated with reduced functional connectivity and DA receptor expression in the mesocorticolimbic DA network.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40032530/\"}\n",
      "{\"id\": \"40027678\", \"title\": \"Effects of Pesticide Exposure on Neuroinflammation and Microglial Gene Expression: Relevance to Mechanisms of Alzheimer's Disease Risk.\", \"abstract\": \"Alzheimer's disease (AD) is characterized by the presence of amyloid-β plaques, neurofibrillary tangles, and neuroinflammation. Previously, we reported serum levels of dichlorodiphenyldichloroethylene (DDE), the primary metabolite of the pesticide dichlorodiphenyltrichloroethane (DDT), were significantly higher in AD patients compared to age-matched controls and that DDT exposure worsened AD pathology in animal models. Here, we investigated the effect of DDT on neuroinflammation in primary mouse microglia (PMG) and C57BL/6J mice. Effects of DDT on inflammation and disease-associated microglia were determined in primary mouse microglia and C57BL/6J mice. PMG exposed to DDT (0.5-5.0 µM) elicited a ∼2-3-fold increase in  These data indicate that DDT increases neuroinflammation, which may result from direct actions of DDT on microglia, providing a novel pathway by which DDT may contribute to AD risk.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40027678/\"}\n",
      "{\"id\": \"39946772\", \"title\": \"Di-Dang-Tang suppresses ferroptosis in the hippocampal CA1 region by targeting PGK1/NRF2/GPX4 signaling pathway to exert neuroprotection in vascular dementia.\", \"abstract\": \"Increasing evidence has emphasized the crucial role of ferroptosis in the pathogenesis of Vascular dementia (VaD). Di-Dang-Tang (DDT) has the effects of removing blood stasis according to the theory of Traditional Chinese medicine (TCM), while its effects on ferroptosis and mechanisms remain unclear. To elucidate whether the neuroprotective effect of DDT treatment is associated with ferroptosis mediated by the Phosphoglycerate kinase 1 (PGK1)/ Nuclear Factor Erythroid 2-related factor (NRF2)/ Glutathione Peroxidase 4 (GPX4) signaling pathway in the hippocampal CA1 region of rats with the 2-vessel occlusion (2VO) model, we conducted a series of experiments. Nissl staining, HE staining and FJB staining were used to assess the effects of DDT on the degeneration and apoptosis of neurons in the CA1 region of the hippocampus. DDT's suppression on ferroptosis and its protective effects were also evaluated by ELISA and DHE fluorescence. Immunofluorescence assay, immunohistochemistry examination, and western blot analysis further validated DDT's regulatory effects on ferroptosis via PGK1/NRF2/GPX4 pathway. Additionally, we explored the key mediating role of PGK1 in the DDT treatment of VaD by overexpressing PGK1 using AAV-OE-PGK1 plasmid injection. DDT significantly attenuated neuronal apoptosis and degeneration in CA1 region and ameliorated cognitive dysfunctions in VaD rats. DDT inhibited ferroptosis in this brain region, as evidenced by an up-regulation of GPX4 and SLC7A11, and a decline in ferroptosis-related indices. Further, DDT activated protein expression of the PGK1/NRF2/GPX4 pathway, alleviating the lipid peroxidation. Notably, the inhibition of ferroptosis by DDT was achieved by suppression of the PGK1 axis signaling pathway.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39946772/\"}\n",
      "{\"id\": \"39892322\", \"title\": \"New Approach Methodologies (NAMs) to assess killer whale (Orcinus orca) estrogen receptor alpha (ERα) transactivation potencies by DDTs and their risks.\", \"abstract\": \"Killer whales (Orcinus orca), as apex predators, accumulate high levels of persistent organic pollutants (POPs) such as dichlorodiphenyltrichloroethane and its analogs (DDTs) and face their risks at the population level. The assessment of the function of estrogen receptor alpha (ERα) is crucial for evaluating impact of DDTs on killer whale endocrine and reproductive health. However, due to ethical constraints, little is known about the effects of DDTs on the function of killer whale ERα (kwERα). This study aimed to assess kwERα transactivation potencies in response to various DDTs (p,p'-DDT, o,p'-DDT, p,p'-DDD, o,p'-DDD, p,p'-DDE, o,p'-DDE, and p,p'-DDOH) by New Approach Methodologies (NAMs). We constructed an in vitro kwERα-expressed reporter gene assay and measured transactivation potencies of DDTs as the 10 % effective concentration (REC\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39892322/\"}\n",
      "{\"id\": \"39869765\", \"title\": \"Waterborne toxicity of several dichlorodiphenyltrichloroethane congeners to Hyalella azteca and its implications for contaminated sediment assessment.\", \"abstract\": \"Although banned long ago in many countries and jurisdictions, the organochlorine pesticide dichlorodiphenyltrichloroethane (DDT) and compounds related to it remain in the aquatic environment, particularly in sediments, and can pose risks to aquatic life. To inform ecological risk assessment of these compounds, we tested the toxicity of six DDT congeners, specifically the p, p' (4,4') forms of DDT, dichlorodiphenyldichloroethylene (DDE), dichlorodiphenyldichloroethane (DDD), and dichlorodiphenylchloroethylene (DDMU), as well as the o, p' (2,4') isomers of DDT and DDD. The epibenthic amphipod, Hyalella azteca, was exposed for 7 days to waterborne chemical and assessed for changes in survival and growth. Median effect concentrations for biomass gain (aggregating effects on growth and survival) ranged from 0.14 µg/L (p, p'DDT) to 5.8 µg/L (o, p'DDD). Among p, p' congeners, relative toxicity was DDT ≫ DDD > DDE ≈ DDMU. Ortho-para' isomers were approximately five-fold less toxic than their p, p' analogs. Much of the observed effect was expressed as lethality, as half maximal effect concentrations based on biomass were on average only 25% lower than the corresponding median lethal concentration. Effects in parallel 7-day and 10-day exposures indicated close comparability between the two durations for o, p'-DDT. Application of these waterborne exposure endpoints in ecological risk assessment of contaminated sediments is discussed.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39869765/\"}\n",
      "{\"id\": \"40066922\", \"title\": \"Tunable optical and thermodynamic properties: the ignition of energetic metal complexes with different crystal fields.\", \"abstract\": \"Primary explosives are generally composed of a metal, energetic ligands and oxyacid anions, and are exploded by optical or thermal initiation pathways to provide energy. Nowadays, near-infrared (NIR) laser initiation is a safe way to ignite explosives to effectively avoid electromagnetic interference. Therefore, low NIR laser sensitivity and high thermal stability are the preconditions for applicable laser-initiated explosives. Here, metallic 1,5-diaminotetrazole perchlorate complexes, [M(DAT)\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40066922/\"}\n",
      "{\"id\": \"40027678\", \"title\": \"Effects of Pesticide Exposure on Neuroinflammation and Microglial Gene Expression: Relevance to Mechanisms of Alzheimer's Disease Risk.\", \"abstract\": \"Alzheimer's disease (AD) is characterized by the presence of amyloid-β plaques, neurofibrillary tangles, and neuroinflammation. Previously, we reported serum levels of dichlorodiphenyldichloroethylene (DDE), the primary metabolite of the pesticide dichlorodiphenyltrichloroethane (DDT), were significantly higher in AD patients compared to age-matched controls and that DDT exposure worsened AD pathology in animal models. Here, we investigated the effect of DDT on neuroinflammation in primary mouse microglia (PMG) and C57BL/6J mice. Effects of DDT on inflammation and disease-associated microglia were determined in primary mouse microglia and C57BL/6J mice. PMG exposed to DDT (0.5-5.0 µM) elicited a ∼2-3-fold increase in  These data indicate that DDT increases neuroinflammation, which may result from direct actions of DDT on microglia, providing a novel pathway by which DDT may contribute to AD risk.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40027678/\"}\n",
      "{\"id\": \"39983969\", \"title\": \"Alterations of early-life gut microbiome in hospitalized infants with chemical pollutants exposure.\", \"abstract\": \"Exposure to chemical pollutants and their effects on the gut microbiome during early life are scarce, especially the effects of mixed exposures. Plasma pollutants levels were measured using gas chromatography -triple quadrupole mass spectrometer (GC-MS/MS) among 304 infants in the neonatal ward at Hunan Children's hospital, China, and gut microbiota was derived from 16S rRNA sequencing. We assessed exposure and alpha diversity using generalized linear models, and variation in beta diversity (Bray-Curtis), taxa abundance (MaAsLin2), and employed Bayesian kernel machine regression (BKMR) to investigate the association of pollutants mixture with alpha diversity and taxa. PBDE-99 was positively associated with the Chao1 index (β = 4.29, 95%CI:1.54,7.03). Exposure to the pesticides trifluralin, γ-BHC, and methidathion significantly affected beta diversity (all P\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39983969/\"}\n",
      "{\"id\": \"39970280\", \"title\": \"Ubiquitin protease Ubp1 cooperates with Ubp10 and Ubp12 to revert lysine-164 PCNA ubiquitylation at replication forks.\", \"abstract\": \"Proliferating cell nuclear antigen (PCNA) is essential for the faithful duplication of eukaryotic genomes. PCNA also orchestrates events necessary to address threats to genomic integrity, such as the DNA damage tolerance (DDT) response, a mechanism by which eukaryotic cells bypass replication-blocking lesions to maintain replisome stability. DDT is regulated by the ubiquitylation of PCNA and the consequent recruitment of specialized polymerases that ensure replication continuity. We have recently described that the deubiquitylases Ubp10 and Ubp12 modulate DDT events by reverting the ubiquitylation of PCNA in Saccharomyces cerevisiae. This study identifies Ubp1 as a novel PCNA deubiquitylase that cooperates with Ubp10 and Ubp12 in the regulation of DDT during DNA replication. Ubp1, previously known as a cytoplasmic protein, also localizes to the nucleus, where it associates with DNA replication forks. Additionally, Ubp1 interacts with and deubiquitylates PCNA. Here, we provide evidence that Ubp1 collaborates with Ubp10 and Ubp12 to facilitate DNA replication by efficiently reverting PCNAK164 ubiquitylation at replication forks under conditions free from exogenous perturbations. Consequently, the deletion of UBP1, UBP10, and UBP12 leads to persistent ubiquitylation of PCNAK164 and a marked delay in S phase progression.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39970280/\"}\n",
      "{\"id\": \"39964481\", \"title\": \"Ubiquitin protease Ubp1 cooperates with Ubp10 and Ubp12 to revert lysine-164 PCNA ubiquitylation at replication forks.\", \"abstract\": \"Proliferating cell nuclear antigen (PCNA) is essential for the faithful duplication of eukaryotic genomes. PCNA also orchestrates events necessary to address threats to genomic integrity, such as the DNA damage tolerance (DDT) response, a mechanism by which eukaryotic cells bypass replication-blocking lesions to maintain replisome stability. DDT is regulated by the ubiquitylation of PCNA and the consequent recruitment of specialized polymerases that ensure replication continuity. We have recently described that the deubiquitylases Ubp10 and Ubp12 modulate DDT events by reverting the ubiquitylation of PCNA in Saccharomyces cerevisiae. This study identifies Ubp1 as a novel PCNA deubiquitylase that cooperates with Ubp10 and Ubp12 in the regulation of DDT during DNA replication. Ubp1, previously known as a cytoplasmic protein, also localizes to the nucleus, where it associates with DNA replication forks. Additionally, Ubp1 interacts with and deubiquitylates PCNA. Here, we provide evidence that Ubp1 collaborates with Ubp10 and Ubp12 to facilitate DNA replication by efficiently reverting PCNAK164 ubiquitylation at replication forks under conditions free from exogenous perturbations. Consequently, the deletion of UBP1, UBP10, and UBP12 leads to persistent ubiquitylation of PCNAK164 and a marked delay in S phase progression.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39964481/\"}\n",
      "{\"id\": \"40009381\", \"title\": \"Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.\", \"abstract\": \"Subgroup definitions for possible deescalation of neoadjuvant cancer treatment are urgently needed in clinical practice. To investigate the effect of BRCA1 and/or BRCA2 tumor pathogenic variants (tPVs) by comparing 2 deescalated neoadjuvant regimens (nab-paclitaxel plus either carboplatin or gemcitabine) on pathologic complete response (pCR), invasive disease-free survival (IDFS), and overall survival (OS) of patients with early-stage triple-negative breast cancer (TNBC). This was a preplanned secondary analysis of a phase 2 prospective randomized clinical trial (ADAPT-TN) conducted by the West German Study Group (WSG) at 45 sites in Germany between June 2013 and February 2015. The trial enrolled patients with noninflammatory early-stage TNBC (clinical tumor size ≥1 cm; estrogen receptor and progesterone receptor expression <1%; and ERBB2 negative). DNA samples from pretreatment biopsies were obtained. Genetic analysis was performed between January 2018 and March 2020. Final data analyses took place in September 2023. Patients were randomized to 12 weeks of treatment with nab-paclitaxel plus either carboplatin or gemcitabine; omission of otherwise mandatory anthracycline-containing chemotherapy was allowed in the case of pCR. tPVs in 20 cancer-associated genes, including BRCA1 and BRCA2, were analyzed using a customized gene panel. The prevalence of BRCA1 and/or BRCA2 tPVs and their effect on pCR rate, IDFS, and OS were evaluated using logistic and Cox proportional hazards regression. Of the 307 patients with DNA samples from pretreatment biopsies available, tumor next-generation sequencing analyses were successful for 266 patients. The 266 patients included in this analysis were female, with a median age of 51 years (range, 26-76 years). A total of 162 patients (60.9%) had a clinical tumor size of 2 cm or greater, and 70 (26.3%) had clinical node-positive disease. BRCA1 and/or BRCA2 tPVs were detected in 42 patients (15.8%). The highest pCR rate among patients with BRCA1 and/or BRCA2 tPVs was seen in the nab-paclitaxel plus carboplatin group (9 of 14 patients [64.3%]) compared with the nab-paclitaxel plus gemcitabine group (10 of 28 [35.7%]) (odds ratio, 3.24 [95% CI, 0.85-12.36]; P = .08); the highest numeric 5-year IDFS and OS rates (84.4% and 92.9%, respectively) were seen in the nab-paclitaxel plus carboplatin group. In this secondary analysis of the WSG-ADAPT-TN randomized clinical trial on tPVs, deescalated nab-paclitaxel plus carboplatin was superior to nab-paclitaxel plus gemcitabine, particularly in patients with BRCA1 and/or BRCA2 tPVs. These findings suggest that BRCA1 and/or BRCA2 tPV status could be a candidate marker for a deescalation strategy in early-stage TNBC; however, prospective validation of survival outcomes in larger cohorts with differentiation between germline and somatic pathogenic variants is necessary. ClinicalTrials.gov Identifier: NCT01815242.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40009381/\"}\n",
      "{\"id\": \"39974072\", \"title\": \"Homologous recombination deficiency in ovarian high-grade serous carcinoma by self-reported race.\", \"abstract\": \"Approximately half of ovarian high-grade serous carcinomas (HGSC) have homologous recombination deficiency (HRD). However, HRD is not well-characterized in Black individuals. To characterize HGSC HRD by self-reported race and evaluate whether differences in HRD are associated with ovarian cancer mortality. Cohort study using data collected from two population-based case-control studies of ovarian cancer. Cases were selected based on self-reported race (178 Black, 123 White) and pathologically-confirmed HGSC. HRD features identified using matched tumor-normal whole-exome DNA sequencing and categorized as germline or somatic variants in homologous recombination pathway genes, or the SBS3 HRD-associated signature. Median difference and 95% confidence intervals (CI) for age at diagnosis and tumor mutation burden, and age and stage-adjusted hazard ratios (HR) and 95%CIs for survival, comparing individuals with an HRD feature to those without, separately by self-reported race. More of the germline and somatic variants detected among Black individuals compared with White individuals were unannotated or variants of uncertain significance (VUS; germline 65% versus 45%; somatic 62% versus 50%, respectively). While the prevalences of many HRD features were similar between Black individuals and White individuals, Black individuals had a higher prevalence of the HRD signature identified using de novo mutational signature analysis (40% versus 29%) and germline  HRD testing informs precision-based medicine approaches that improve outcomes, but a higher proportion of VUS among Black individuals may complicate referral for such care. Our findings emphasize the importance of recruiting diverse individuals in genomics research and better characterizing VUS.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39974072/\"}\n",
      "{\"id\": \"39964682\", \"title\": \"Pathogenic Germline Variants in Patients With Metaplastic Breast Cancer.\", \"abstract\": \"Metaplastic breast cancer (MpBC) is a rare, heterogeneous disease often associated with inferior outcomes. A growing body of literature describes the clinical and molecular features of MpBC, yet limited data describe the pathogenic germline variants (PGVs) in breast cancer susceptibility genes among affected individuals. To examine the frequency and types of PGVs in breast cancer genes among patients with MpBC. This is a descriptive retrospective cohort study of patients who received a diagnosis of MpBC at the University of Pennsylvania between January 2010 and May 2023. Electronic medical records were reviewed for demographic, clinicopathologic, and germline genetic testing information. Germline variant status was independently confirmed by a licensed genetic counselor and a physician with expertise in genetics. MpBC diagnosis and subtype were confirmed by a breast pathologist. Participants were identified via query of an institutional pathology database for reports signed between January 2010 and May 2023 including the term metaplastic. Among 320 initially obtained reports, 272 individuals had confirmed MpBC and were included in the study. Germline genetic testing to investigate the presence of PGVs in breast cancer susceptibility genes. The primary outcome measurement was the prevalence of PGVs in breast cancer susceptibility genes among participants. The hypothesis that individuals with MpBC have an enrichment of PGVs in genes associated with inherited breast cancer risk was formulated before data collection. The total sample size was 272 women, and the median age at diagnosis was 58 years (range, 20-102 years); all were biological female patients; 143 of 272 (52.6%) had documentation of germline genetic testing; and participants with testing were significantly younger than those without (median age, 53 years [range, 20-79 years] vs 63 years [range, 29-102 years]; P < .001). Of the 143 patients, 24 (16.8%) had a PGV in a breast cancer susceptibility gene (BRCA1, n = 17; BRCA2, n = 5; PALB2, n = 1; CHEK2, n = 1). Patients with PGV-associated MpBC received a diagnosis at a younger age than those with sporadic disease, but there were no significant differences in hormone receptor positivity, ERBB2 status, or metaplastic subtype. In this cohort study of patients with MpBC, a substantial proportion of clinically tested patients had a PGV in a breast cancer susceptibility gene, most commonly BRCA1. Germline testing was high yield in patients with MpBC, many of whom would be included in current germline testing eligibility criteria.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39964682/\"}\n",
      "{\"id\": \"39946983\", \"title\": \"The predominant role of p62/SQSTM1 over NBR1 in methylmercury-induced cytotoxicity and cellular defense.\", \"abstract\": \"p62/SQSTM1 (p62) and neighbor of BRCA1 gene 1 (NBR1) are two important cargo receptors involved in selective autophagy. While p62 is known to safeguard cells against the toxic effects of the environmental toxicant methylmercury (MeHg), the specific functions of p62 and NBR1 in MeHg-exposed cells remain unclear. In this study, we aimed to elucidate the distinct roles of p62 and NBR1 in conferring protection against cytotoxicity induced by MeHg. We found that MeHg increased both the mRNA and protein levels of p62 while decreasing those of NBR1. Upon exposure to MeHg, p62-knockout (KO) cells exhibited an approximately 30 % reduction in cell viability compared to wild-type (WT) cells; however, no such reduction was observed in NBR1KO cells. Additionally, p62KO cells exhibited a 1.5-fold increase in intracellular mercury (Hg) concentration compared to the WT following MeHg exposure, whereas NBR1KO cells had Hg levels comparable to those of WT cells. Upon exposure to MeHg, Nrf2 signaling activation was significantly reduced in p62KO cells compared to that in WT cells, whereas NBR1KO cells displayed Nrf2 activation levels similar to those of WT cells. Overall, these results suggest that p62, rather than NBR1, plays a crucial role in mitigating MeHg-induced cytotoxicity by reducing intracellular Hg levels through the activation of the Nrf2 signaling pathway.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39946983/\"}\n",
      "{\"id\": \"39915607\", \"title\": \"Methylstat sensitizes ovarian cancer cells to PARP-inhibition by targeting the histone demethylases JMJD1B/C.\", \"abstract\": \"PARP-inhibitors (PARPi) are an integral part of ovarian cancer treatment. However, overcoming acquired PARPi resistance or increasing the benefit of PARPi in patients without homologous recombination deficiency (HRD) remains an unmet clinical need. We sought to identify genetic modulators of PARPi response, guiding pharmacological PARPi sensitization. CRISPR-Cas9 mediated loss-of-function screen with a focused sgRNA library revealed that DNA-demethylases JMJD1B/JMJD1C, targetable by the small inhibitor methylstat, promote PARPi resistance. Methylstat synergistically interacted with olaparib, and (re-)sensitized ovarian cancer cells to PARPi treatment, surpassing the efficacy of common demethylase inhibitors. Genetic knockout of JMJD1B and/or JMJD1C phenocopied the effect of methylstat in an additive manner. Validation studies revealed methylstat to be a universal PARPi-sensitizing drug, effective, regardless of PARPi resistance status or BRCA1 mutational background. Methylstat modulated clonal cancer dynamics by mitigating positive selection of PARPi-resistant or BRCA1-proficient cells under olaparib treatment. Using a model of PARPi-induced cellular toxicity, we showed that methylstat impairs cellular DNA repair, indicated by an increased susceptibility of ovarian cancer cells to olaparib-induced DNA double strand breaks after methylstat exposure. This study proposes the histone demethylase inhibitor methylstat as an epigenetic drug for overcoming PARPi-resistance or for increasing efficacy of PARPi beyond HRD in ovarian cancer patients.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/39915607/\"}\n",
      "{\"id\": \"40079199\", \"title\": \"Spermidine alleviates copper-induced oxidative stress, inflammation and cuproptosis in the liver.\", \"abstract\": \"Copper exposure poses potential detrimental effects on both public and ecosystem health. Spermidine, an antioxidant, has shown promise in reducing oxidative stress and inflammation within the liver. However, its specific role in mitigating copper-induced hepatic cuproptosis and disturbances in copper metabolism remains unexplored. Consequently, this research aims to investigate to examine the impact of spermidine on hepatic cuproptosis and the related disturbances in copper metabolism. In the study, we established a model of copper-induced liver toxicity by feeding C57BL/6 mice a high-copper diet for three months. Histopathological and biochemical analyses revealed that copper exposure induced hepatic inflammatory cell infiltration, hepatocyte degeneration, elevated levels of MDA, ROS, and Cu\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40079199/\"}\n",
      "{\"id\": \"40078368\", \"title\": \"Prolactin drives cortical neuron maturation and dendritic development during murine embryonic stem cell differentiation.\", \"abstract\": \"Prolactin (PRL) is a pleiotropic hormone implicated in various physiological processes; however, its contribution to neurodevelopment, particularly early corticogenesis, remains insufficiently characterized. In this study, we investigate PRL's regulatory influence on the initial stages of cortical development, with an emphasis on its effects on neuronal and astrocytic differentiation. We employed a standardized in vitro differentiation protocol to generate cortical neurons from mouse embryonic stem cells (mESCs). Prolactin receptor (PRLr) expression was evaluated in pluripotent stem cells, neural stem cells (NSCs), immature neurons, and mature neurons using both PCR and immunofluorescence. These analyses revealed dynamic changes in PRLr expression throughout the differentiation process. Additionally, cells were treated with varying concentrations of PRL during early and late differentiation phases, enabling assessment of its impact on neuronal phenotypic distribution and morphological complexity. Early PRL administration significantly enhanced the population of β-tubulin III + immature neurons, promoting neuronal survival without altering NSC proliferation. Furthermore, PRL treatment increased the abundance of Tbr1 + and NeuN + neurons, augmented dendritic complexity, and accelerated neuronal maturation. In contrast, PRL exposure at later stages of neural differentiation did not yield comparable effects. Notably, PRL delayed the maturation of protoplasmic astrocytes, although the total astrocyte population was not affected. These findings highlight PRL's pivotal role as a regulator of early corticogenesis by modulating neuronal survival, dendritic development, and astrocyte maturation. PRL thus emerges as a potential key factor in neurodevelopment, underscoring its importance in the hormonal regulation of neural differentiation and maturation. These insights may have broader implications for understanding the molecular and cellular mechanisms underlying normal and pathological neurodevelopment.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40078368/\"}\n",
      "{\"id\": \"40077868\", \"title\": \"Smartphone-Manipulated Mild-Temperature Photothermal Control of the TfR-LYTAC Platform for Tumor Treatment.\", \"abstract\": \"A lysosome-targeting chimera (LYTAC) offers a novel strategy for degrading extracellular proteins previously considered to be undruggable by hijacking the lysosomal degradation system. However, clinical use of LYTAC has been limited due to the potential for uncontrolled degradation and systemic toxicity. Based on our previously developed genetically encoded TfR-LYTAC, here, we introduce a photothermal-inducible switch in the engineered bacterium to enable spatiotemporal expression of TfR-LYTAC. We also developed precise photothermal systems to control LYTAC expression via cellphone manipulation to avoid burns of normal tissues, especially the skin, caused by intense laser light. The engineered bacterium exhibited significant tumor-suppressing effects upon exposure to the phone-manipulated laser in both subcutaneously transplanted melanoma and colon tumor models with no skin damage to the mice. Our approach enables LYTAC precision medicine and provides a generalizable platform for developing light-driven LYTAC. Our study provides a platform for outpatient or home treatment and is a further step for telemedicine.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40077868/\"}\n",
      "{\"id\": \"40077783\", \"title\": \"The Impact of Tartrazine on DNA Methylation, Histone Deacetylation, and Genomic Stability in Human Cell Lines.\", \"abstract\": \"Tartrazine (TRZ), a synthetic red azo dye derived from coal tar, is widely used as a food colorant in various food products, pharmaceuticals, and cosmetics. This study aims to investigate the impact of TRZ on the expression levels of DNA methyltransferases ( The selected human cell lines were exposed to different concentrations of TRZ (20 µM, 40 µM, and 80 µM), with DMBA serving as a positive control. After treatment, we quantified the expression levels of  Our findings indicate that TRZ significantly upregulates the expression of  These results suggest that TRZ may play a role in carcinogenesis and epigenetic modifications. The observed upregulation of \", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40077783/\"}\n",
      "{\"id\": \"40077744\", \"title\": \"Bitter and Sweet Diets Alter Taste Response and Alcohol Consumption Behavior in Mice.\", \"abstract\": \"Taste guides the consumption of food and alcohol for both humans and rodents. Given that chronic dietary exposure to bitter and sweet foods are purported to alter the perception of bitter and sweet tastes respectively, we hypothesized that dietary habits may shape how the taste properties of ethanol are perceived and thus how it is consumed. Using C57BL/6 mice as a model, we contrasted taste behavior, morphology, and expression after a 4-week diet featuring consistent bitter, sweet, or neutral (water) stimuli. Our results demonstrated that a 4-week bitter diet containing a quinine solution increased preference for ethanol, while a 4-week sweet diet consisting of a sucralose solution did not alter ethanol preference nor intake. The quinine diet also reduced the number of sweet- or umami-sensing T1R3-positive cells in the circumvallate papillae taste buds of the mice. Based on the behavioral changes observed with the bitter diet, it is possible that either bitter or sweet taste, or both together, drive the increase in ethanol preference. The implications of these findings for alcohol consumption are that dietary habits that do not necessarily concern alcohol may be capable of altering alcohol preference via taste habituation. Habitual intake of bitter and/or sweet foods can shift the perception of taste over time. Changes to how the taste components of alcohol are perceived may also alter how acceptable the taste of alcohol is when experienced as a whole, thereby having the unintended consequence of shifting alcohol consumption levels. Our study demonstrates another side to bitter habituation, which, thus far, has been studied in the more positive context of developing a set of dietary tactics for promoting bitter vegetable intake.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40077744/\"}\n",
      "{\"id\": \"40079209\", \"title\": \"A mixed-methods study assessing the performance of a clinical decision support tool for \", \"abstract\": \"To better understand clinicians' rationale for ordering testing for  A mixed-methods, case series was performed from March 2, 2017 to December 31, 2018. Yale New Haven Hospital, a 1,541 bed tertiary academic medical center. Hospitalized patients ≥ 18 years old, and clinicians who were alerted by the CDS. CDS was triggered in real-time when a clinician sought to order testing for CDI for a patient who received one or more doses of laxatives within the preceding 24 hours. A total of 3,376 CDS alerts were triggered during the 21-month study period from 2,567 unique clinician interactions. Clinicians bypassed the CDS alert 74.5% of the time, more frequent among residents (48.3% bypass vs. 39.9% accept) and advanced practice providers (APPs) (34.9% bypass vs. 30.6% accept) than attendings (11.3% bypass vs. 22.5% accept). Ordering clinicians noted increased stool frequency/output (48%), current antibiotic exposure (34%), and instructions by an attending physician to test (28%) were among the most common reasons for overriding the alert and proceeding with testing for CDI. Testing for CDI despite patient laxative use was associated with an increased clinician concern for CDI, patient risk for CDI, and attending physician instruction for testing. Attendings frequently accepted CDS guidance while residents and APPs often reinstated CDI test orders, suggesting a need for greater empowerment and discretion when ordering tests.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40079209/\"}\n",
      "{\"id\": \"40079194\", \"title\": \"Assessing Environmental Justice in Mexico: How Polluting Industries and Healthcare Disparities Impact Congenital Heart Defects.\", \"abstract\": \"Congenital heart defects (CHDs) are the most prevalent birth defects globally and the second leading cause of death in Mexican children under five. This study examines how industrial activity and social vulnerabilities independently and jointly influence CHD incidence across 2446 Mexican municipalities from 2008 to 2019. Using negative binomial regression models, we evaluated associations between polluting industries, healthcare access, and CHD incidence. We analyzed these factors independently, jointly, and through interaction terms to assess potential effect modification by healthcare access. Incidence rate ratios (IRRs) and 95% confidence intervals were estimated across healthcare access strata. Municipalities without healthcare facilities were more likely to host polluting industries, highlighting structural inequities. The presence of polluting industries was associated with increased CHD incidence, even after adjusting for healthcare access. For instance, municipalities with poor healthcare access and two or more polluting industries exhibited a 42% higher CHD incidence (IRR = 1.42, 95% CI: 1.25-1.60) compared to a 26% increase in municipalities with better healthcare access (IRR = 1.26, 95% CI: 1.02-1.57). These results show how environmental pollutant exposure and social vulnerabilities interact synergistically, disproportionately impacting socially vulnerable populations. Targeted policy interventions addressing both environmental pollution and healthcare inequities are crucial. Further research is also needed to clarify the mechanisms linking pollution to CHDs and to guide public health strategies aimed at reducing these disparities in Mexico.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40079194/\"}\n",
      "{\"id\": \"40078791\", \"title\": \"Burn inhalation injury and intubation with dexamethasone-eluting endotracheal tubes modulate local microbiome and alter airway inflammation.\", \"abstract\": \"Inhalation injuries, caused by exposure to extreme heat and chemical irritants, lead to complications with speaking, swallowing, and breathing. This study investigates the effects of thermal injury and endotracheal tube (ETT) placement on the airway microbiome and inflammatory response. A secondary aim is to assess the impact of localized dexamethasone delivery via a drug-eluting ETT to reduce laryngeal scarring. Inhalation injury was developed in swine by administering heated air (150°C-160°C) under endoscopic visualization. Following injury, segments of regular or dexamethasone-loaded endotracheal tubes (ETTs) were placed in the injured airways for 3 or 7 days. Computed tomography (CT) scans were used to assess airway narrowing post-injury. Biofilm formation on the ETTs was investigated using micro-CT and microscopy. The airway microbiome was analyzed via 16S rRNA sequencing. Inflammatory markers were quantified using an immunoassay and macrophage populations in laryngeal tissue were assessed with CD86 and CD206 staining. Tracheal tissues were also histologically examined for epithelial thickness, collagen area, and mucin production. CT scans confirmed airway narrowing post-injury, particularly around ETT sites. Biofilm formation was more extensive on dexamethasone-coated ETTs at later timepoints. Beta diversity analysis revealed significant shifts in microbial composition related to ETT type (R Thermal inhalation injury and ETT placement significantly impact airway inflammation, structural integrity, and microbiome composition. Dexamethasone-eluting ETTs, intended to reduce inflammation, increased biofilm formation and elevated cytokine levels, suggesting complex interactions between the drug coating and the host immune response. The airway microbiome shifted significantly with specific taxa thriving in the inflamed environment.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40078791/\"}\n",
      "{\"id\": \"40077903\", \"title\": \"Assessment of Food Effect and pH-Dependent Drug-Drug Interactions of Fruquintinib in Healthy Subjects.\", \"abstract\": \"This two-sequence, three-period study (NCT04645940) was designed to evaluate the effect of food and concomitant rabeprazole, a proton pump inhibitor, on the pharmacokinetics (PK) and safety of fruquintinib and its metabolite M11 after a single oral dose of fruquintinib 5 mg in healthy subjects. In the food effect treatment periods, 14 subjects were randomized in a 1:1 ratio utilizing a two-sequence (fed/fasted vs. fasted/fed), two-period, cross-over design. Fruquintinib was administered on Day 1 (Period 1) and Day 15 (Period 2). In the drug-interaction period (Period 3), all subjects received rabeprazole 40 mg 1 h prior to fruquintinib under fasted conditions, following a 6-day lead-in of rabeprazole 40 mg once daily. PK samples to measure fruquintinib and M11 were collected pre-dose and over 168 h after fruquintinib dosing. Administration of fruquintinib with a high-fat meal resulted in similar systemic exposure compared with fasted conditions. In addition, coadministration of fruquintinib with rabeprazole resulted in similar exposure compared with fruquintinib alone. For both evaluations, 90% confidence intervals for the ratio of geometric least square mean of the area under the curve and peak concentration for fruquintinib and M11 were entirely within 80%-125% bounds. The study results showed no effects of food or rabeprazole on fruquintinib PK, and support that fruquintinib can be taken without regard to food or concurrent gastric acid-reducing agents.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40077903/\"}\n",
      "{\"id\": \"40077761\", \"title\": \"Maternal Obesity and Neurodevelopment of the Offspring.\", \"abstract\": \"An increasing amount of evidence, derived from both human epidemiological studies and animal research, suggests that exposure to maternal obesity in utero is linked to adverse neurodevelopmental outcomes in the offspring. These can include attention deficit hyperactivity disorder, autism spectrum disorders, intellectual disability, and cerebral palsy. A thorough search in Medline/PubMed and Google Scholar databases was performed by two independent reviewers in order to investigate the link between the exposure to maternal obesity and neurodevelopmental outcomes in the offspring. A list of keywords, including maternal obesity, maternal overweight, maternal diet, neurodevelopment, and neuropsychiatric disorders, was used in the search algorithm. The existing evidence regarding the potential mechanisms through which maternal obesity may impact offspring neurodevelopment and programming, such as inflammation, hormone dysregulation, alterations to the microbiome, and epigenetics, as well as evidence from animal studies, was summarized in this narrative review. Maternal obesity seems to be overall associated with various neuropsychiatric and neurodevelopmental disorders. However, more robust data from future studies are needed to establish this association, which will take into account the role of potential confounders such as genetic factors and gene-environment interactions.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40077761/\"}\n",
      "{\"id\": \"40075743\", \"title\": \"Mutant KRAS and GATA6 Stratify Survival in Patients Treated with Chemotherapy for Pancreatic Adenocarcinoma: A Prospective Cohort Study.\", \"abstract\": \"Several pancreatic adenocarcinoma (PA) biomarkers beyond the traditional carbohydrate antigen (CA)19-9 have been identified but are lacking large-scale prospective validation. This prospective cohort study evaluated the prognostic impact of potential PA biomarkers. We enrolled 238 of 288 patients with histologically proven PA. We assessed candidate biomarkers, including CA19-9, germline  We analyzed biomarker efficacy in 200 (median age 65 years; 55% male) of the enrolled patients who received chemotherapy. A high mutant  Plasma mutant \", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40075743/\"}\n",
      "{\"id\": \"40074706\", \"title\": \"Identification and mechanism analysis of biomarkers related to butyrate metabolism in COVID-19 patients.\", \"abstract\": \"Butyrate may inhibit SARS-CoV-2 replication and affect the development of COVID-19. However, there have been no systematic comprehensive analyses of the role of butyrate metabolism-related genes (BMRGs) in COVID-19. We performed differential expression analysis of BMRGs in the brain, liver and pancreas of COVID-19 patients and controls in GSE157852 and GSE151803. The differentially expressed genes (DEGs) and module genes between COVID-19 patients and healthy controls in GSE171110 were screened through 'limma' and 'WGANA' R package, respectively, followed by an intersection with BMRGs via 'ggvenn' R package. Six machine learning algorithms were employed to determine the best model for identifying biomarkers, and receiver operating characteristic (ROC) curves were plotted to evaluate the diagnostic value of the biomarkers in COVID-19. Moreover, the differences in immune-infiltrating cells between the COVID-19 and control groups were compared using CIBERSORT. The differences in immune cells and expression levels of biomarkers in immune cells among different tissues were analysed using GSE171668. The BMRGs were the most different in the brain between the COVID-19 and control groups, including 21 upregulated and 16 downregulated genes. Five important common BMRGs were screened as biomarkers for COVID-19 using XGBoost, namely CCNB1, CCNA2, BRCA1, HBB and HSPA5, with increased diagnostic performance. Enrichment analysis revealed that these five genes were related to the cell cycle, cell proliferation and cell senescence. The infiltrating abundance of 12 immune cells was different between the COVID-19 and control groups. Finally, the expression levels of HSPA5, BRCA1 and HBB were higher in annotated cells than in CCNB1 and CCNA2, and there were four different types of immune cells in the liver, heart, lungs and kidneys. These five genes may be potential biomarkers of butyrate metabolism in COVID-19 patients. These findings provide a direction for further studies on the molecular mechanisms underlying COVID-19.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40074706/\"}\n",
      "{\"id\": \"40050279\", \"title\": \"SART3 promotes homologous recombination repair by stimulating DNA-RNA hybrids removal and DNA end resection.\", \"abstract\": \"DNA-RNA hybrids triggered by double-strand breaks (DSBs) are crucial intermediates during DSB repair, and their timely resolution requires numbers of RNA helicases, including DEAD box 1 (DDX1). However, how these helicases are recruited to DSB-induced hybrids in time remains largely unclear. Here, we revealed that squamous cell carcinoma antigen recognized by T cells 3 (SART3) promotes DDX1 binding to DNA-RNA hybrids at DSBs for optimal homologous recombination (HR) repair. SART3 itself associates with DNA-RNA hybrids and PAR chains and accumulates at DSBs in both PARylation- and DNA-RNA hybrids-dependent fashion. SART3 also associates with DDX1 and is necessary for DDX1 enrichment at DSBs. The defective SART3-DDX1 association observed in cells expressing the cancer-associated variant SART3-R836W impairs not only the accumulation of DDX1, but also hybrid removal and HR efficiency. Moreover, SART3 promotes DNA end resection through enhancing USP15-BARD1 association and BRCA1-BARD1 retention. Together, our study reveals an role of SART3 in DSB repair, rendering SART3 a promising target for cancer therapy.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40050279/\"}\n",
      "{\"id\": \"40036611\", \"title\": \"Natural product Pulsatilla saponin D sensitizes BRCA-proficient ovarian cancers to PARP inhibitors through inhibiting homologous recombination repair.\", \"abstract\": \"As a strategy in the development of effective cancer therapeutics, synthetic lethality has been used in clinical practice. Poly adenosine diphosphate (ADP)-ribose polymerase inhibitors are the first approved drug utilized synthetic lethality and achieved promising therapeutic efficacy in cancer cells with BRCA1/2 mutation. Nonetheless, most cancer patients with wild-type BRCA1/2 gene are not qualified for PARPi therapy. To induce BRCAness phenotype in cancer cells with normal BRCA1/2 status, we identified Pulsatilla Saponin D (SB365), which efficiently inhibited recruitment of BRCA1 at DNA double-strand breaks, leading to homologous recombination repair deficiency. We utilized the HR repair reporter system. The reporter cells were treated with a natural compounds library to identify the agent that significantly decreased HR activity. Then, we detected the expression of HR related proteins using immunofluorescence and western blot. Colony formation and CCK8 was used to detect the inhibitory effect of Pulsatilla Saponin D on cell proliferation. Apoptosis was measured using Annexin V/PI staining. Comet assay kits were used to carry out the comet assay. Ovarian cancer xenograft model, immunohistochemical staining and Hematoxylin-Eosin staining was used to detect the antitumor efficacy and toxicity of Pulsatilla Saponin D. Pulsatilla Saponin D greatly increased PARPi-induced DNA DSBs, growth inhibition and apoptosis in ovarian cancer cells. Combined administration of PARPi and Pulsatilla Saponin D induced synergistic anti-tumor effects in ovarian cancer cells and xenograft mouse model without obvious toxicity. In summary, our study found Pulsatilla Saponin D is a novel HR repair inhibitor and would optimize clinical application of PARP inhibitors on cancer patients with WT BRCA1/2.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40036611/\"}\n",
      "{\"id\": \"40033056\", \"title\": \"The transcriptomic architecture of common cancers reflects synthetic lethal interactions.\", \"abstract\": \"To maintain cell fitness, deleterious genetic alterations are buffered by compensatory changes in additional genes. In cancer, buffering processes could be targeted by synthetic lethality. However, despite the large-scale identification of synthetic lethal effects in preclinical models, evidence that these operate clinically is limited. This impedes the application of synthetic lethal approaches. By integrating molecular profiling data from >9,000 cancers with synthetic lethal screens, we show that transcriptomic buffering of tumor suppressor gene (TSG) loss by hyperexpression of synthetic lethal partners is a common phenomenon, extending to multiple TSGs and histotypes. Transcriptomic buffering is also notable in cancers that phenocopy TSG loss, such as BRCAness cancers, where expression of BRCA1/2 synthetic lethal genes correlates with clinical outcome. Synthetic lethal genes that exhibit transcriptomic buffering also represent more robust synthetic lethal effects. These observations have implications for understanding how tumor cells tolerate TSG loss, in part explain transcriptomic architectures in cancer and provide insight into target selection.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40033056/\"}\n",
      "{\"id\": \"40071159\", \"title\": \"Pathogenic variants in \", \"abstract\": \"Breast and ovarian cancers are significant global health challenges, with inherited variations in breast cancer gene 1 (\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40071159/\"}\n",
      "{\"id\": \"40067927\", \"title\": \"Harnessing STING Signaling and Natural Killer Cells overcomes PARP Inhibitor Resistance in Homologous Recombination Deficient Breast Cancer.\", \"abstract\": \"Homologous recombination deficiency (HRD) contributes to genomic instability and leads to sensitivity to poly ADP-ribose polymerase inhibitors (PARPi). HRD also activates the cyclic GMP-AMP synthase (cGAS)-STimulator of INterferon Genes (STING)-Interferon (IFN) pathway, highlighting the need to understand the impact of cGAS-STING-IFN signaling on PARPi efficacy. In this study, we analyzed a cohort of thirty-five breast cancer (BC) patient-derived xenografts (PDX) and mouse-derived allografts (MDA). PARPi sensitivity correlated with HRD, increased genomic instability, and activation of the cGAS-STING-IFN signaling pathway. Single-cell analyses showed that IFN signaling and IFN-based immune interactions were suppressed in preclinical models with acquired resistance to PARPi, lacking concomitant clonal expansion of functional CD8+ T cells. However, the combination of PARPi and a novel STING agonist (STINGa) increased immune infiltration and resulted in superior antitumor activity in these tumors. Notably, the efficacy of PARPi monotherapy and the combination treatment with a STINGa was dependent on Natural Killer (NK) cells. In agreement, BC patients with BRCA1/BRCA2 mutations and good responses to PARPi showed higher abundancy of CD56+ NK cells in the tumor microenvironment and treatment-engaged CD56bright NK cells in the peripheral immune compartment, compared to those with poor responses. Therefore, these findings propose the combination of PARPi and STINGa as a potential novel strategy to enhance the therapeutic response in patients with acquired PARPi resistance and highlight a pivotal role of NK cells in the PARPi antitumor activity.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40067927/\"}\n",
      "{\"id\": \"40044664\", \"title\": \"Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients.\", \"abstract\": \"Putting pancreatic adenocarcinoma (PAAD) screening into perspective for high-risk individuals could significantly reduce cancer morbidity and mortality. Previous studies have profiled somatic mutations in PAAD. In contrast, the prevalence of mutations in PAAD predisposition genes has not been defined, especially in the Asian population. Using a multi-tier cohort design and whole genome/exome sequencing, we create a comprehensive germline mutation map of PAAD in 1,123 Chinese cancer patients in comparison with 11 pan-ethnic studies. For well-known pathogenic/likely pathogenic germline variants, Chinese patients exhibit overlapping but distinct germline mutation patterns comparing with Western cohorts, highlighted by lower mutation rates in known PAAD genes including BRCA1, BRCA2, ATM, CDKN2A, and CHEK2, and distinct mutations in CFTR, RAD51D, FANCA, ERCC2, and GNAS exclusive to Chinese patients. CFTR emerges as a top candidate gene following loss of heterozygosity analysis. Using an integrative multi-omics and functional validation paradigm, we discover that deleterious variants of uncertain significance may compromise CFTR's tumor suppressor function, and demonstrate the clinical relevance by using patient derived organoids for drug screen. Our multifaceted approach not only deepens the knowledge of population differences in PAAD germline mutations but also unveils potential avenues for targeted therapeutic interventions.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40044664/\"}\n",
      "{\"id\": \"40033056\", \"title\": \"The transcriptomic architecture of common cancers reflects synthetic lethal interactions.\", \"abstract\": \"To maintain cell fitness, deleterious genetic alterations are buffered by compensatory changes in additional genes. In cancer, buffering processes could be targeted by synthetic lethality. However, despite the large-scale identification of synthetic lethal effects in preclinical models, evidence that these operate clinically is limited. This impedes the application of synthetic lethal approaches. By integrating molecular profiling data from >9,000 cancers with synthetic lethal screens, we show that transcriptomic buffering of tumor suppressor gene (TSG) loss by hyperexpression of synthetic lethal partners is a common phenomenon, extending to multiple TSGs and histotypes. Transcriptomic buffering is also notable in cancers that phenocopy TSG loss, such as BRCAness cancers, where expression of BRCA1/2 synthetic lethal genes correlates with clinical outcome. Synthetic lethal genes that exhibit transcriptomic buffering also represent more robust synthetic lethal effects. These observations have implications for understanding how tumor cells tolerate TSG loss, in part explain transcriptomic architectures in cancer and provide insight into target selection.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40033056/\"}\n",
      "{\"id\": \"40020204\", \"title\": \"Breast, Colorectal, and Pancreatic Cancer Mortality With Pathogenic Variants in \", \"abstract\": \"Oncologists encounter patients with pathogenic variants (PVs) in  Patients who were 20 years or older, diagnosed in 2013-2019 with breast, colorectal, or pancreatic cancer, and reported to SEER registries in California and Georgia were linked to germline genetic testing results from four clinical laboratories and followed through 2021. Multivariable models of cancer mortality were fit; for each cancer, the reference group was the average hazard across all genetically tested patients with that diagnosis. Each cancer was modeled separately, followed by a single model that interacted the cancer type with all covariates. In addition to fixed effects models, random effects models were used as a regularization approach to reduce overfitting. A total of 70,272 tested patients with breast (48,473 estrogen receptor-/progesterone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative; 9,957 HER2-positive; 11,842 triple-negative) cancer, 5,822 with colorectal cancer, and 1,861 with pancreatic cancer were analyzed; the mean follow-up was 3.9 years. Patients with  Patients with \", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40020204/\"}\n",
      "{\"id\": \"40079237\", \"title\": \"Insect metamorphosis and chitin metabolism under miRNA regulation: a review with current advances.\", \"abstract\": \"Insect metamorphosis is a complex developmental process regulated by microRNAs (miRNAs) and hormonal signaling pathways. Key genes driving insect ontogenic changes are precisely modulated by miRNAs, which interact with 20-hydroxyecdysone (20E) and juvenile hormone (JH) to coordinate developmental transitions. Over the past decade, significant progress has been made in understanding miRNA biogenesis, their regulatory roles in gene expression, and their involvement in critical biological processes, including metamorphosis and chitin metabolism. miRNAs are now recognized as essential regulators of chitin metabolism and hormonal signaling, ensuring precise control of insect development. Disrupting the expression of participating genes in hormone signaling pathways through miRNAs leads to aberrant metamorphosis and consequent lethal outcomes, highlighting their potential as targets for pest control. This review summarizes current advances in miRNA-mediated regulation of insect metamorphosis and chitin metabolism, with a focus on their interactions with 20E and JH signaling pathways. By integrating recent findings, we provide insights into the molecular mechanisms underlying miRNA function in developmental transitions and their potential applications in insect pest management strategies. © 2025 Society of Chemical Industry.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40079237/\"}\n",
      "{\"id\": \"40079200\", \"title\": \"Identification and validation of transcriptome-wide association study-derived genes as potential druggable targets for osteoarthritis.\", \"abstract\": \"Osteoarthritis (OA) is a widespread chronic degenerative joint disease with an increasing global impact. The pathogenesis of OA involves complex interactions between genetic and environmental factors. Despite this, the specific genetic mechanisms underlying OA remain only partially understood, hindering the development of targeted therapeutic strategies. A transcriptome-wide association study (TWAS) was conducted for site-specific OA phenotypes using functional summary-based imputation (FUSION). High-confidence candidate genes were identified through rigorous quality control measures, including joint/conditional analysis, permutation tests, best model evaluation, and colocalization analysis. Co-expression network analysis was performed to elucidate the functional biology of these candidate genes. Druggable gene targets and their structural models were retrieved from the DrugBank and SWISS-MODEL databases. Finally, the enrichment of mitogen-activated protein kinase 3 ( Utilizing the FUSION algorithm, TWAS identified 794 candidate genes for OA. After quality control, 14 genes were classified as high-confidence genes, with seven recognized as potential drug targets including  The present study identified tissue-specific candidate genes and validated high-confidence druggable targets for OA, providing new insights into the genetic landscape and biological processes involved in OA. Further functional studies are warranted to confirm these findings.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40079200/\"}\n",
      "{\"id\": \"40079180\", \"title\": \"Design, synthesis and biological evaluation of pyrazolo[3,4-\", \"abstract\": \"The discovery of novel, selective inhibitors targeting CDK2 and PIM1 kinases, which regulate cell survival, proliferation, and treatment resistance, is crucial for advancing cancer therapy. This study reports the design, synthesis, and biological evaluation of three novel pyrazolo[3,4-\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40079180/\"}\n",
      "{\"id\": \"40079158\", \"title\": \"Biological Activity of Biomarkers Associated With Metastasis in Osteosarcoma Cell Lines.\", \"abstract\": \"Osteosarcoma, a highly aggressive bone cancer primarily affecting children and young adults, remains a significant challenge in clinical oncology. Metastasis stands as the primary cause of mortality in osteosarcoma patients. However, the mechanisms driving this process remain incompletely understood. Clarifying the molecular pathways involved in metastasis is essential for enhancing patient prognoses and facilitating the development of targeted therapeutic strategies. RNA sequencing (RNA-Seq) analysis was employed to compare three conditions, hFOB1.19 versus Saos-2, hFOB1.19 versus SJSA-1, and Saos-2 versus SJSA-1, involving non-cancer osteoblasts (hFOB1.19) and highly metastatic osteosarcoma cell lines (Saos-2 and SJSA-1). Additionally, ENA datasets of RNA-Seq from osteosarcoma biopsies were included. Differentially expressed genes (DEGs) were identified and analyzed through enrichment pathway analysis and protein-protein interaction (PPI) networks. Additionally, for gene candidates, a biochemical evaluation was performed. DEGs associated with biological functions pertinent to migration, invasion, and metastasis in osteosarcoma were identified. Notably, matrix metalloproteinase-2 (MMP-2) emerged as a promising candidate. Both canonical or full-length (FL-mmp-2) and N-terminal truncated (NTT-mmp-2) isoforms were discerned in biopsies. Moreover, MMP-2's activity was characterized in cell lines. Additionally, mRNA expression of voltage-gated sodium channels (Na The gene functional enrichment analysis of DEGs enabled the identification of interaction networks in osteosarcoma, thereby revealing potential biomarkers. Moreover, the elucidated co-participation of TTX-sensitive Na\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40079158/\"}\n",
      "{\"id\": \"40079144\", \"title\": \"March2 Alleviates Aortic Aneurysm/Dissection by Regulating PKM2 Polymerization.\", \"abstract\": \"Aortic aneurysm/dissection (AAD) is a life-threatening disease lacking effective pharmacological treatment. Protein ubiquitination plays a pivotal role in cardiovascular diseases. However, the possible contribution of the E3 ubiquitin ligase March2 (membrane-associated RING finger protein 2) to the cause of AAD remains elusive. Integrated single-cell RNA sequencing analysis was conducted in human AAD tissues. Based on the screening results, we generated a mouse line of smooth muscle cell-specific March2 knockout. β-Aminopropionitrile monofumarate was used to establish AAD. Cleavage under targets and tagmentation and cleavage under targets and tagmentation-quantitative polymerase chain reaction were performed to identify possible target genes for histone H3K18 lactylation. March2 expression was downregulated in aorta from patients with AAD or β-aminopropionitrile monofumarate-induced AAD mice. β-Aminopropionitrile monofumarate-induced AAD was significantly accentuated in March2 global (March2 Our findings demonstrated that March2 is a novel endogenous defender that prevents AAD by inhibiting vascular smooth muscle cell apoptosis, suggesting that March2 represents a potential therapeutic target for AAD.\", \"pub_date\": \"2025\", \"url\": \"https://pubmed.ncbi.nlm.nih.gov/40079144/\"}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. Scientific Plausibility: The hypothesis that DDT exposure may influence BRCA1 expression through its interaction with BRCA1 lacks scientific plausibility. The phrasing suggests a circular reasoning since it posits that DDT influences BRCA1 expression by interacting with BRCA1 itself, which does not provide a clear mechanism or pathway. While environmental pollutants can affect gene expression, the specific assertion that DDT interacts directly with the BRCA1 protein to modulate its expression is not well-supported by existing biological principles.\n",
      "\n",
      "2. Novelty: While the study of environmental factors affecting BRCA1 expression is an area of interest, the specific assertion that DDT interacts with BRCA1 is not a novel concept. Many studies have explored the influence of environmental toxins on gene expression, particularly in the context of cancer. However, the specific claim made here lacks novelty as it does not present a new mechanism or pathway.\n",
      "\n",
      "3. Testability: The hypothesis is somewhat testable, but it lacks clarity. It could potentially be examined using experimental approaches that measure BRCA1 expression levels in the presence of DDT exposure. However, without a clear mechanism for how DDT interacts with BRCA1, defining specific tests becomes challenging.\n",
      "\n",
      "4. Clinical/Biological Relevance: The topic of environmental pollutants like DDT influencing BRCA1 expression has potential clinical implications, especially in cancer risk assessment and prevention. However, the lack of clarity in the proposed interaction diminishes the relevance of the hypothesis in a clinical context.\n",
      "\n",
      "5. Confidence & Reliability: The supporting literature does not provide strong evidence for the specific interaction between DDT and BRCA1. There are broader discussions on the effects of pollutants on gene expression, but the connection made here lacks empirical support and specificity.\n",
      "\n",
      "6. Technical Clarity & Completeness: The hypothesis is unclear and poorly articulated. It fails to provide a reasonable mechanism or context for how DDT could interact with BRCA1 to influence its expression. More detail is needed regarding the proposed interactions and underlying biological mechanisms.\n",
      "\n",
      "Overall Score: 4\n",
      "\n",
      "Feedback: The hypothesis requires significant refinement and clarification to enhance its scientific plausibility and testability. The assertion that DDT interacts directly with BRCA1 is circular and lacks a solid foundation in biological principles. To strengthen this hypothesis, it would be beneficial to explore how DDT might influence BRCA1 expression through indirect pathways, such as epigenetic modifications or signaling pathways. Clearer articulation of the proposed mechanisms and supporting evidence will also improve the overall credibility and relevance of the hypothesis."
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">6</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">26760</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">509</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0043</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0063</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0095</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m6\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m26760\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m509\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0043\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0063\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0095\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Critic Output]\n",
      "1. Scientific Plausibility: The hypothesis that DDT exposure may influence BRCA1 expression through its interaction with BRCA1 lacks scientific plausibility. The phrasing suggests a circular reasoning since it posits that DDT influences BRCA1 expression by interacting with BRCA1 itself, which does not provide a clear mechanism or pathway. While environmental pollutants can affect gene expression, the specific assertion that DDT interacts directly with the BRCA1 protein to modulate its expression is not well-supported by existing biological principles.\n",
      "\n",
      "2. Novelty: While the study of environmental factors affecting BRCA1 expression is an area of interest, the specific assertion that DDT interacts with BRCA1 is not a novel concept. Many studies have explored the influence of environmental toxins on gene expression, particularly in the context of cancer. However, the specific claim made here lacks novelty as it does not present a new mechanism or pathway.\n",
      "\n",
      "3. Testability: The hypothesis is somewhat testable, but it lacks clarity. It could potentially be examined using experimental approaches that measure BRCA1 expression levels in the presence of DDT exposure. However, without a clear mechanism for how DDT interacts with BRCA1, defining specific tests becomes challenging.\n",
      "\n",
      "4. Clinical/Biological Relevance: The topic of environmental pollutants like DDT influencing BRCA1 expression has potential clinical implications, especially in cancer risk assessment and prevention. However, the lack of clarity in the proposed interaction diminishes the relevance of the hypothesis in a clinical context.\n",
      "\n",
      "5. Confidence & Reliability: The supporting literature does not provide strong evidence for the specific interaction between DDT and BRCA1. There are broader discussions on the effects of pollutants on gene expression, but the connection made here lacks empirical support and specificity.\n",
      "\n",
      "6. Technical Clarity & Completeness: The hypothesis is unclear and poorly articulated. It fails to provide a reasonable mechanism or context for how DDT could interact with BRCA1 to influence its expression. More detail is needed regarding the proposed interactions and underlying biological mechanisms.\n",
      "\n",
      "Overall Score: 4\n",
      "\n",
      "Feedback: The hypothesis requires significant refinement and clarification to enhance its scientific plausibility and testability. The assertion that DDT interacts directly with BRCA1 is circular and lacks a solid foundation in biological principles. To strengthen this hypothesis, it would be beneficial to explore how DDT might influence BRCA1 expression through indirect pathways, such as epigenetic modifications or signaling pathways. Clearer articulation of the proposed mechanisms and supporting evidence will also improve the overall credibility and relevance of the hypothesis.\n",
      "\n",
      "[Critic] Extracted Overall Score: 4.0\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "neo4j:DDT,BRCA1,epigenetic modifications,signaling pathways,mechanisms"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">4</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">1395</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">23</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0002</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0003</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0097</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m4\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m1395\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m23\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0002\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0003\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0097\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Revision Decision Output]\n",
      "neo4j:DDT,BRCA1,epigenetic modifications,signaling pathways,mechanisms\n",
      "\n",
      "[Neo4j Call] Querying Neo4j with keyword: 'BRCA1 --[disease_disease | parent-child]--> BTC\n",
      "BRCA1 --[phenotype_protein | associated with]--> Abnormality of chromosome stability, Chromosome breakage\n",
      "BRCA1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, ITGAM, IVL, LAGE3, NOS1, PPP2CA, Pseudoaneurysm, RNA binding, RNA polymerase binding, enzyme binding, tubulin binding\n",
      "BRCA1 --[cellcomp_protein | interacts with]--> ADRA2B, Abnormal pulmonary fissure morphology, BRCA1-A complex, CALD1, HTRA1, Increased pitch variability of speech, MS4A1, PRPS2, PSMB6, PTGFR, RAD23A, dysraphism-cleft lip/palate-limb reduction defects syndrome, ribonucleoprotein complex\n",
      "BRCA1 --[pathway_protein | interacts with]--> Defective DNA double strand break response due to BARD1 loss of function, Defective DNA double strand break response due to BRCA1 loss of function, G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Meiotic recombination, Meiotic synapsis, Metalloprotease DUBs, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA), SUMOylation of DNA damage response and repair proteins, TP53 Regulates Transcription of DNA Repair Genes, Transcriptional Regulation by E2F6\n",
      "BRCA1 --[exposure_protein | interacts with]--> DDT\n",
      "BRCA1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "BRCA1 --[protein_protein | ppi]--> AURKA, BARD1, BRAP, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, HNRNPA2B1, INPP1, JUN, JUND, KAT5, MAPK14, MYC, PCNA, PIK3R1, PLK1, PPP1CA, PRPF3, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "BRCA1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "BRCA1 --[disease_protein | associated with]--> BRAP, ETS1\n",
      "DDT --[protein_protein | ppi]--> UBC\n",
      "DDT --[cellcomp_protein | interacts with]--> PTGFR\n",
      "DDT --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "DDT --[exposure_protein | interacts with]--> BRCA1\n",
      "BTC --[protein_protein | ppi]--> GATA1\n",
      "BTC --[disease_disease | parent-child]--> BRCA1\n",
      "BTC --[molfunc_protein | interacts with]--> PPP2CA\n",
      "BTC --[cellcomp_protein | interacts with]--> RAD23A\n",
      "BTC --[disease_phenotype_positive | phenotype present]--> KAT5\n",
      "BTC --[anatomy_protein_present | expression present]--> ETS1, ETS2\n",
      "Chromosome breakage --[phenotype_protein | associated with]--> BRCA1, MYC\n",
      "Chromosome breakage --[phenotype_phenotype | parent-child]--> Abnormality of chromosome stability\n",
      "Abnormality of chromosome stability --[phenotype_protein | associated with]--> BRCA1, MYC\n",
      "Abnormality of chromosome stability --[phenotype_phenotype | parent-child]--> Chromosome breakage\n",
      "PPP2CA --[cellcomp_protein | interacts with]--> PRPS2, RAD23A\n",
      "PPP2CA --[protein_protein | ppi]--> CDK2, CSNK2B, EGR1, EP300, ETS1, JUN, MAPK14, MYC, SMAD3, UBC\n",
      "PPP2CA --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PPP2CA --[molfunc_molfunc | parent-child]--> enzyme binding\n",
      "PPP2CA --[molfunc_protein | interacts with]--> ADGRE5, ADRA2B, AURKA, BARD1, BRAP, BRCA1, BRCA2, BTC, CALD1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, IVL, JUN, JUND, KAT5, LAGE3, MAPK14, MS4A1, MYC, NDUFS2, NOS1, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "IVL --[cellcomp_protein | interacts with]--> PTGFR, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "IVL --[molfunc_protein | interacts with]--> BRCA1, EP300, KAT5, PPP2CA\n",
      "IVL --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "ADGRE5 --[cellcomp_protein | interacts with]--> RAD23A\n",
      "ADGRE5 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "ADGRE5 --[anatomy_protein_present | expression present]--> CDK2, E2F3, ETS1, ETS2\n",
      "ADGRE5 --[molfunc_protein | interacts with]--> BRCA1, CCNT1, EGR1, ETS1, GATA1, HNF4A, JUN, JUND, PPP2CA, SMAD3, SP1, SPI1\n",
      "ITGAM --[cellcomp_protein | interacts with]--> RAD23A\n",
      "ITGAM --[molfunc_molfunc | parent-child]--> DNA binding\n",
      "ITGAM --[protein_protein | ppi]--> SP1, SPI1\n",
      "ITGAM --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "ITGAM --[molfunc_protein | interacts with]--> BRCA1, EP300, PCNA, PPP2CA, RAD23A\n",
      "LAGE3 --[protein_protein | ppi]--> UBC\n",
      "LAGE3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "LAGE3 --[molfunc_protein | interacts with]--> BRAP, BRCA1, EGR1, EP300, GATA1, HNF4A, PPP2CA, SF1, SMAD3\n",
      "LAGE3 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "NOS1 --[protein_protein | ppi]--> EGR1, SUMO1, UBC\n",
      "NOS1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1\n",
      "NOS1 --[molfunc_protein | interacts with]--> BARD1, BRAP, BRCA1, PPP2CA\n",
      "NOS1 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2, PTGFR, RAD23A\n",
      "RNA binding --[disease_disease | parent-child]--> JUN\n",
      "RNA binding --[molfunc_molfunc | parent-child]--> JUN, JUND\n",
      "RNA binding --[molfunc_protein | interacts with]--> BARD1, BRCA1, CDKN2A, CSTF1, EIF3B, HNRNPA2B1, JUN, PRPF3, SF1, SPI1, SUMO1, SUMO2, UBC, UBE2I\n",
      "enzyme binding --[molfunc_molfunc | parent-child]--> PPP2CA, RNA polymerase binding\n",
      "enzyme binding --[molfunc_protein | interacts with]--> BRCA1, JUN, JUND, MAPK14, PCNA, SUMO1, TERF2, UBE2I\n",
      "RNA polymerase binding --[molfunc_protein | interacts with]--> BRCA1, CCNT1\n",
      "RNA polymerase binding --[molfunc_molfunc | parent-child]--> enzyme binding\n",
      "DNA binding --[molfunc_molfunc | parent-child]--> ITGAM\n",
      "DNA binding --[molfunc_protein | interacts with]--> BRCA1, CCNT1, E2F1, E2F4, EGR1, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, JUN, MYC, SP1, TERF1\n",
      "tubulin binding --[molfunc_protein | interacts with]--> BRCA1\n",
      "Pseudoaneurysm --[molfunc_protein | interacts with]--> AURKA, BRCA1, JUN, NDUFS2, SMAD3, SUMO1, SUMO2, UBC\n",
      "ADRA2B --[molfunc_protein | interacts with]--> PPP2CA\n",
      "ADRA2B --[anatomy_protein_present | expression present]--> E2F3, ETS1\n",
      "ADRA2B --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "ADRA2B --[cellcomp_protein | interacts with]--> BARD1, BRAP, BRCA1, RAD23A\n",
      "HTRA1 --[protein_protein | ppi]--> CSNK2B\n",
      "HTRA1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "HTRA1 --[cellcomp_protein | interacts with]--> AURKA, BARD1, BRAP, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EP300, ETS1, ETS2, GATA1, HNF4A, HNRNPA2B1, JUN, JUND, KAT5, LAGE3, MAPK14, MS4A1, MYC, NDUFS2, NOS1, PCNA, PLK1, PPP1CA, PRPF3, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, UBC, UBE2I\n",
      "HTRA1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "RAD23A --[molfunc_protein | interacts with]--> ITGAM, PPP2CA\n",
      "RAD23A --[protein_protein | ppi]--> CCNA2, CCNB1, CHEK1, EP300, GATA1, MYC, UBC\n",
      "RAD23A --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "RAD23A --[cellcomp_protein | interacts with]--> ADGRE5, ADRA2B, Abnormal pulmonary fissure morphology, BRCA1, BTC, CALD1, CSNK2A1, CSNK2B, ETS2, HTRA1, ITGAM, JUN, MS4A1, NOS1, PIK3R1, PPP1CA, PPP2CA, PRPS2, PTGFR, SMAD3, STAT2, SUMO1, UBC\n",
      "PRPS2 --[protein_protein | ppi]--> UBC\n",
      "PRPS2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PRPS2 --[cellcomp_protein | interacts with]--> AURKA, BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, E2F1, E2F3, EGR1, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, HNRNPA2B1, JUN, KAT5, LAGE3, MAPK14, MYC, NOS1, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PSMB6, PTGFR, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, SUMO1, SUMO2, TERF1, TERF2, UBC, UBE2I\n",
      "PRPS2 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "CALD1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CALD1 --[protein_protein | ppi]--> CDK2, TERF1\n",
      "CALD1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CALD1 --[cellcomp_protein | interacts with]--> BRCA1, BRCA2, RAD23A\n",
      "PSMB6 --[disease_disease | parent-child]--> EP300\n",
      "PSMB6 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PSMB6 --[protein_protein | ppi]--> PLK1, UBC\n",
      "PSMB6 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PSMB6 --[cellcomp_protein | interacts with]--> BRCA1, EP300, HTRA1, PRPS2, PTGFR\n",
      "MS4A1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "MS4A1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "MS4A1 --[protein_protein | ppi]--> SPI1\n",
      "MS4A1 --[anatomy_protein_present | expression present]--> ETS2\n",
      "MS4A1 --[cellcomp_protein | interacts with]--> BRCA1, HTRA1, RAD23A, TUBGCP5\n",
      "PTGFR --[anatomy_protein_present | expression present]--> ETS1\n",
      "PTGFR --[cellcomp_protein | interacts with]--> BARD1, BRAP, BRCA1, CCNA2, CCNB1, CDK2, CDKN2A, CHEK1, CSNK2B, DDT, E2F4, EGR1, ETS1, HNF4A, HNRNPA2B1, IVL, LAGE3, MAPK14, NOS1, PIK3R1, PLK1, PPP1CA, PRPS2, PSMB6, PTGFR, RAD23A, SMAD3, SP1, TERF1, UBC, UBE2I\n",
      "BRCA1-A complex --[cellcomp_protein | interacts with]--> BARD1, BRCA1\n",
      "Abnormal pulmonary fissure morphology --[cellcomp_cellcomp | parent-child]--> ribonucleoprotein complex\n",
      "Abnormal pulmonary fissure morphology --[cellcomp_protein | interacts with]--> BRCA1, BRCA2, CHEK1, E2F1, MYC, NOS1, RAD23A\n",
      "dysraphism-cleft lip/palate-limb reduction defects syndrome --[cellcomp_protein | interacts with]--> BRCA1, IVL, LAGE3, PCNA, SF1, SUMO1, TERF1, TERF2\n",
      "ribonucleoprotein complex --[cellcomp_cellcomp | parent-child]--> Abnormal pulmonary fissure morphology\n",
      "ribonucleoprotein complex --[cellcomp_protein | interacts with]--> BRCA1, HNRNPA2B1\n",
      "Increased pitch variability of speech --[cellcomp_protein | interacts with]--> BARD1, BRCA1\n",
      "Meiotic synapsis --[pathway_protein | interacts with]--> BRCA1, H2AC4, TERF1, TERF2, UBE2I\n",
      "Meiotic recombination --[pathway_protein | interacts with]--> BRCA1, BRCA2, CDK2, H2AC4\n",
      "Transcriptional Regulation by E2F6 --[pathway_protein | interacts with]--> BRCA1, CHEK1, E2F1\n",
      "SUMOylation of DNA damage response and repair proteins --[pathway_protein | interacts with]--> BRCA1, CDKN2A, SUMO1, SUMO2, UBE2I\n",
      "TP53 Regulates Transcription of DNA Repair Genes --[pathway_protein | interacts with]--> BRCA1, CCNT1, CHEK1, JUN\n",
      "Regulation of TP53 Activity through Phosphorylation --[pathway_protein | interacts with]--> AURKA, BARD1, BRCA1, CCNA2, CDK2, CHEK1, CSNK2A1, CSNK2B, KAT5, MAPK14, UBC\n",
      "Metalloprotease DUBs --[pathway_protein | interacts with]--> BARD1, BRCA1, EP300, H2AC4, UBC\n",
      "Nonhomologous End-Joining (NHEJ) --[pathway_protein | interacts with]--> BARD1, BRCA1, KAT5, SUMO1\n",
      "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5\n",
      "Resolution of D-loop Structures through Holliday Junction Intermediates --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5\n",
      "HDR through Single Strand Annealing (SSA) --[pathway_protein | interacts with]--> BARD1, BRCA1, KAT5\n",
      "Processing of DNA double-strand break ends --[pathway_protein | interacts with]--> BARD1, BRCA1, CCNA2, CDK2, CHEK1, KAT5, SUMO1, SUMO2, UBC, UBE2I\n",
      "Presynaptic phase of homologous DNA pairing and strand exchange --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, CHEK1, KAT5\n",
      "Presynaptic phase of homologous DNA pairing and strand exchange --[pathway_pathway | parent-child]--> Homologous DNA Pairing and Strand Exchange\n",
      "Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks --[pathway_protein | interacts with]--> BARD1, BRCA1, KAT5, SUMO1, UBC, UBE2I\n",
      "Defective DNA double strand break response due to BRCA1 loss of function --[pathway_protein | interacts with]--> BARD1, BRCA1\n",
      "Defective DNA double strand break response due to BARD1 loss of function --[pathway_protein | interacts with]--> BARD1, BRCA1\n",
      "HDR through Homologous Recombination (HRR) --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5, PCNA, UBC\n",
      "HDR through Homologous Recombination (HRR) --[pathway_pathway | parent-child]--> Homologous DNA Pairing and Strand Exchange\n",
      "Homologous DNA Pairing and Strand Exchange --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5\n",
      "Homologous DNA Pairing and Strand Exchange --[pathway_pathway | parent-child]--> HDR through Homologous Recombination (HRR), Presynaptic phase of homologous DNA pairing and strand exchange\n",
      "G2/M DNA damage checkpoint --[pathway_protein | interacts with]--> BARD1, BRCA1, CHEK1, KAT5, SUMO1\n",
      "NDUFS2 --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm\n",
      "NDUFS2 --[cellcomp_protein | interacts with]--> HTRA1\n",
      "NDUFS2 --[protein_protein | ppi]--> MYC\n",
      "NDUFS2 --[anatomy_protein_absent | expression absent]--> ADGRE5, ADRA2B, AURKA, BARD1, BRCA1, CCNB1, CDK2, CHEK1, E2F1, E2F3, GATA1, IVL, MS4A1, SPI1\n",
      "NDUFS2 --[anatomy_protein_present | expression present]--> BRAP, CALD1, CDK2, CSNK2A1, E2F3, E2F4, EIF3B, EP300, ETS1, ETS2, HNRNPA2B1, HTRA1, INPP1, JUN, JUND, MAPK14, NDUFS2, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PSMB6, RAD23A, SF1, SKP2, SP1, STAT2, TERF1, TERF2, UBC, UBE2I\n",
      "EGR1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, LAGE3, PPP2CA\n",
      "EGR1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "EGR1 --[protein_protein | ppi]--> BRCA1, CCNT1, CDK2, CDKN2A, EP300, ETS1, ETS2, JUN, JUND, NOS1, PPP2CA, SMAD3, SP1, SUMO1, UBC\n",
      "EGR1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "EGR1 --[disease_protein | associated with]--> BRAP\n",
      "MYC --[phenotype_protein | associated with]--> Abnormality of chromosome stability, Chromosome breakage\n",
      "MYC --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2\n",
      "MYC --[protein_protein | ppi]--> AURKA, BRCA1, BRCA2, CCNB1, CCNT1, CDKN2A, CSNK2A1, CSTF1, E2F1, E2F4, EIF3B, EP300, GATA1, HNF4A, JUN, KAT5, MAPK14, NDUFS2, PLK1, PPP2CA, RAD23A, SKP2, SMAD3, SP1, UBC\n",
      "MYC --[anatomy_protein_present | expression present]--> CDK2, E2F3, ETS1, ETS2\n",
      "MYC --[disease_protein | associated with]--> BRAP\n",
      "MYC --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "TUBGCP5 --[protein_protein | ppi]--> BRCA1, ETS1, UBC\n",
      "TUBGCP5 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "TUBGCP5 --[cellcomp_protein | interacts with]--> MS4A1\n",
      "TUBGCP5 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "CCNB1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CCNB1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "CCNB1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "CCNB1 --[protein_protein | ppi]--> BRCA1, CCNA2, CDK2, E2F4, EP300, ETS1, MYC, PCNA, PLK1, RAD23A, SKP2, SP1, UBC\n",
      "CCNB1 --[anatomy_protein_present | expression present]--> ETS1, ETS2\n",
      "CDK2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CDK2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "CDK2 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "CDK2 --[protein_protein | ppi]--> BARD1, BRCA1, BRCA2, CALD1, CCNA2, CCNB1, CHEK1, E2F1, E2F4, EGR1, EP300, H2AC4, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, SKP2, SMAD3, SP1, TERF2, UBC\n",
      "CDK2 --[pathway_protein | interacts with]--> Meiotic recombination, Processing of DNA double-strand break ends, Regulation of TP53 Activity through Phosphorylation\n",
      "CDK2 --[anatomy_protein_present | expression present]--> ADGRE5, BARD1, BRAP, BRCA1, CALD1, CCNT1, CSNK2A1, DDT, E2F1, E2F3, E2F4, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NDUFS2, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SMAD3, STAT2, TERF1, TERF2, UBC, UBE2I\n",
      "PIK3R1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PIK3R1 --[cellcomp_protein | interacts with]--> PRPS2, PTGFR, RAD23A\n",
      "PIK3R1 --[protein_protein | ppi]--> AURKA, BRCA1, CDK2, CHEK1, CSNK2A1, E2F4, EP300, ETS1, GATA1, UBC\n",
      "PIK3R1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PIK3R1 --[disease_protein | associated with]--> BRAP\n",
      "ETS2 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "ETS2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A\n",
      "ETS2 --[protein_protein | ppi]--> BRCA1, EGR1, EP300, ETS1, JUN, SPI1, UBC\n",
      "ETS2 --[anatomy_protein_present | expression present]--> ADGRE5, AURKA, BARD1, BRAP, BRCA1, BRCA2, BTC, CALD1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSTF1, DDT, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, MS4A1, MYC, NDUFS2, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "SP1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "SP1 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNA2, CCNB1, CDK2, CDKN2A, E2F1, E2F3, EGR1, EP300, ETS1, GATA1, H2AC4, HNF4A, ITGAM, JUN, MAPK14, MYC, SKP2, SMAD3, SUMO1, UBC\n",
      "SP1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA\n",
      "SP1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "AURKA --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm\n",
      "AURKA --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "AURKA --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "AURKA --[protein_protein | ppi]--> BARD1, BRCA1, E2F4, EP300, HNF4A, MYC, PIK3R1, PLK1, PPP1CA, SUMO1, UBC, UBE2I\n",
      "AURKA --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "AURKA --[disease_protein | associated with]--> BRAP\n",
      "AURKA --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "KAT5 --[disease_phenotype_positive | phenotype present]--> BTC\n",
      "KAT5 --[molfunc_protein | interacts with]--> IVL, PPP2CA\n",
      "KAT5 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "KAT5 --[protein_protein | ppi]--> BARD1, BRCA1, CDKN2A, E2F1, E2F4, EP300, ETS1, MAPK14, MYC, SUMO1, UBC, UBE2I\n",
      "KAT5 --[pathway_protein | interacts with]--> G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\n",
      "KAT5 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "INPP1 --[protein_protein | ppi]--> BRCA1\n",
      "INPP1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "INPP1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PRPF3 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "PRPF3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "PRPF3 --[protein_protein | ppi]--> BRCA1, CDK2, CHEK1, CSNK2A1, SUMO2, UBC\n",
      "PRPF3 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "SF1 --[molfunc_protein | interacts with]--> LAGE3, PPP2CA, RNA binding\n",
      "SF1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "SF1 --[protein_protein | ppi]--> BRCA1, UBC\n",
      "SF1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "E2F1 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "E2F1 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2\n",
      "E2F1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "E2F1 --[protein_protein | ppi]--> BRCA1, CCNA2, CDK2, CDKN2A, CSTF1, E2F3, E2F4, EP300, JUND, KAT5, MYC, SKP2, SP1, UBC\n",
      "E2F1 --[pathway_protein | interacts with]--> Transcriptional Regulation by E2F6\n",
      "E2F1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "BRCA2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "BRCA2 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, CALD1, HTRA1, PRPS2\n",
      "BRCA2 --[pathway_protein | interacts with]--> HDR through Homologous Recombination (HRR), Homologous DNA Pairing and Strand Exchange, Meiotic recombination, Presynaptic phase of homologous DNA pairing and strand exchange, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\n",
      "BRCA2 --[protein_protein | ppi]--> BARD1, BRCA1, CCNA2, CDK2, E2F4, ETS1, MYC, PCNA, PLK1, SKP2, SMAD3, SP1, UBC\n",
      "BRCA2 --[anatomy_protein_present | expression present]--> ETS2\n",
      "BRCA2 --[disease_protein | associated with]--> BRAP\n",
      "SKP2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "SKP2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "SKP2 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNA2, CCNB1, CDK2, E2F1, E2F4, EP300, MAPK14, MYC, PPP1CA, SP1, UBC\n",
      "SKP2 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "HNRNPA2B1 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "HNRNPA2B1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, ribonucleoprotein complex\n",
      "HNRNPA2B1 --[protein_protein | ppi]--> BRCA1, CHEK1, CSNK2A1, CSNK2B, SUMO1, SUMO2, UBC\n",
      "HNRNPA2B1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "SUMO1 --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm, RNA binding, enzyme binding\n",
      "SUMO1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "SUMO1 --[protein_protein | ppi]--> AURKA, BRCA1, E2F4, EGR1, ETS1, GATA1, H2AC4, HNRNPA2B1, JUN, KAT5, NOS1, PCNA, SP1, SUMO2, UBC, UBE2I\n",
      "SUMO1 --[pathway_protein | interacts with]--> G2/M DNA damage checkpoint, Nonhomologous End-Joining (NHEJ), Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, SUMOylation of DNA damage response and repair proteins\n",
      "SUMO1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "CHEK1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CHEK1 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2, PTGFR\n",
      "CHEK1 --[pathway_protein | interacts with]--> G2/M DNA damage checkpoint, Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Regulation of TP53 Activity through Phosphorylation, TP53 Regulates Transcription of DNA Repair Genes, Transcriptional Regulation by E2F6\n",
      "CHEK1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "CHEK1 --[protein_protein | ppi]--> BRCA1, CDK2, CSNK2A1, CSNK2B, E2F3, E2F4, ETS1, HNRNPA2B1, PCNA, PIK3R1, PRPF3, RAD23A, UBC\n",
      "CHEK1 --[anatomy_protein_present | expression present]--> ETS1, ETS2\n",
      "TERF2 --[molfunc_protein | interacts with]--> PPP2CA, enzyme binding\n",
      "TERF2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "TERF2 --[pathway_protein | interacts with]--> Meiotic synapsis\n",
      "TERF2 --[protein_protein | ppi]--> BRCA1, CDK2, EP300, TERF1, UBC, UBE2I\n",
      "TERF2 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "ETS1 --[disease_protein | associated with]--> BRCA1\n",
      "ETS1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA\n",
      "ETS1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "ETS1 --[protein_protein | ppi]--> BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F4, EGR1, EP300, ETS2, HNF4A, JUN, JUND, KAT5, MAPK14, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TUBGCP5, UBC, UBE2I\n",
      "ETS1 --[anatomy_protein_present | expression present]--> ADGRE5, ADRA2B, AURKA, BARD1, BRAP, BRCA1, BTC, CALD1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, DDT, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NDUFS2, NOS1, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, PTGFR, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "TERF1 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "TERF1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "TERF1 --[pathway_protein | interacts with]--> Meiotic synapsis\n",
      "TERF1 --[protein_protein | ppi]--> BRCA1, CALD1, CSNK2A1, EP300, PLK1, TERF2, UBC\n",
      "TERF1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "H2AC4 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "H2AC4 --[cellcomp_protein | interacts with]--> PRPS2\n",
      "H2AC4 --[pathway_protein | interacts with]--> Meiotic recombination, Meiotic synapsis, Metalloprotease DUBs\n",
      "H2AC4 --[protein_protein | ppi]--> BRCA1, CDK2, EP300, GATA1, JUN, JUND, SP1, SUMO1, UBC\n",
      "GATA1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "GATA1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "GATA1 --[protein_protein | ppi]--> BRCA1, BTC, CSTF1, EP300, H2AC4, JUN, MYC, PIK3R1, PLK1, RAD23A, SMAD3, SP1, SPI1, SUMO1, UBC\n",
      "GATA1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, LAGE3, PPP2CA\n",
      "CSNK2B --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CSNK2B --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "CSNK2B --[protein_protein | ppi]--> BRCA1, CHEK1, CSNK2A1, E2F4, ETS1, HNRNPA2B1, HTRA1, JUN, MAPK14, PPP1CA, PPP2CA, SPI1, SUMO2, UBC\n",
      "CSNK2B --[anatomy_protein_present | expression present]--> E2F3, ETS1\n",
      "CSNK2B --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "PPP1CA --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PPP1CA --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "PPP1CA --[protein_protein | ppi]--> AURKA, BRCA1, CDK2, CSNK2B, ETS1, SKP2, UBC\n",
      "PPP1CA --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PCNA --[molfunc_protein | interacts with]--> ITGAM, PPP2CA, enzyme binding\n",
      "PCNA --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "PCNA --[protein_protein | ppi]--> BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CDK2, CHEK1, CSTF1, E2F4, EP300, ETS1, SUMO1, SUMO2, UBC\n",
      "PCNA --[pathway_protein | interacts with]--> HDR through Homologous Recombination (HRR)\n",
      "PCNA --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "SUMO2 --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm, RNA binding\n",
      "SUMO2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "SUMO2 --[pathway_protein | interacts with]--> Processing of DNA double-strand break ends, SUMOylation of DNA damage response and repair proteins\n",
      "SUMO2 --[protein_protein | ppi]--> BRCA1, CSNK2B, EP300, ETS1, HNRNPA2B1, JUN, JUND, PCNA, PRPF3, SUMO1, UBC, UBE2I\n",
      "SUMO2 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "SMAD3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "SMAD3 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNT1, CDK2, E2F4, EGR1, EP300, ETS1, GATA1, HNF4A, JUN, JUND, MYC, PPP2CA, SP1, UBC\n",
      "SMAD3 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "SMAD3 --[molfunc_protein | interacts with]--> ADGRE5, LAGE3, PPP2CA, Pseudoaneurysm\n",
      "E2F4 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "E2F4 --[cellcomp_protein | interacts with]--> HTRA1, PTGFR\n",
      "E2F4 --[protein_protein | ppi]--> AURKA, BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CHEK1, CSNK2B, CSTF1, E2F1, E2F3, EP300, ETS1, KAT5, MYC, PCNA, PIK3R1, PLK1, SKP2, SMAD3, STAT2, SUMO1, UBC\n",
      "E2F4 --[anatomy_protein_present | expression present]--> AURKA, BARD1, BRAP, BRCA1, CALD1, CCNA2, CCNT1, CDK2, CDKN2A, CSNK2A1, CSTF1, DDT, E2F1, E2F3, EGR1, EIF3B, EP300, ETS1, ETS2, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, NDUFS2, NOS1, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "UBE2I --[molfunc_protein | interacts with]--> PPP2CA, RNA binding, enzyme binding\n",
      "UBE2I --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "UBE2I --[protein_protein | ppi]--> AURKA, BRCA1, CDKN2A, EP300, ETS1, HNF4A, JUN, KAT5, SUMO1, SUMO2, TERF2, UBC\n",
      "UBE2I --[pathway_protein | interacts with]--> Meiotic synapsis, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, SUMOylation of DNA damage response and repair proteins\n",
      "UBE2I --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "E2F3 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "E2F3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "E2F3 --[protein_protein | ppi]--> BRCA1, CHEK1, E2F1, E2F4, SP1\n",
      "E2F3 --[anatomy_protein_present | expression present]--> ADGRE5, ADRA2B, AURKA, BARD1, BRAP, BRCA1, CALD1, CCNT1, CDK2, CDKN2A, CSNK2A1, CSNK2B, DDT, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NDUFS2, NOS1, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "E2F3 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "SPI1 --[molfunc_protein | interacts with]--> ADGRE5, PPP2CA, RNA binding\n",
      "SPI1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "SPI1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "SPI1 --[protein_protein | ppi]--> BRCA1, CSNK2A1, CSNK2B, ETS1, ETS2, GATA1, ITGAM, JUN, MS4A1\n",
      "SPI1 --[anatomy_protein_present | expression present]--> E2F3, ETS1\n",
      "EP300 --[disease_disease | parent-child]--> PSMB6\n",
      "EP300 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PSMB6\n",
      "EP300 --[protein_protein | ppi]--> AURKA, BRCA1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, E2F1, E2F4, EGR1, EIF3B, ETS1, ETS2, GATA1, H2AC4, HNF4A, JUN, JUND, KAT5, MAPK14, MYC, PCNA, PIK3R1, PLK1, PPP2CA, RAD23A, SKP2, SMAD3, SP1, STAT2, SUMO2, TERF1, TERF2, UBC, UBE2I\n",
      "EP300 --[pathway_protein | interacts with]--> Metalloprotease DUBs\n",
      "EP300 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "EP300 --[molfunc_protein | interacts with]--> DNA binding, ITGAM, IVL, LAGE3, PPP2CA\n",
      "STAT2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "STAT2 --[cellcomp_protein | interacts with]--> HTRA1, RAD23A\n",
      "STAT2 --[protein_protein | ppi]--> BRCA1, E2F4, EP300, ETS1, UBC\n",
      "STAT2 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CSTF1 --[protein_protein | ppi]--> BARD1, BRCA1, E2F1, E2F4, ETS1, GATA1, HNF4A, MYC, PCNA, UBC\n",
      "CSTF1 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "CSTF1 --[cellcomp_protein | interacts with]--> HTRA1\n",
      "CSTF1 --[anatomy_protein_present | expression present]--> E2F4, ETS1, ETS2\n",
      "UBC --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm, RNA binding\n",
      "UBC --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "UBC --[protein_protein | ppi]--> AURKA, BARD1, BRAP, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, DDT, E2F1, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, GATA1, H2AC4, HNRNPA2B1, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NOS1, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBE2I\n",
      "UBC --[pathway_protein | interacts with]--> HDR through Homologous Recombination (HRR), Metalloprotease DUBs, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation\n",
      "UBC --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "MAPK14 --[molfunc_protein | interacts with]--> PPP2CA, enzyme binding\n",
      "MAPK14 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "MAPK14 --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "MAPK14 --[protein_protein | ppi]--> BRCA1, CDKN2A, CSNK2A1, CSNK2B, EP300, ETS1, HNF4A, JUN, KAT5, MYC, PPP2CA, SKP2, SP1, UBC\n",
      "MAPK14 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CDKN2A --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "CDKN2A --[cellcomp_protein | interacts with]--> PRPS2, PTGFR\n",
      "CDKN2A --[pathway_protein | interacts with]--> SUMOylation of DNA damage response and repair proteins\n",
      "CDKN2A --[protein_protein | ppi]--> BRCA1, E2F1, EGR1, EP300, KAT5, MAPK14, MYC, SP1, UBC, UBE2I\n",
      "CDKN2A --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "JUND --[cellcomp_protein | interacts with]--> HTRA1\n",
      "JUND --[molfunc_molfunc | parent-child]--> RNA binding\n",
      "JUND --[protein_protein | ppi]--> BRCA1, E2F1, EGR1, EP300, ETS1, H2AC4, HNF4A, JUN, SMAD3, SUMO2, UBC\n",
      "JUND --[molfunc_protein | interacts with]--> ADGRE5, PPP2CA, enzyme binding\n",
      "JUND --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CCNA2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CCNA2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "CCNA2 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNB1, CDK2, E2F1, E2F4, EP300, ETS1, PCNA, RAD23A, SKP2, SP1, UBC\n",
      "CCNA2 --[pathway_protein | interacts with]--> Processing of DNA double-strand break ends, Regulation of TP53 Activity through Phosphorylation\n",
      "CCNA2 --[anatomy_protein_present | expression present]--> E2F4, ETS1, ETS2\n",
      "PLK1 --[protein_protein | ppi]--> AURKA, BRCA1, BRCA2, CCNB1, CCNT1, E2F4, EP300, ETS1, GATA1, MYC, PSMB6, TERF1, UBC\n",
      "PLK1 --[anatomy_protein_present | expression present]--> CDK2, ETS2\n",
      "PLK1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PLK1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "EIF3B --[disease_phenotype_positive | phenotype present]--> BARD1\n",
      "EIF3B --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "EIF3B --[protein_protein | ppi]--> BRCA1, EP300, MYC, UBC\n",
      "EIF3B --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CCNT1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA, RNA polymerase binding\n",
      "CCNT1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "CCNT1 --[pathway_protein | interacts with]--> TP53 Regulates Transcription of DNA Repair Genes\n",
      "CCNT1 --[protein_protein | ppi]--> BRCA1, E2F4, EGR1, EP300, ETS1, MYC, PLK1, SMAD3, UBC\n",
      "CCNT1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "HNF4A --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, LAGE3, PPP2CA\n",
      "HNF4A --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "HNF4A --[protein_protein | ppi]--> AURKA, BRCA1, CSTF1, EP300, ETS1, JUND, MAPK14, MYC, SMAD3, SP1, UBE2I\n",
      "HNF4A --[anatomy_protein_present | expression present]--> CDK2, E2F3, ETS1, ETS2\n",
      "BRAP --[molfunc_protein | interacts with]--> LAGE3, NOS1, PPP2CA\n",
      "BRAP --[cellcomp_protein | interacts with]--> ADRA2B, HTRA1, PTGFR\n",
      "BRAP --[protein_protein | ppi]--> BRCA1, UBC\n",
      "BRAP --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "BRAP --[disease_protein | associated with]--> AURKA, BRCA1, BRCA2, EGR1, MYC, PIK3R1\n",
      "CSNK2A1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CSNK2A1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A\n",
      "CSNK2A1 --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "CSNK2A1 --[protein_protein | ppi]--> BRCA1, CHEK1, CSNK2B, ETS1, HNRNPA2B1, JUN, MAPK14, MYC, PIK3R1, PRPF3, SPI1, TERF1, UBC\n",
      "CSNK2A1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "BARD1 --[molfunc_protein | interacts with]--> NOS1, PPP2CA, RNA binding\n",
      "BARD1 --[cellcomp_protein | interacts with]--> ADRA2B, BRCA1-A complex, HTRA1, Increased pitch variability of speech, PRPS2, PTGFR\n",
      "BARD1 --[pathway_protein | interacts with]--> Defective DNA double strand break response due to BARD1 loss of function, Defective DNA double strand break response due to BRCA1 loss of function, G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Metalloprotease DUBs, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\n",
      "BARD1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "BARD1 --[protein_protein | ppi]--> AURKA, BRCA1, BRCA2, CDK2, CSTF1, E2F4, ETS1, KAT5, PCNA, UBC\n",
      "BARD1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "BARD1 --[disease_phenotype_positive | phenotype present]--> EIF3B\n",
      "JUN --[disease_disease | parent-child]--> RNA binding\n",
      "JUN --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A\n",
      "JUN --[pathway_protein | interacts with]--> TP53 Regulates Transcription of DNA Repair Genes\n",
      "JUN --[molfunc_molfunc | parent-child]--> RNA binding\n",
      "JUN --[protein_protein | ppi]--> BRCA1, CSNK2A1, CSNK2B, EGR1, EP300, ETS1, ETS2, GATA1, H2AC4, JUND, MAPK14, MYC, PPP2CA, SMAD3, SP1, SPI1, SUMO1, SUMO2, UBC, UBE2I\n",
      "JUN --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "JUN --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA, Pseudoaneurysm, RNA binding, enzyme binding'\n",
      "[Neo4j Output] Aggregated KG Summary:\n",
      "\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Refined Hypothesis:\n",
      "- 'DDT exposure may influence BRCA1 expression through its direct interaction with BRCA1, potentially affecting the protein's involvement in various cellular processes such as DNA damage response and repair mechanisms. This interaction may lead to alterations in BRCA1's expression levels, impacting its associated phenotypes, including chromosome stability and breakage.'"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">4</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">30120</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">71</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0046</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0069</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0143</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m4\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m30120\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m71\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0046\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0069\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0143\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Refine Output]\n",
      "Refined Hypothesis:\n",
      "- 'DDT exposure may influence BRCA1 expression through its direct interaction with BRCA1, potentially affecting the protein's involvement in various cellular processes such as DNA damage response and repair mechanisms. This interaction may lead to alterations in BRCA1's expression levels, impacting its associated phenotypes, including chromosome stability and breakage.'\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. Scientific Plausibility: The refined hypothesis that DDT exposure may influence BRCA1 expression through direct interaction with BRCA1 is somewhat plausible; however, it does require more substantial mechanistic clarity. Current understanding suggests that environmental toxins can affect protein expression, but the specific assertion that DDT interacts directly with BRCA1, which is a critical protein in DNA damage response and repair, needs to be substantiated by experimental evidence.\n",
      "\n",
      "2. Novelty: The idea that DDT could influence BRCA1 expression introduces a potentially novel angle in the study of environmental toxins and cancer biology. However, exploring the effects of environmental pollutants on gene expression is not new, and the research could benefit from a clearer focus on how this specific interaction could differ from other known mechanisms.\n",
      "\n",
      "3. Testability: The hypothesis is testable through experimental approaches, such as co-immunoprecipitation to evaluate if DDT physically interacts with BRCA1, and assays measuring BRCA1 expression levels in cell lines exposed to DDT. However, the hypothesis would benefit from a more detailed outline of the experimental designs to validate the interaction and its biological consequences.\n",
      "\n",
      "4. Clinical/Biological Relevance: The relevance of this hypothesis to clinical outcomes is significant, especially in the context of breast cancer and other malignancies associated with BRCA1 mutations. Understanding how DDT exposure could impact BRCA1 function and expression could have implications for risk assessment and preventive strategies in cancer.\n",
      "\n",
      "5. Confidence & Reliability: While some literature supports the idea that environmental factors can affect gene expression (including BRCA1), the specific claim of DDT interacting with BRCA1 lacks substantial direct evidence at this time. More empirical studies are needed to enhance confidence in the proposed interaction.\n",
      "\n",
      "6. Technical Clarity & Completeness: The hypothesis is generally clear in its intent but could be improved by providing additional context on how the interaction is hypothesized to occur and its downstream effects on cellular processes. More detailed explanations about the mechanisms through which DDT could alter BRCA1 function would also enhance clarity.\n",
      "\n",
      "Overall Score: 6\n",
      "\n",
      "Feedback: The refined hypothesis presents an intriguing idea linking DDT exposure to BRCA1 expression and its implications for cellular processes like DNA repair. However, the hypothesis needs stronger empirical grounding to support the claim of direct interaction and a more detailed conceptual framework for how this interaction could affect BRCA1 function. Further research is warranted to explore these connections and their potential relevance to breast cancer and environmental health."
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">46889</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">498</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0073</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0137</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0216</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m46889\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m498\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0073\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0137\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0216\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Critic Output]\n",
      "1. Scientific Plausibility: The refined hypothesis that DDT exposure may influence BRCA1 expression through direct interaction with BRCA1 is somewhat plausible; however, it does require more substantial mechanistic clarity. Current understanding suggests that environmental toxins can affect protein expression, but the specific assertion that DDT interacts directly with BRCA1, which is a critical protein in DNA damage response and repair, needs to be substantiated by experimental evidence.\n",
      "\n",
      "2. Novelty: The idea that DDT could influence BRCA1 expression introduces a potentially novel angle in the study of environmental toxins and cancer biology. However, exploring the effects of environmental pollutants on gene expression is not new, and the research could benefit from a clearer focus on how this specific interaction could differ from other known mechanisms.\n",
      "\n",
      "3. Testability: The hypothesis is testable through experimental approaches, such as co-immunoprecipitation to evaluate if DDT physically interacts with BRCA1, and assays measuring BRCA1 expression levels in cell lines exposed to DDT. However, the hypothesis would benefit from a more detailed outline of the experimental designs to validate the interaction and its biological consequences.\n",
      "\n",
      "4. Clinical/Biological Relevance: The relevance of this hypothesis to clinical outcomes is significant, especially in the context of breast cancer and other malignancies associated with BRCA1 mutations. Understanding how DDT exposure could impact BRCA1 function and expression could have implications for risk assessment and preventive strategies in cancer.\n",
      "\n",
      "5. Confidence & Reliability: While some literature supports the idea that environmental factors can affect gene expression (including BRCA1), the specific claim of DDT interacting with BRCA1 lacks substantial direct evidence at this time. More empirical studies are needed to enhance confidence in the proposed interaction.\n",
      "\n",
      "6. Technical Clarity & Completeness: The hypothesis is generally clear in its intent but could be improved by providing additional context on how the interaction is hypothesized to occur and its downstream effects on cellular processes. More detailed explanations about the mechanisms through which DDT could alter BRCA1 function would also enhance clarity.\n",
      "\n",
      "Overall Score: 6\n",
      "\n",
      "Feedback: The refined hypothesis presents an intriguing idea linking DDT exposure to BRCA1 expression and its implications for cellular processes like DNA repair. However, the hypothesis needs stronger empirical grounding to support the claim of direct interaction and a more detailed conceptual framework for how this interaction could affect BRCA1 function. Further research is warranted to explore these connections and their potential relevance to breast cancer and environmental health.\n",
      "\n",
      "[Critic] Extracted Overall Score: 6.0\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "neo4j:DDT,BRCA1,DNA damage response,repair mechanisms,chromosome stability,interaction pathways"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">6</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">2141</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">25</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0003</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0007</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0219</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m6\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m2141\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m25\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0003\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0007\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0219\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Revision Decision Output]\n",
      "neo4j:DDT,BRCA1,DNA damage response,repair mechanisms,chromosome stability,interaction pathways\n",
      "\n",
      "[Neo4j Call] Querying Neo4j with keyword: 'BRCA1 --[disease_disease | parent-child]--> BTC\n",
      "BRCA1 --[phenotype_protein | associated with]--> Abnormality of chromosome stability, Chromosome breakage\n",
      "BRCA1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, ITGAM, IVL, LAGE3, NOS1, PPP2CA, Pseudoaneurysm, RNA binding, RNA polymerase binding, enzyme binding, tubulin binding\n",
      "BRCA1 --[cellcomp_protein | interacts with]--> ADRA2B, Abnormal pulmonary fissure morphology, BRCA1-A complex, CALD1, HTRA1, Increased pitch variability of speech, MS4A1, PRPS2, PSMB6, PTGFR, RAD23A, dysraphism-cleft lip/palate-limb reduction defects syndrome, ribonucleoprotein complex\n",
      "BRCA1 --[pathway_protein | interacts with]--> Defective DNA double strand break response due to BARD1 loss of function, Defective DNA double strand break response due to BRCA1 loss of function, G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Meiotic recombination, Meiotic synapsis, Metalloprotease DUBs, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA), SUMOylation of DNA damage response and repair proteins, TP53 Regulates Transcription of DNA Repair Genes, Transcriptional Regulation by E2F6\n",
      "BRCA1 --[exposure_protein | interacts with]--> DDT\n",
      "BRCA1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "BRCA1 --[protein_protein | ppi]--> AURKA, BARD1, BRAP, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, HNRNPA2B1, INPP1, JUN, JUND, KAT5, MAPK14, MYC, PCNA, PIK3R1, PLK1, PPP1CA, PRPF3, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "BRCA1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "BRCA1 --[disease_protein | associated with]--> BRAP, ETS1\n",
      "DDT --[protein_protein | ppi]--> UBC\n",
      "DDT --[cellcomp_protein | interacts with]--> PTGFR\n",
      "DDT --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "DDT --[exposure_protein | interacts with]--> BRCA1\n",
      "BTC --[protein_protein | ppi]--> GATA1\n",
      "BTC --[disease_disease | parent-child]--> BRCA1\n",
      "BTC --[molfunc_protein | interacts with]--> PPP2CA\n",
      "BTC --[cellcomp_protein | interacts with]--> RAD23A\n",
      "BTC --[disease_phenotype_positive | phenotype present]--> KAT5\n",
      "BTC --[anatomy_protein_present | expression present]--> ETS1, ETS2\n",
      "Chromosome breakage --[phenotype_protein | associated with]--> BRCA1, MYC\n",
      "Chromosome breakage --[phenotype_phenotype | parent-child]--> Abnormality of chromosome stability\n",
      "Abnormality of chromosome stability --[phenotype_protein | associated with]--> BRCA1, MYC\n",
      "Abnormality of chromosome stability --[phenotype_phenotype | parent-child]--> Chromosome breakage\n",
      "PPP2CA --[cellcomp_protein | interacts with]--> PRPS2, RAD23A\n",
      "PPP2CA --[protein_protein | ppi]--> CDK2, CSNK2B, EGR1, EP300, ETS1, JUN, MAPK14, MYC, SMAD3, UBC\n",
      "PPP2CA --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PPP2CA --[molfunc_molfunc | parent-child]--> enzyme binding\n",
      "PPP2CA --[molfunc_protein | interacts with]--> ADGRE5, ADRA2B, AURKA, BARD1, BRAP, BRCA1, BRCA2, BTC, CALD1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, IVL, JUN, JUND, KAT5, LAGE3, MAPK14, MS4A1, MYC, NDUFS2, NOS1, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "IVL --[cellcomp_protein | interacts with]--> PTGFR, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "IVL --[molfunc_protein | interacts with]--> BRCA1, EP300, KAT5, PPP2CA\n",
      "IVL --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "ADGRE5 --[cellcomp_protein | interacts with]--> RAD23A\n",
      "ADGRE5 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "ADGRE5 --[anatomy_protein_present | expression present]--> CDK2, E2F3, ETS1, ETS2\n",
      "ADGRE5 --[molfunc_protein | interacts with]--> BRCA1, CCNT1, EGR1, ETS1, GATA1, HNF4A, JUN, JUND, PPP2CA, SMAD3, SP1, SPI1\n",
      "ITGAM --[cellcomp_protein | interacts with]--> RAD23A\n",
      "ITGAM --[molfunc_molfunc | parent-child]--> DNA binding\n",
      "ITGAM --[protein_protein | ppi]--> SP1, SPI1\n",
      "ITGAM --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "ITGAM --[molfunc_protein | interacts with]--> BRCA1, EP300, PCNA, PPP2CA, RAD23A\n",
      "LAGE3 --[protein_protein | ppi]--> UBC\n",
      "LAGE3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "LAGE3 --[molfunc_protein | interacts with]--> BRAP, BRCA1, EGR1, EP300, GATA1, HNF4A, PPP2CA, SF1, SMAD3\n",
      "LAGE3 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "NOS1 --[protein_protein | ppi]--> EGR1, SUMO1, UBC\n",
      "NOS1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1\n",
      "NOS1 --[molfunc_protein | interacts with]--> BARD1, BRAP, BRCA1, PPP2CA\n",
      "NOS1 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2, PTGFR, RAD23A\n",
      "RNA binding --[disease_disease | parent-child]--> JUN\n",
      "RNA binding --[molfunc_molfunc | parent-child]--> JUN, JUND\n",
      "RNA binding --[molfunc_protein | interacts with]--> BARD1, BRCA1, CDKN2A, CSTF1, EIF3B, HNRNPA2B1, JUN, PRPF3, SF1, SPI1, SUMO1, SUMO2, UBC, UBE2I\n",
      "enzyme binding --[molfunc_molfunc | parent-child]--> PPP2CA, RNA polymerase binding\n",
      "enzyme binding --[molfunc_protein | interacts with]--> BRCA1, JUN, JUND, MAPK14, PCNA, SUMO1, TERF2, UBE2I\n",
      "RNA polymerase binding --[molfunc_protein | interacts with]--> BRCA1, CCNT1\n",
      "RNA polymerase binding --[molfunc_molfunc | parent-child]--> enzyme binding\n",
      "DNA binding --[molfunc_molfunc | parent-child]--> ITGAM\n",
      "DNA binding --[molfunc_protein | interacts with]--> BRCA1, CCNT1, E2F1, E2F4, EGR1, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, JUN, MYC, SP1, TERF1\n",
      "tubulin binding --[molfunc_protein | interacts with]--> BRCA1\n",
      "Pseudoaneurysm --[molfunc_protein | interacts with]--> AURKA, BRCA1, JUN, NDUFS2, SMAD3, SUMO1, SUMO2, UBC\n",
      "ADRA2B --[molfunc_protein | interacts with]--> PPP2CA\n",
      "ADRA2B --[anatomy_protein_present | expression present]--> E2F3, ETS1\n",
      "ADRA2B --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "ADRA2B --[cellcomp_protein | interacts with]--> BARD1, BRAP, BRCA1, RAD23A\n",
      "HTRA1 --[protein_protein | ppi]--> CSNK2B\n",
      "HTRA1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "HTRA1 --[cellcomp_protein | interacts with]--> AURKA, BARD1, BRAP, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EP300, ETS1, ETS2, GATA1, HNF4A, HNRNPA2B1, JUN, JUND, KAT5, LAGE3, MAPK14, MS4A1, MYC, NDUFS2, NOS1, PCNA, PLK1, PPP1CA, PRPF3, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, UBC, UBE2I\n",
      "HTRA1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "RAD23A --[molfunc_protein | interacts with]--> ITGAM, PPP2CA\n",
      "RAD23A --[protein_protein | ppi]--> CCNA2, CCNB1, CHEK1, EP300, GATA1, MYC, UBC\n",
      "RAD23A --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "RAD23A --[cellcomp_protein | interacts with]--> ADGRE5, ADRA2B, Abnormal pulmonary fissure morphology, BRCA1, BTC, CALD1, CSNK2A1, CSNK2B, ETS2, HTRA1, ITGAM, JUN, MS4A1, NOS1, PIK3R1, PPP1CA, PPP2CA, PRPS2, PTGFR, SMAD3, STAT2, SUMO1, UBC\n",
      "PRPS2 --[protein_protein | ppi]--> UBC\n",
      "PRPS2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PRPS2 --[cellcomp_protein | interacts with]--> AURKA, BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, E2F1, E2F3, EGR1, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, HNRNPA2B1, JUN, KAT5, LAGE3, MAPK14, MYC, NOS1, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PSMB6, PTGFR, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, SUMO1, SUMO2, TERF1, TERF2, UBC, UBE2I\n",
      "PRPS2 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "CALD1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CALD1 --[protein_protein | ppi]--> CDK2, TERF1\n",
      "CALD1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CALD1 --[cellcomp_protein | interacts with]--> BRCA1, BRCA2, RAD23A\n",
      "PSMB6 --[disease_disease | parent-child]--> EP300\n",
      "PSMB6 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PSMB6 --[protein_protein | ppi]--> PLK1, UBC\n",
      "PSMB6 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PSMB6 --[cellcomp_protein | interacts with]--> BRCA1, EP300, HTRA1, PRPS2, PTGFR\n",
      "MS4A1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "MS4A1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "MS4A1 --[protein_protein | ppi]--> SPI1\n",
      "MS4A1 --[anatomy_protein_present | expression present]--> ETS2\n",
      "MS4A1 --[cellcomp_protein | interacts with]--> BRCA1, HTRA1, RAD23A, TUBGCP5\n",
      "PTGFR --[anatomy_protein_present | expression present]--> ETS1\n",
      "PTGFR --[cellcomp_protein | interacts with]--> BARD1, BRAP, BRCA1, CCNA2, CCNB1, CDK2, CDKN2A, CHEK1, CSNK2B, DDT, E2F4, EGR1, ETS1, HNF4A, HNRNPA2B1, IVL, LAGE3, MAPK14, NOS1, PIK3R1, PLK1, PPP1CA, PRPS2, PSMB6, PTGFR, RAD23A, SMAD3, SP1, TERF1, UBC, UBE2I\n",
      "BRCA1-A complex --[cellcomp_protein | interacts with]--> BARD1, BRCA1\n",
      "Abnormal pulmonary fissure morphology --[cellcomp_cellcomp | parent-child]--> ribonucleoprotein complex\n",
      "Abnormal pulmonary fissure morphology --[cellcomp_protein | interacts with]--> BRCA1, BRCA2, CHEK1, E2F1, MYC, NOS1, RAD23A\n",
      "dysraphism-cleft lip/palate-limb reduction defects syndrome --[cellcomp_protein | interacts with]--> BRCA1, IVL, LAGE3, PCNA, SF1, SUMO1, TERF1, TERF2\n",
      "ribonucleoprotein complex --[cellcomp_cellcomp | parent-child]--> Abnormal pulmonary fissure morphology\n",
      "ribonucleoprotein complex --[cellcomp_protein | interacts with]--> BRCA1, HNRNPA2B1\n",
      "Increased pitch variability of speech --[cellcomp_protein | interacts with]--> BARD1, BRCA1\n",
      "Meiotic synapsis --[pathway_protein | interacts with]--> BRCA1, H2AC4, TERF1, TERF2, UBE2I\n",
      "Meiotic recombination --[pathway_protein | interacts with]--> BRCA1, BRCA2, CDK2, H2AC4\n",
      "Transcriptional Regulation by E2F6 --[pathway_protein | interacts with]--> BRCA1, CHEK1, E2F1\n",
      "SUMOylation of DNA damage response and repair proteins --[pathway_protein | interacts with]--> BRCA1, CDKN2A, SUMO1, SUMO2, UBE2I\n",
      "TP53 Regulates Transcription of DNA Repair Genes --[pathway_protein | interacts with]--> BRCA1, CCNT1, CHEK1, JUN\n",
      "Regulation of TP53 Activity through Phosphorylation --[pathway_protein | interacts with]--> AURKA, BARD1, BRCA1, CCNA2, CDK2, CHEK1, CSNK2A1, CSNK2B, KAT5, MAPK14, UBC\n",
      "Metalloprotease DUBs --[pathway_protein | interacts with]--> BARD1, BRCA1, EP300, H2AC4, UBC\n",
      "Nonhomologous End-Joining (NHEJ) --[pathway_protein | interacts with]--> BARD1, BRCA1, KAT5, SUMO1\n",
      "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5\n",
      "Resolution of D-loop Structures through Holliday Junction Intermediates --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5\n",
      "HDR through Single Strand Annealing (SSA) --[pathway_protein | interacts with]--> BARD1, BRCA1, KAT5\n",
      "Processing of DNA double-strand break ends --[pathway_protein | interacts with]--> BARD1, BRCA1, CCNA2, CDK2, CHEK1, KAT5, SUMO1, SUMO2, UBC, UBE2I\n",
      "Presynaptic phase of homologous DNA pairing and strand exchange --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, CHEK1, KAT5\n",
      "Presynaptic phase of homologous DNA pairing and strand exchange --[pathway_pathway | parent-child]--> Homologous DNA Pairing and Strand Exchange\n",
      "Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks --[pathway_protein | interacts with]--> BARD1, BRCA1, KAT5, SUMO1, UBC, UBE2I\n",
      "Defective DNA double strand break response due to BRCA1 loss of function --[pathway_protein | interacts with]--> BARD1, BRCA1\n",
      "Defective DNA double strand break response due to BARD1 loss of function --[pathway_protein | interacts with]--> BARD1, BRCA1\n",
      "HDR through Homologous Recombination (HRR) --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5, PCNA, UBC\n",
      "HDR through Homologous Recombination (HRR) --[pathway_pathway | parent-child]--> Homologous DNA Pairing and Strand Exchange\n",
      "Homologous DNA Pairing and Strand Exchange --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5\n",
      "Homologous DNA Pairing and Strand Exchange --[pathway_pathway | parent-child]--> HDR through Homologous Recombination (HRR), Presynaptic phase of homologous DNA pairing and strand exchange\n",
      "G2/M DNA damage checkpoint --[pathway_protein | interacts with]--> BARD1, BRCA1, CHEK1, KAT5, SUMO1\n",
      "NDUFS2 --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm\n",
      "NDUFS2 --[cellcomp_protein | interacts with]--> HTRA1\n",
      "NDUFS2 --[protein_protein | ppi]--> MYC\n",
      "NDUFS2 --[anatomy_protein_absent | expression absent]--> ADGRE5, ADRA2B, AURKA, BARD1, BRCA1, CCNB1, CDK2, CHEK1, E2F1, E2F3, GATA1, IVL, MS4A1, SPI1\n",
      "NDUFS2 --[anatomy_protein_present | expression present]--> BRAP, CALD1, CDK2, CSNK2A1, E2F3, E2F4, EIF3B, EP300, ETS1, ETS2, HNRNPA2B1, HTRA1, INPP1, JUN, JUND, MAPK14, NDUFS2, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PSMB6, RAD23A, SF1, SKP2, SP1, STAT2, TERF1, TERF2, UBC, UBE2I\n",
      "EGR1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, LAGE3, PPP2CA\n",
      "EGR1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "EGR1 --[protein_protein | ppi]--> BRCA1, CCNT1, CDK2, CDKN2A, EP300, ETS1, ETS2, JUN, JUND, NOS1, PPP2CA, SMAD3, SP1, SUMO1, UBC\n",
      "EGR1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "EGR1 --[disease_protein | associated with]--> BRAP\n",
      "MYC --[phenotype_protein | associated with]--> Abnormality of chromosome stability, Chromosome breakage\n",
      "MYC --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2\n",
      "MYC --[protein_protein | ppi]--> AURKA, BRCA1, BRCA2, CCNB1, CCNT1, CDKN2A, CSNK2A1, CSTF1, E2F1, E2F4, EIF3B, EP300, GATA1, HNF4A, JUN, KAT5, MAPK14, NDUFS2, PLK1, PPP2CA, RAD23A, SKP2, SMAD3, SP1, UBC\n",
      "MYC --[anatomy_protein_present | expression present]--> CDK2, E2F3, ETS1, ETS2\n",
      "MYC --[disease_protein | associated with]--> BRAP\n",
      "MYC --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "TUBGCP5 --[protein_protein | ppi]--> BRCA1, ETS1, UBC\n",
      "TUBGCP5 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "TUBGCP5 --[cellcomp_protein | interacts with]--> MS4A1\n",
      "TUBGCP5 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "CCNB1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CCNB1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "CCNB1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "CCNB1 --[protein_protein | ppi]--> BRCA1, CCNA2, CDK2, E2F4, EP300, ETS1, MYC, PCNA, PLK1, RAD23A, SKP2, SP1, UBC\n",
      "CCNB1 --[anatomy_protein_present | expression present]--> ETS1, ETS2\n",
      "CDK2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CDK2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "CDK2 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "CDK2 --[protein_protein | ppi]--> BARD1, BRCA1, BRCA2, CALD1, CCNA2, CCNB1, CHEK1, E2F1, E2F4, EGR1, EP300, H2AC4, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, SKP2, SMAD3, SP1, TERF2, UBC\n",
      "CDK2 --[pathway_protein | interacts with]--> Meiotic recombination, Processing of DNA double-strand break ends, Regulation of TP53 Activity through Phosphorylation\n",
      "CDK2 --[anatomy_protein_present | expression present]--> ADGRE5, BARD1, BRAP, BRCA1, CALD1, CCNT1, CSNK2A1, DDT, E2F1, E2F3, E2F4, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NDUFS2, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SMAD3, STAT2, TERF1, TERF2, UBC, UBE2I\n",
      "PIK3R1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PIK3R1 --[cellcomp_protein | interacts with]--> PRPS2, PTGFR, RAD23A\n",
      "PIK3R1 --[protein_protein | ppi]--> AURKA, BRCA1, CDK2, CHEK1, CSNK2A1, E2F4, EP300, ETS1, GATA1, UBC\n",
      "PIK3R1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PIK3R1 --[disease_protein | associated with]--> BRAP\n",
      "ETS2 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "ETS2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A\n",
      "ETS2 --[protein_protein | ppi]--> BRCA1, EGR1, EP300, ETS1, JUN, SPI1, UBC\n",
      "ETS2 --[anatomy_protein_present | expression present]--> ADGRE5, AURKA, BARD1, BRAP, BRCA1, BRCA2, BTC, CALD1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSTF1, DDT, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, MS4A1, MYC, NDUFS2, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "SP1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "SP1 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNA2, CCNB1, CDK2, CDKN2A, E2F1, E2F3, EGR1, EP300, ETS1, GATA1, H2AC4, HNF4A, ITGAM, JUN, MAPK14, MYC, SKP2, SMAD3, SUMO1, UBC\n",
      "SP1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA\n",
      "SP1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "AURKA --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm\n",
      "AURKA --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "AURKA --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "AURKA --[protein_protein | ppi]--> BARD1, BRCA1, E2F4, EP300, HNF4A, MYC, PIK3R1, PLK1, PPP1CA, SUMO1, UBC, UBE2I\n",
      "AURKA --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "AURKA --[disease_protein | associated with]--> BRAP\n",
      "AURKA --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "KAT5 --[disease_phenotype_positive | phenotype present]--> BTC\n",
      "KAT5 --[molfunc_protein | interacts with]--> IVL, PPP2CA\n",
      "KAT5 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "KAT5 --[protein_protein | ppi]--> BARD1, BRCA1, CDKN2A, E2F1, E2F4, EP300, ETS1, MAPK14, MYC, SUMO1, UBC, UBE2I\n",
      "KAT5 --[pathway_protein | interacts with]--> G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\n",
      "KAT5 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "INPP1 --[protein_protein | ppi]--> BRCA1\n",
      "INPP1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "INPP1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PRPF3 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "PRPF3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "PRPF3 --[protein_protein | ppi]--> BRCA1, CDK2, CHEK1, CSNK2A1, SUMO2, UBC\n",
      "PRPF3 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "SF1 --[molfunc_protein | interacts with]--> LAGE3, PPP2CA, RNA binding\n",
      "SF1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "SF1 --[protein_protein | ppi]--> BRCA1, UBC\n",
      "SF1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "E2F1 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "E2F1 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2\n",
      "E2F1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "E2F1 --[protein_protein | ppi]--> BRCA1, CCNA2, CDK2, CDKN2A, CSTF1, E2F3, E2F4, EP300, JUND, KAT5, MYC, SKP2, SP1, UBC\n",
      "E2F1 --[pathway_protein | interacts with]--> Transcriptional Regulation by E2F6\n",
      "E2F1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "BRCA2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "BRCA2 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, CALD1, HTRA1, PRPS2\n",
      "BRCA2 --[pathway_protein | interacts with]--> HDR through Homologous Recombination (HRR), Homologous DNA Pairing and Strand Exchange, Meiotic recombination, Presynaptic phase of homologous DNA pairing and strand exchange, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\n",
      "BRCA2 --[protein_protein | ppi]--> BARD1, BRCA1, CCNA2, CDK2, E2F4, ETS1, MYC, PCNA, PLK1, SKP2, SMAD3, SP1, UBC\n",
      "BRCA2 --[anatomy_protein_present | expression present]--> ETS2\n",
      "BRCA2 --[disease_protein | associated with]--> BRAP\n",
      "SKP2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "SKP2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "SKP2 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNA2, CCNB1, CDK2, E2F1, E2F4, EP300, MAPK14, MYC, PPP1CA, SP1, UBC\n",
      "SKP2 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "HNRNPA2B1 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "HNRNPA2B1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, ribonucleoprotein complex\n",
      "HNRNPA2B1 --[protein_protein | ppi]--> BRCA1, CHEK1, CSNK2A1, CSNK2B, SUMO1, SUMO2, UBC\n",
      "HNRNPA2B1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "SUMO1 --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm, RNA binding, enzyme binding\n",
      "SUMO1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "SUMO1 --[protein_protein | ppi]--> AURKA, BRCA1, E2F4, EGR1, ETS1, GATA1, H2AC4, HNRNPA2B1, JUN, KAT5, NOS1, PCNA, SP1, SUMO2, UBC, UBE2I\n",
      "SUMO1 --[pathway_protein | interacts with]--> G2/M DNA damage checkpoint, Nonhomologous End-Joining (NHEJ), Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, SUMOylation of DNA damage response and repair proteins\n",
      "SUMO1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "CHEK1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CHEK1 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2, PTGFR\n",
      "CHEK1 --[pathway_protein | interacts with]--> G2/M DNA damage checkpoint, Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Regulation of TP53 Activity through Phosphorylation, TP53 Regulates Transcription of DNA Repair Genes, Transcriptional Regulation by E2F6\n",
      "CHEK1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "CHEK1 --[protein_protein | ppi]--> BRCA1, CDK2, CSNK2A1, CSNK2B, E2F3, E2F4, ETS1, HNRNPA2B1, PCNA, PIK3R1, PRPF3, RAD23A, UBC\n",
      "CHEK1 --[anatomy_protein_present | expression present]--> ETS1, ETS2\n",
      "TERF2 --[molfunc_protein | interacts with]--> PPP2CA, enzyme binding\n",
      "TERF2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "TERF2 --[pathway_protein | interacts with]--> Meiotic synapsis\n",
      "TERF2 --[protein_protein | ppi]--> BRCA1, CDK2, EP300, TERF1, UBC, UBE2I\n",
      "TERF2 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "ETS1 --[disease_protein | associated with]--> BRCA1\n",
      "ETS1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA\n",
      "ETS1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "ETS1 --[protein_protein | ppi]--> BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F4, EGR1, EP300, ETS2, HNF4A, JUN, JUND, KAT5, MAPK14, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TUBGCP5, UBC, UBE2I\n",
      "ETS1 --[anatomy_protein_present | expression present]--> ADGRE5, ADRA2B, AURKA, BARD1, BRAP, BRCA1, BTC, CALD1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, DDT, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NDUFS2, NOS1, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, PTGFR, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "TERF1 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "TERF1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "TERF1 --[pathway_protein | interacts with]--> Meiotic synapsis\n",
      "TERF1 --[protein_protein | ppi]--> BRCA1, CALD1, CSNK2A1, EP300, PLK1, TERF2, UBC\n",
      "TERF1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "H2AC4 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "H2AC4 --[cellcomp_protein | interacts with]--> PRPS2\n",
      "H2AC4 --[pathway_protein | interacts with]--> Meiotic recombination, Meiotic synapsis, Metalloprotease DUBs\n",
      "H2AC4 --[protein_protein | ppi]--> BRCA1, CDK2, EP300, GATA1, JUN, JUND, SP1, SUMO1, UBC\n",
      "GATA1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "GATA1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "GATA1 --[protein_protein | ppi]--> BRCA1, BTC, CSTF1, EP300, H2AC4, JUN, MYC, PIK3R1, PLK1, RAD23A, SMAD3, SP1, SPI1, SUMO1, UBC\n",
      "GATA1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, LAGE3, PPP2CA\n",
      "CSNK2B --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CSNK2B --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "CSNK2B --[protein_protein | ppi]--> BRCA1, CHEK1, CSNK2A1, E2F4, ETS1, HNRNPA2B1, HTRA1, JUN, MAPK14, PPP1CA, PPP2CA, SPI1, SUMO2, UBC\n",
      "CSNK2B --[anatomy_protein_present | expression present]--> E2F3, ETS1\n",
      "CSNK2B --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "PPP1CA --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PPP1CA --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "PPP1CA --[protein_protein | ppi]--> AURKA, BRCA1, CDK2, CSNK2B, ETS1, SKP2, UBC\n",
      "PPP1CA --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PCNA --[molfunc_protein | interacts with]--> ITGAM, PPP2CA, enzyme binding\n",
      "PCNA --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "PCNA --[protein_protein | ppi]--> BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CDK2, CHEK1, CSTF1, E2F4, EP300, ETS1, SUMO1, SUMO2, UBC\n",
      "PCNA --[pathway_protein | interacts with]--> HDR through Homologous Recombination (HRR)\n",
      "PCNA --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "SUMO2 --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm, RNA binding\n",
      "SUMO2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "SUMO2 --[pathway_protein | interacts with]--> Processing of DNA double-strand break ends, SUMOylation of DNA damage response and repair proteins\n",
      "SUMO2 --[protein_protein | ppi]--> BRCA1, CSNK2B, EP300, ETS1, HNRNPA2B1, JUN, JUND, PCNA, PRPF3, SUMO1, UBC, UBE2I\n",
      "SUMO2 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "SMAD3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "SMAD3 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNT1, CDK2, E2F4, EGR1, EP300, ETS1, GATA1, HNF4A, JUN, JUND, MYC, PPP2CA, SP1, UBC\n",
      "SMAD3 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "SMAD3 --[molfunc_protein | interacts with]--> ADGRE5, LAGE3, PPP2CA, Pseudoaneurysm\n",
      "E2F4 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "E2F4 --[cellcomp_protein | interacts with]--> HTRA1, PTGFR\n",
      "E2F4 --[protein_protein | ppi]--> AURKA, BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CHEK1, CSNK2B, CSTF1, E2F1, E2F3, EP300, ETS1, KAT5, MYC, PCNA, PIK3R1, PLK1, SKP2, SMAD3, STAT2, SUMO1, UBC\n",
      "E2F4 --[anatomy_protein_present | expression present]--> AURKA, BARD1, BRAP, BRCA1, CALD1, CCNA2, CCNT1, CDK2, CDKN2A, CSNK2A1, CSTF1, DDT, E2F1, E2F3, EGR1, EIF3B, EP300, ETS1, ETS2, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, NDUFS2, NOS1, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "UBE2I --[molfunc_protein | interacts with]--> PPP2CA, RNA binding, enzyme binding\n",
      "UBE2I --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "UBE2I --[protein_protein | ppi]--> AURKA, BRCA1, CDKN2A, EP300, ETS1, HNF4A, JUN, KAT5, SUMO1, SUMO2, TERF2, UBC\n",
      "UBE2I --[pathway_protein | interacts with]--> Meiotic synapsis, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, SUMOylation of DNA damage response and repair proteins\n",
      "UBE2I --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "E2F3 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "E2F3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "E2F3 --[protein_protein | ppi]--> BRCA1, CHEK1, E2F1, E2F4, SP1\n",
      "E2F3 --[anatomy_protein_present | expression present]--> ADGRE5, ADRA2B, AURKA, BARD1, BRAP, BRCA1, CALD1, CCNT1, CDK2, CDKN2A, CSNK2A1, CSNK2B, DDT, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NDUFS2, NOS1, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "E2F3 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "SPI1 --[molfunc_protein | interacts with]--> ADGRE5, PPP2CA, RNA binding\n",
      "SPI1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "SPI1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "SPI1 --[protein_protein | ppi]--> BRCA1, CSNK2A1, CSNK2B, ETS1, ETS2, GATA1, ITGAM, JUN, MS4A1\n",
      "SPI1 --[anatomy_protein_present | expression present]--> E2F3, ETS1\n",
      "EP300 --[disease_disease | parent-child]--> PSMB6\n",
      "EP300 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PSMB6\n",
      "EP300 --[protein_protein | ppi]--> AURKA, BRCA1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, E2F1, E2F4, EGR1, EIF3B, ETS1, ETS2, GATA1, H2AC4, HNF4A, JUN, JUND, KAT5, MAPK14, MYC, PCNA, PIK3R1, PLK1, PPP2CA, RAD23A, SKP2, SMAD3, SP1, STAT2, SUMO2, TERF1, TERF2, UBC, UBE2I\n",
      "EP300 --[pathway_protein | interacts with]--> Metalloprotease DUBs\n",
      "EP300 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "EP300 --[molfunc_protein | interacts with]--> DNA binding, ITGAM, IVL, LAGE3, PPP2CA\n",
      "STAT2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "STAT2 --[cellcomp_protein | interacts with]--> HTRA1, RAD23A\n",
      "STAT2 --[protein_protein | ppi]--> BRCA1, E2F4, EP300, ETS1, UBC\n",
      "STAT2 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CSTF1 --[protein_protein | ppi]--> BARD1, BRCA1, E2F1, E2F4, ETS1, GATA1, HNF4A, MYC, PCNA, UBC\n",
      "CSTF1 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "CSTF1 --[cellcomp_protein | interacts with]--> HTRA1\n",
      "CSTF1 --[anatomy_protein_present | expression present]--> E2F4, ETS1, ETS2\n",
      "UBC --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm, RNA binding\n",
      "UBC --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "UBC --[protein_protein | ppi]--> AURKA, BARD1, BRAP, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, DDT, E2F1, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, GATA1, H2AC4, HNRNPA2B1, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NOS1, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBE2I\n",
      "UBC --[pathway_protein | interacts with]--> HDR through Homologous Recombination (HRR), Metalloprotease DUBs, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation\n",
      "UBC --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "MAPK14 --[molfunc_protein | interacts with]--> PPP2CA, enzyme binding\n",
      "MAPK14 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "MAPK14 --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "MAPK14 --[protein_protein | ppi]--> BRCA1, CDKN2A, CSNK2A1, CSNK2B, EP300, ETS1, HNF4A, JUN, KAT5, MYC, PPP2CA, SKP2, SP1, UBC\n",
      "MAPK14 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CDKN2A --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "CDKN2A --[cellcomp_protein | interacts with]--> PRPS2, PTGFR\n",
      "CDKN2A --[pathway_protein | interacts with]--> SUMOylation of DNA damage response and repair proteins\n",
      "CDKN2A --[protein_protein | ppi]--> BRCA1, E2F1, EGR1, EP300, KAT5, MAPK14, MYC, SP1, UBC, UBE2I\n",
      "CDKN2A --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "JUND --[cellcomp_protein | interacts with]--> HTRA1\n",
      "JUND --[molfunc_molfunc | parent-child]--> RNA binding\n",
      "JUND --[protein_protein | ppi]--> BRCA1, E2F1, EGR1, EP300, ETS1, H2AC4, HNF4A, JUN, SMAD3, SUMO2, UBC\n",
      "JUND --[molfunc_protein | interacts with]--> ADGRE5, PPP2CA, enzyme binding\n",
      "JUND --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CCNA2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CCNA2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "CCNA2 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNB1, CDK2, E2F1, E2F4, EP300, ETS1, PCNA, RAD23A, SKP2, SP1, UBC\n",
      "CCNA2 --[pathway_protein | interacts with]--> Processing of DNA double-strand break ends, Regulation of TP53 Activity through Phosphorylation\n",
      "CCNA2 --[anatomy_protein_present | expression present]--> E2F4, ETS1, ETS2\n",
      "PLK1 --[protein_protein | ppi]--> AURKA, BRCA1, BRCA2, CCNB1, CCNT1, E2F4, EP300, ETS1, GATA1, MYC, PSMB6, TERF1, UBC\n",
      "PLK1 --[anatomy_protein_present | expression present]--> CDK2, ETS2\n",
      "PLK1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PLK1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "EIF3B --[disease_phenotype_positive | phenotype present]--> BARD1\n",
      "EIF3B --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "EIF3B --[protein_protein | ppi]--> BRCA1, EP300, MYC, UBC\n",
      "EIF3B --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CCNT1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA, RNA polymerase binding\n",
      "CCNT1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "CCNT1 --[pathway_protein | interacts with]--> TP53 Regulates Transcription of DNA Repair Genes\n",
      "CCNT1 --[protein_protein | ppi]--> BRCA1, E2F4, EGR1, EP300, ETS1, MYC, PLK1, SMAD3, UBC\n",
      "CCNT1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "HNF4A --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, LAGE3, PPP2CA\n",
      "HNF4A --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "HNF4A --[protein_protein | ppi]--> AURKA, BRCA1, CSTF1, EP300, ETS1, JUND, MAPK14, MYC, SMAD3, SP1, UBE2I\n",
      "HNF4A --[anatomy_protein_present | expression present]--> CDK2, E2F3, ETS1, ETS2\n",
      "BRAP --[molfunc_protein | interacts with]--> LAGE3, NOS1, PPP2CA\n",
      "BRAP --[cellcomp_protein | interacts with]--> ADRA2B, HTRA1, PTGFR\n",
      "BRAP --[protein_protein | ppi]--> BRCA1, UBC\n",
      "BRAP --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "BRAP --[disease_protein | associated with]--> AURKA, BRCA1, BRCA2, EGR1, MYC, PIK3R1\n",
      "CSNK2A1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CSNK2A1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A\n",
      "CSNK2A1 --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "CSNK2A1 --[protein_protein | ppi]--> BRCA1, CHEK1, CSNK2B, ETS1, HNRNPA2B1, JUN, MAPK14, MYC, PIK3R1, PRPF3, SPI1, TERF1, UBC\n",
      "CSNK2A1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "BARD1 --[molfunc_protein | interacts with]--> NOS1, PPP2CA, RNA binding\n",
      "BARD1 --[cellcomp_protein | interacts with]--> ADRA2B, BRCA1-A complex, HTRA1, Increased pitch variability of speech, PRPS2, PTGFR\n",
      "BARD1 --[pathway_protein | interacts with]--> Defective DNA double strand break response due to BARD1 loss of function, Defective DNA double strand break response due to BRCA1 loss of function, G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Metalloprotease DUBs, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\n",
      "BARD1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "BARD1 --[protein_protein | ppi]--> AURKA, BRCA1, BRCA2, CDK2, CSTF1, E2F4, ETS1, KAT5, PCNA, UBC\n",
      "BARD1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "BARD1 --[disease_phenotype_positive | phenotype present]--> EIF3B\n",
      "JUN --[disease_disease | parent-child]--> RNA binding\n",
      "JUN --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A\n",
      "JUN --[pathway_protein | interacts with]--> TP53 Regulates Transcription of DNA Repair Genes\n",
      "JUN --[molfunc_molfunc | parent-child]--> RNA binding\n",
      "JUN --[protein_protein | ppi]--> BRCA1, CSNK2A1, CSNK2B, EGR1, EP300, ETS1, ETS2, GATA1, H2AC4, JUND, MAPK14, MYC, PPP2CA, SMAD3, SP1, SPI1, SUMO1, SUMO2, UBC, UBE2I\n",
      "JUN --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "JUN --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA, Pseudoaneurysm, RNA binding, enzyme binding'\n",
      "[Neo4j Output] Aggregated KG Summary:\n",
      "\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Refined Hypothesis:\n",
      "- 'DDT exposure may influence BRCA1 expression through its direct interaction with BRCA1, potentially affecting the protein's role in cellular processes, particularly in DNA damage response and repair mechanisms. This interaction could lead to alterations in BRCA1 expression levels and impair its function, which is associated with phenotypes such as chromosome instability and breakage. Moreover, the disruption in BRCA1 activity may have downstream effects on related pathways, including the G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ), further compromising genomic integrity.'"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">6</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">45219</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">118</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0069</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0137</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0288</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m6\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m45219\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m118\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0069\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0137\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0288\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Refine Output]\n",
      "Refined Hypothesis:\n",
      "- 'DDT exposure may influence BRCA1 expression through its direct interaction with BRCA1, potentially affecting the protein's role in cellular processes, particularly in DNA damage response and repair mechanisms. This interaction could lead to alterations in BRCA1 expression levels and impair its function, which is associated with phenotypes such as chromosome instability and breakage. Moreover, the disruption in BRCA1 activity may have downstream effects on related pathways, including the G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ), further compromising genomic integrity.'\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1. Scientific Plausibility: The refined hypothesis that DDT exposure may influence BRCA1 expression through direct interaction is scientifically plausible. DDT is a known environmental pollutant, and emerging evidence suggests that environmental toxins can modulate gene expression and protein function. The focus on BRCA1, a key player in DNA damage response and repair mechanisms, aligns with current understanding of cancer biology.\n",
      "\n",
      "2. Novelty: The hypothesis introduces a potentially novel angle by suggesting a direct interaction between DDT and BRCA1 that could impact its expression and function. While the role of environmental toxins in cancer risk is established, linking DDT specifically to BRCA1-related pathways adds an innovative component to the research.\n",
      "\n",
      "3. Testability: The hypothesis is testable through a variety of experimental approaches. Researchers could examine the interaction between DDT and BRCA1 through co-immunoprecipitation assays, validate expression changes through quantitative PCR and Western blots, and investigate functional outcomes on DNA damage response and repair mechanisms in cell lines exposed to DDT.\n",
      "\n",
      "4. Clinical/Biological Relevance: Understanding how DDT affects BRCA1 function and expression is clinically relevant, particularly in the context of breast cancer and other BRCA1-related malignancies. If DDT exposure is shown to impair BRCA1 function, this could have significant implications for cancer risk assessment and prevention strategies.\n",
      "\n",
      "5. Confidence & Reliability: The existing literature indicates that environmental pollutants can influence gene expression, but direct evidence linking DDT to BRCA1’s function is limited. The hypothesis would gain confidence from experimental data demonstrating the proposed interaction and its effects.\n",
      "\n",
      "6. Technical Clarity & Completeness: The refined hypothesis is well-articulated and logically structured, outlining the potential consequences of the proposed interaction. However, it could benefit from more detail regarding the specific mechanisms by which DDT might alter BRCA1 function and expression levels, as well as the nature of the expected downstream effects on pathways like the G2/M checkpoint and NHEJ.\n",
      "\n",
      "Overall Score: 7\n",
      "\n",
      "Feedback: The refined hypothesis offers a compelling avenue for research into the effects of DDT on BRCA1 and its implications for DNA damage response mechanisms. While the scientific basis is solid, experimental validation is crucial to establish the direct interaction and its consequences on BRCA1 function. The hypothesis presents an important opportunity to explore environmental risks related to cancer, and clarifying the mechanisms involved will enhance its impact and relevance. Further studies should focus on elucidating the pathways involved and assessing the broader implications for cancer biology."
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">10</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">67054</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">510</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0104</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0240</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0392</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m10\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m67054\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m510\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0104\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0240\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0392\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Critic Output]\n",
      "1. Scientific Plausibility: The refined hypothesis that DDT exposure may influence BRCA1 expression through direct interaction is scientifically plausible. DDT is a known environmental pollutant, and emerging evidence suggests that environmental toxins can modulate gene expression and protein function. The focus on BRCA1, a key player in DNA damage response and repair mechanisms, aligns with current understanding of cancer biology.\n",
      "\n",
      "2. Novelty: The hypothesis introduces a potentially novel angle by suggesting a direct interaction between DDT and BRCA1 that could impact its expression and function. While the role of environmental toxins in cancer risk is established, linking DDT specifically to BRCA1-related pathways adds an innovative component to the research.\n",
      "\n",
      "3. Testability: The hypothesis is testable through a variety of experimental approaches. Researchers could examine the interaction between DDT and BRCA1 through co-immunoprecipitation assays, validate expression changes through quantitative PCR and Western blots, and investigate functional outcomes on DNA damage response and repair mechanisms in cell lines exposed to DDT.\n",
      "\n",
      "4. Clinical/Biological Relevance: Understanding how DDT affects BRCA1 function and expression is clinically relevant, particularly in the context of breast cancer and other BRCA1-related malignancies. If DDT exposure is shown to impair BRCA1 function, this could have significant implications for cancer risk assessment and prevention strategies.\n",
      "\n",
      "5. Confidence & Reliability: The existing literature indicates that environmental pollutants can influence gene expression, but direct evidence linking DDT to BRCA1’s function is limited. The hypothesis would gain confidence from experimental data demonstrating the proposed interaction and its effects.\n",
      "\n",
      "6. Technical Clarity & Completeness: The refined hypothesis is well-articulated and logically structured, outlining the potential consequences of the proposed interaction. However, it could benefit from more detail regarding the specific mechanisms by which DDT might alter BRCA1 function and expression levels, as well as the nature of the expected downstream effects on pathways like the G2/M checkpoint and NHEJ.\n",
      "\n",
      "Overall Score: 7\n",
      "\n",
      "Feedback: The refined hypothesis offers a compelling avenue for research into the effects of DDT on BRCA1 and its implications for DNA damage response mechanisms. While the scientific basis is solid, experimental validation is crucial to establish the direct interaction and its consequences on BRCA1 function. The hypothesis presents an important opportunity to explore environmental risks related to cancer, and clarifying the mechanisms involved will enhance its impact and relevance. Further studies should focus on elucidating the pathways involved and assessing the broader implications for cancer biology.\n",
      "\n",
      "[Critic] Extracted Overall Score: 7.0\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "neo4j:DDT,BRCA1,DNA damage response,G2/M checkpoint,NHEJ,genomic integrity,mechanisms"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">2948</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">29</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0005</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0011</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0396</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m2948\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m29\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0005\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0011\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0396\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Revision Decision Output]\n",
      "neo4j:DDT,BRCA1,DNA damage response,G2/M checkpoint,NHEJ,genomic integrity,mechanisms\n",
      "\n",
      "[Neo4j Call] Querying Neo4j with keyword: 'BRCA1 --[disease_disease | parent-child]--> BTC\n",
      "BRCA1 --[phenotype_protein | associated with]--> Abnormality of chromosome stability, Chromosome breakage\n",
      "BRCA1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, ITGAM, IVL, LAGE3, NOS1, PPP2CA, Pseudoaneurysm, RNA binding, RNA polymerase binding, enzyme binding, tubulin binding\n",
      "BRCA1 --[cellcomp_protein | interacts with]--> ADRA2B, Abnormal pulmonary fissure morphology, BRCA1-A complex, CALD1, HTRA1, Increased pitch variability of speech, MS4A1, PRPS2, PSMB6, PTGFR, RAD23A, dysraphism-cleft lip/palate-limb reduction defects syndrome, ribonucleoprotein complex\n",
      "BRCA1 --[pathway_protein | interacts with]--> Defective DNA double strand break response due to BARD1 loss of function, Defective DNA double strand break response due to BRCA1 loss of function, G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Meiotic recombination, Meiotic synapsis, Metalloprotease DUBs, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA), SUMOylation of DNA damage response and repair proteins, TP53 Regulates Transcription of DNA Repair Genes, Transcriptional Regulation by E2F6\n",
      "BRCA1 --[exposure_protein | interacts with]--> DDT\n",
      "BRCA1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "BRCA1 --[protein_protein | ppi]--> AURKA, BARD1, BRAP, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, HNRNPA2B1, INPP1, JUN, JUND, KAT5, MAPK14, MYC, PCNA, PIK3R1, PLK1, PPP1CA, PRPF3, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "BRCA1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "BRCA1 --[disease_protein | associated with]--> BRAP, ETS1\n",
      "DDT --[protein_protein | ppi]--> UBC\n",
      "DDT --[cellcomp_protein | interacts with]--> PTGFR\n",
      "DDT --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "DDT --[exposure_protein | interacts with]--> BRCA1\n",
      "BTC --[protein_protein | ppi]--> GATA1\n",
      "BTC --[disease_disease | parent-child]--> BRCA1\n",
      "BTC --[molfunc_protein | interacts with]--> PPP2CA\n",
      "BTC --[cellcomp_protein | interacts with]--> RAD23A\n",
      "BTC --[disease_phenotype_positive | phenotype present]--> KAT5\n",
      "BTC --[anatomy_protein_present | expression present]--> ETS1, ETS2\n",
      "Chromosome breakage --[phenotype_protein | associated with]--> BRCA1, MYC\n",
      "Chromosome breakage --[phenotype_phenotype | parent-child]--> Abnormality of chromosome stability\n",
      "Abnormality of chromosome stability --[phenotype_protein | associated with]--> BRCA1, MYC\n",
      "Abnormality of chromosome stability --[phenotype_phenotype | parent-child]--> Chromosome breakage\n",
      "PPP2CA --[cellcomp_protein | interacts with]--> PRPS2, RAD23A\n",
      "PPP2CA --[protein_protein | ppi]--> CDK2, CSNK2B, EGR1, EP300, ETS1, JUN, MAPK14, MYC, SMAD3, UBC\n",
      "PPP2CA --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PPP2CA --[molfunc_molfunc | parent-child]--> enzyme binding\n",
      "PPP2CA --[molfunc_protein | interacts with]--> ADGRE5, ADRA2B, AURKA, BARD1, BRAP, BRCA1, BRCA2, BTC, CALD1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, IVL, JUN, JUND, KAT5, LAGE3, MAPK14, MS4A1, MYC, NDUFS2, NOS1, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "IVL --[cellcomp_protein | interacts with]--> PTGFR, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "IVL --[molfunc_protein | interacts with]--> BRCA1, EP300, KAT5, PPP2CA\n",
      "IVL --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "ADGRE5 --[cellcomp_protein | interacts with]--> RAD23A\n",
      "ADGRE5 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "ADGRE5 --[anatomy_protein_present | expression present]--> CDK2, E2F3, ETS1, ETS2\n",
      "ADGRE5 --[molfunc_protein | interacts with]--> BRCA1, CCNT1, EGR1, ETS1, GATA1, HNF4A, JUN, JUND, PPP2CA, SMAD3, SP1, SPI1\n",
      "ITGAM --[cellcomp_protein | interacts with]--> RAD23A\n",
      "ITGAM --[molfunc_molfunc | parent-child]--> DNA binding\n",
      "ITGAM --[protein_protein | ppi]--> SP1, SPI1\n",
      "ITGAM --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "ITGAM --[molfunc_protein | interacts with]--> BRCA1, EP300, PCNA, PPP2CA, RAD23A\n",
      "LAGE3 --[protein_protein | ppi]--> UBC\n",
      "LAGE3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "LAGE3 --[molfunc_protein | interacts with]--> BRAP, BRCA1, EGR1, EP300, GATA1, HNF4A, PPP2CA, SF1, SMAD3\n",
      "LAGE3 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "NOS1 --[protein_protein | ppi]--> EGR1, SUMO1, UBC\n",
      "NOS1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1\n",
      "NOS1 --[molfunc_protein | interacts with]--> BARD1, BRAP, BRCA1, PPP2CA\n",
      "NOS1 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2, PTGFR, RAD23A\n",
      "RNA binding --[disease_disease | parent-child]--> JUN\n",
      "RNA binding --[molfunc_molfunc | parent-child]--> JUN, JUND\n",
      "RNA binding --[molfunc_protein | interacts with]--> BARD1, BRCA1, CDKN2A, CSTF1, EIF3B, HNRNPA2B1, JUN, PRPF3, SF1, SPI1, SUMO1, SUMO2, UBC, UBE2I\n",
      "enzyme binding --[molfunc_molfunc | parent-child]--> PPP2CA, RNA polymerase binding\n",
      "enzyme binding --[molfunc_protein | interacts with]--> BRCA1, JUN, JUND, MAPK14, PCNA, SUMO1, TERF2, UBE2I\n",
      "RNA polymerase binding --[molfunc_protein | interacts with]--> BRCA1, CCNT1\n",
      "RNA polymerase binding --[molfunc_molfunc | parent-child]--> enzyme binding\n",
      "DNA binding --[molfunc_molfunc | parent-child]--> ITGAM\n",
      "DNA binding --[molfunc_protein | interacts with]--> BRCA1, CCNT1, E2F1, E2F4, EGR1, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, JUN, MYC, SP1, TERF1\n",
      "tubulin binding --[molfunc_protein | interacts with]--> BRCA1\n",
      "Pseudoaneurysm --[molfunc_protein | interacts with]--> AURKA, BRCA1, JUN, NDUFS2, SMAD3, SUMO1, SUMO2, UBC\n",
      "ADRA2B --[molfunc_protein | interacts with]--> PPP2CA\n",
      "ADRA2B --[anatomy_protein_present | expression present]--> E2F3, ETS1\n",
      "ADRA2B --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "ADRA2B --[cellcomp_protein | interacts with]--> BARD1, BRAP, BRCA1, RAD23A\n",
      "HTRA1 --[protein_protein | ppi]--> CSNK2B\n",
      "HTRA1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "HTRA1 --[cellcomp_protein | interacts with]--> AURKA, BARD1, BRAP, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F1, E2F3, E2F4, EGR1, EP300, ETS1, ETS2, GATA1, HNF4A, HNRNPA2B1, JUN, JUND, KAT5, LAGE3, MAPK14, MS4A1, MYC, NDUFS2, NOS1, PCNA, PLK1, PPP1CA, PRPF3, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, UBC, UBE2I\n",
      "HTRA1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "RAD23A --[molfunc_protein | interacts with]--> ITGAM, PPP2CA\n",
      "RAD23A --[protein_protein | ppi]--> CCNA2, CCNB1, CHEK1, EP300, GATA1, MYC, UBC\n",
      "RAD23A --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "RAD23A --[cellcomp_protein | interacts with]--> ADGRE5, ADRA2B, Abnormal pulmonary fissure morphology, BRCA1, BTC, CALD1, CSNK2A1, CSNK2B, ETS2, HTRA1, ITGAM, JUN, MS4A1, NOS1, PIK3R1, PPP1CA, PPP2CA, PRPS2, PTGFR, SMAD3, STAT2, SUMO1, UBC\n",
      "PRPS2 --[protein_protein | ppi]--> UBC\n",
      "PRPS2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PRPS2 --[cellcomp_protein | interacts with]--> AURKA, BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, E2F1, E2F3, EGR1, EP300, ETS1, ETS2, GATA1, H2AC4, HNF4A, HNRNPA2B1, JUN, KAT5, LAGE3, MAPK14, MYC, NOS1, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PSMB6, PTGFR, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, SUMO1, SUMO2, TERF1, TERF2, UBC, UBE2I\n",
      "PRPS2 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "CALD1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CALD1 --[protein_protein | ppi]--> CDK2, TERF1\n",
      "CALD1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CALD1 --[cellcomp_protein | interacts with]--> BRCA1, BRCA2, RAD23A\n",
      "PSMB6 --[disease_disease | parent-child]--> EP300\n",
      "PSMB6 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PSMB6 --[protein_protein | ppi]--> PLK1, UBC\n",
      "PSMB6 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PSMB6 --[cellcomp_protein | interacts with]--> BRCA1, EP300, HTRA1, PRPS2, PTGFR\n",
      "MS4A1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "MS4A1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "MS4A1 --[protein_protein | ppi]--> SPI1\n",
      "MS4A1 --[anatomy_protein_present | expression present]--> ETS2\n",
      "MS4A1 --[cellcomp_protein | interacts with]--> BRCA1, HTRA1, RAD23A, TUBGCP5\n",
      "PTGFR --[anatomy_protein_present | expression present]--> ETS1\n",
      "PTGFR --[cellcomp_protein | interacts with]--> BARD1, BRAP, BRCA1, CCNA2, CCNB1, CDK2, CDKN2A, CHEK1, CSNK2B, DDT, E2F4, EGR1, ETS1, HNF4A, HNRNPA2B1, IVL, LAGE3, MAPK14, NOS1, PIK3R1, PLK1, PPP1CA, PRPS2, PSMB6, PTGFR, RAD23A, SMAD3, SP1, TERF1, UBC, UBE2I\n",
      "BRCA1-A complex --[cellcomp_protein | interacts with]--> BARD1, BRCA1\n",
      "Abnormal pulmonary fissure morphology --[cellcomp_cellcomp | parent-child]--> ribonucleoprotein complex\n",
      "Abnormal pulmonary fissure morphology --[cellcomp_protein | interacts with]--> BRCA1, BRCA2, CHEK1, E2F1, MYC, NOS1, RAD23A\n",
      "dysraphism-cleft lip/palate-limb reduction defects syndrome --[cellcomp_protein | interacts with]--> BRCA1, IVL, LAGE3, PCNA, SF1, SUMO1, TERF1, TERF2\n",
      "ribonucleoprotein complex --[cellcomp_cellcomp | parent-child]--> Abnormal pulmonary fissure morphology\n",
      "ribonucleoprotein complex --[cellcomp_protein | interacts with]--> BRCA1, HNRNPA2B1\n",
      "Increased pitch variability of speech --[cellcomp_protein | interacts with]--> BARD1, BRCA1\n",
      "Meiotic synapsis --[pathway_protein | interacts with]--> BRCA1, H2AC4, TERF1, TERF2, UBE2I\n",
      "Meiotic recombination --[pathway_protein | interacts with]--> BRCA1, BRCA2, CDK2, H2AC4\n",
      "Transcriptional Regulation by E2F6 --[pathway_protein | interacts with]--> BRCA1, CHEK1, E2F1\n",
      "SUMOylation of DNA damage response and repair proteins --[pathway_protein | interacts with]--> BRCA1, CDKN2A, SUMO1, SUMO2, UBE2I\n",
      "TP53 Regulates Transcription of DNA Repair Genes --[pathway_protein | interacts with]--> BRCA1, CCNT1, CHEK1, JUN\n",
      "Regulation of TP53 Activity through Phosphorylation --[pathway_protein | interacts with]--> AURKA, BARD1, BRCA1, CCNA2, CDK2, CHEK1, CSNK2A1, CSNK2B, KAT5, MAPK14, UBC\n",
      "Metalloprotease DUBs --[pathway_protein | interacts with]--> BARD1, BRCA1, EP300, H2AC4, UBC\n",
      "Nonhomologous End-Joining (NHEJ) --[pathway_protein | interacts with]--> BARD1, BRCA1, KAT5, SUMO1\n",
      "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5\n",
      "Resolution of D-loop Structures through Holliday Junction Intermediates --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5\n",
      "HDR through Single Strand Annealing (SSA) --[pathway_protein | interacts with]--> BARD1, BRCA1, KAT5\n",
      "Processing of DNA double-strand break ends --[pathway_protein | interacts with]--> BARD1, BRCA1, CCNA2, CDK2, CHEK1, KAT5, SUMO1, SUMO2, UBC, UBE2I\n",
      "Presynaptic phase of homologous DNA pairing and strand exchange --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, CHEK1, KAT5\n",
      "Presynaptic phase of homologous DNA pairing and strand exchange --[pathway_pathway | parent-child]--> Homologous DNA Pairing and Strand Exchange\n",
      "Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks --[pathway_protein | interacts with]--> BARD1, BRCA1, KAT5, SUMO1, UBC, UBE2I\n",
      "Defective DNA double strand break response due to BRCA1 loss of function --[pathway_protein | interacts with]--> BARD1, BRCA1\n",
      "Defective DNA double strand break response due to BARD1 loss of function --[pathway_protein | interacts with]--> BARD1, BRCA1\n",
      "HDR through Homologous Recombination (HRR) --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5, PCNA, UBC\n",
      "HDR through Homologous Recombination (HRR) --[pathway_pathway | parent-child]--> Homologous DNA Pairing and Strand Exchange\n",
      "Homologous DNA Pairing and Strand Exchange --[pathway_protein | interacts with]--> BARD1, BRCA1, BRCA2, KAT5\n",
      "Homologous DNA Pairing and Strand Exchange --[pathway_pathway | parent-child]--> HDR through Homologous Recombination (HRR), Presynaptic phase of homologous DNA pairing and strand exchange\n",
      "G2/M DNA damage checkpoint --[pathway_protein | interacts with]--> BARD1, BRCA1, CHEK1, KAT5, SUMO1\n",
      "NDUFS2 --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm\n",
      "NDUFS2 --[cellcomp_protein | interacts with]--> HTRA1\n",
      "NDUFS2 --[protein_protein | ppi]--> MYC\n",
      "NDUFS2 --[anatomy_protein_absent | expression absent]--> ADGRE5, ADRA2B, AURKA, BARD1, BRCA1, CCNB1, CDK2, CHEK1, E2F1, E2F3, GATA1, IVL, MS4A1, SPI1\n",
      "NDUFS2 --[anatomy_protein_present | expression present]--> BRAP, CALD1, CDK2, CSNK2A1, E2F3, E2F4, EIF3B, EP300, ETS1, ETS2, HNRNPA2B1, HTRA1, INPP1, JUN, JUND, MAPK14, NDUFS2, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PSMB6, RAD23A, SF1, SKP2, SP1, STAT2, TERF1, TERF2, UBC, UBE2I\n",
      "EGR1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, LAGE3, PPP2CA\n",
      "EGR1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "EGR1 --[protein_protein | ppi]--> BRCA1, CCNT1, CDK2, CDKN2A, EP300, ETS1, ETS2, JUN, JUND, NOS1, PPP2CA, SMAD3, SP1, SUMO1, UBC\n",
      "EGR1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "EGR1 --[disease_protein | associated with]--> BRAP\n",
      "MYC --[phenotype_protein | associated with]--> Abnormality of chromosome stability, Chromosome breakage\n",
      "MYC --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2\n",
      "MYC --[protein_protein | ppi]--> AURKA, BRCA1, BRCA2, CCNB1, CCNT1, CDKN2A, CSNK2A1, CSTF1, E2F1, E2F4, EIF3B, EP300, GATA1, HNF4A, JUN, KAT5, MAPK14, NDUFS2, PLK1, PPP2CA, RAD23A, SKP2, SMAD3, SP1, UBC\n",
      "MYC --[anatomy_protein_present | expression present]--> CDK2, E2F3, ETS1, ETS2\n",
      "MYC --[disease_protein | associated with]--> BRAP\n",
      "MYC --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "TUBGCP5 --[protein_protein | ppi]--> BRCA1, ETS1, UBC\n",
      "TUBGCP5 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "TUBGCP5 --[cellcomp_protein | interacts with]--> MS4A1\n",
      "TUBGCP5 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "CCNB1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CCNB1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "CCNB1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "CCNB1 --[protein_protein | ppi]--> BRCA1, CCNA2, CDK2, E2F4, EP300, ETS1, MYC, PCNA, PLK1, RAD23A, SKP2, SP1, UBC\n",
      "CCNB1 --[anatomy_protein_present | expression present]--> ETS1, ETS2\n",
      "CDK2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CDK2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "CDK2 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "CDK2 --[protein_protein | ppi]--> BARD1, BRCA1, BRCA2, CALD1, CCNA2, CCNB1, CHEK1, E2F1, E2F4, EGR1, EP300, H2AC4, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, SKP2, SMAD3, SP1, TERF2, UBC\n",
      "CDK2 --[pathway_protein | interacts with]--> Meiotic recombination, Processing of DNA double-strand break ends, Regulation of TP53 Activity through Phosphorylation\n",
      "CDK2 --[anatomy_protein_present | expression present]--> ADGRE5, BARD1, BRAP, BRCA1, CALD1, CCNT1, CSNK2A1, DDT, E2F1, E2F3, E2F4, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NDUFS2, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SMAD3, STAT2, TERF1, TERF2, UBC, UBE2I\n",
      "PIK3R1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PIK3R1 --[cellcomp_protein | interacts with]--> PRPS2, PTGFR, RAD23A\n",
      "PIK3R1 --[protein_protein | ppi]--> AURKA, BRCA1, CDK2, CHEK1, CSNK2A1, E2F4, EP300, ETS1, GATA1, UBC\n",
      "PIK3R1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PIK3R1 --[disease_protein | associated with]--> BRAP\n",
      "ETS2 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "ETS2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A\n",
      "ETS2 --[protein_protein | ppi]--> BRCA1, EGR1, EP300, ETS1, JUN, SPI1, UBC\n",
      "ETS2 --[anatomy_protein_present | expression present]--> ADGRE5, AURKA, BARD1, BRAP, BRCA1, BRCA2, BTC, CALD1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSTF1, DDT, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, MS4A1, MYC, NDUFS2, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "SP1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "SP1 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNA2, CCNB1, CDK2, CDKN2A, E2F1, E2F3, EGR1, EP300, ETS1, GATA1, H2AC4, HNF4A, ITGAM, JUN, MAPK14, MYC, SKP2, SMAD3, SUMO1, UBC\n",
      "SP1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA\n",
      "SP1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "AURKA --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm\n",
      "AURKA --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "AURKA --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "AURKA --[protein_protein | ppi]--> BARD1, BRCA1, E2F4, EP300, HNF4A, MYC, PIK3R1, PLK1, PPP1CA, SUMO1, UBC, UBE2I\n",
      "AURKA --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "AURKA --[disease_protein | associated with]--> BRAP\n",
      "AURKA --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "KAT5 --[disease_phenotype_positive | phenotype present]--> BTC\n",
      "KAT5 --[molfunc_protein | interacts with]--> IVL, PPP2CA\n",
      "KAT5 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "KAT5 --[protein_protein | ppi]--> BARD1, BRCA1, CDKN2A, E2F1, E2F4, EP300, ETS1, MAPK14, MYC, SUMO1, UBC, UBE2I\n",
      "KAT5 --[pathway_protein | interacts with]--> G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\n",
      "KAT5 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "INPP1 --[protein_protein | ppi]--> BRCA1\n",
      "INPP1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "INPP1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PRPF3 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "PRPF3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "PRPF3 --[protein_protein | ppi]--> BRCA1, CDK2, CHEK1, CSNK2A1, SUMO2, UBC\n",
      "PRPF3 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "SF1 --[molfunc_protein | interacts with]--> LAGE3, PPP2CA, RNA binding\n",
      "SF1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "SF1 --[protein_protein | ppi]--> BRCA1, UBC\n",
      "SF1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "E2F1 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "E2F1 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2\n",
      "E2F1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "E2F1 --[protein_protein | ppi]--> BRCA1, CCNA2, CDK2, CDKN2A, CSTF1, E2F3, E2F4, EP300, JUND, KAT5, MYC, SKP2, SP1, UBC\n",
      "E2F1 --[pathway_protein | interacts with]--> Transcriptional Regulation by E2F6\n",
      "E2F1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "BRCA2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "BRCA2 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, CALD1, HTRA1, PRPS2\n",
      "BRCA2 --[pathway_protein | interacts with]--> HDR through Homologous Recombination (HRR), Homologous DNA Pairing and Strand Exchange, Meiotic recombination, Presynaptic phase of homologous DNA pairing and strand exchange, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\n",
      "BRCA2 --[protein_protein | ppi]--> BARD1, BRCA1, CCNA2, CDK2, E2F4, ETS1, MYC, PCNA, PLK1, SKP2, SMAD3, SP1, UBC\n",
      "BRCA2 --[anatomy_protein_present | expression present]--> ETS2\n",
      "BRCA2 --[disease_protein | associated with]--> BRAP\n",
      "SKP2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "SKP2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "SKP2 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNA2, CCNB1, CDK2, E2F1, E2F4, EP300, MAPK14, MYC, PPP1CA, SP1, UBC\n",
      "SKP2 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "HNRNPA2B1 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "HNRNPA2B1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, ribonucleoprotein complex\n",
      "HNRNPA2B1 --[protein_protein | ppi]--> BRCA1, CHEK1, CSNK2A1, CSNK2B, SUMO1, SUMO2, UBC\n",
      "HNRNPA2B1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "SUMO1 --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm, RNA binding, enzyme binding\n",
      "SUMO1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "SUMO1 --[protein_protein | ppi]--> AURKA, BRCA1, E2F4, EGR1, ETS1, GATA1, H2AC4, HNRNPA2B1, JUN, KAT5, NOS1, PCNA, SP1, SUMO2, UBC, UBE2I\n",
      "SUMO1 --[pathway_protein | interacts with]--> G2/M DNA damage checkpoint, Nonhomologous End-Joining (NHEJ), Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, SUMOylation of DNA damage response and repair proteins\n",
      "SUMO1 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "CHEK1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CHEK1 --[cellcomp_protein | interacts with]--> Abnormal pulmonary fissure morphology, HTRA1, PRPS2, PTGFR\n",
      "CHEK1 --[pathway_protein | interacts with]--> G2/M DNA damage checkpoint, Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Regulation of TP53 Activity through Phosphorylation, TP53 Regulates Transcription of DNA Repair Genes, Transcriptional Regulation by E2F6\n",
      "CHEK1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "CHEK1 --[protein_protein | ppi]--> BRCA1, CDK2, CSNK2A1, CSNK2B, E2F3, E2F4, ETS1, HNRNPA2B1, PCNA, PIK3R1, PRPF3, RAD23A, UBC\n",
      "CHEK1 --[anatomy_protein_present | expression present]--> ETS1, ETS2\n",
      "TERF2 --[molfunc_protein | interacts with]--> PPP2CA, enzyme binding\n",
      "TERF2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "TERF2 --[pathway_protein | interacts with]--> Meiotic synapsis\n",
      "TERF2 --[protein_protein | ppi]--> BRCA1, CDK2, EP300, TERF1, UBC, UBE2I\n",
      "TERF2 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "ETS1 --[disease_protein | associated with]--> BRCA1\n",
      "ETS1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA\n",
      "ETS1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "ETS1 --[protein_protein | ppi]--> BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CHEK1, CSNK2A1, CSNK2B, CSTF1, E2F4, EGR1, EP300, ETS2, HNF4A, JUN, JUND, KAT5, MAPK14, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TUBGCP5, UBC, UBE2I\n",
      "ETS1 --[anatomy_protein_present | expression present]--> ADGRE5, ADRA2B, AURKA, BARD1, BRAP, BRCA1, BTC, CALD1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, DDT, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NDUFS2, NOS1, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, PTGFR, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "TERF1 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "TERF1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "TERF1 --[pathway_protein | interacts with]--> Meiotic synapsis\n",
      "TERF1 --[protein_protein | ppi]--> BRCA1, CALD1, CSNK2A1, EP300, PLK1, TERF2, UBC\n",
      "TERF1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "H2AC4 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "H2AC4 --[cellcomp_protein | interacts with]--> PRPS2\n",
      "H2AC4 --[pathway_protein | interacts with]--> Meiotic recombination, Meiotic synapsis, Metalloprotease DUBs\n",
      "H2AC4 --[protein_protein | ppi]--> BRCA1, CDK2, EP300, GATA1, JUN, JUND, SP1, SUMO1, UBC\n",
      "GATA1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "GATA1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "GATA1 --[protein_protein | ppi]--> BRCA1, BTC, CSTF1, EP300, H2AC4, JUN, MYC, PIK3R1, PLK1, RAD23A, SMAD3, SP1, SPI1, SUMO1, UBC\n",
      "GATA1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, LAGE3, PPP2CA\n",
      "CSNK2B --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CSNK2B --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "CSNK2B --[protein_protein | ppi]--> BRCA1, CHEK1, CSNK2A1, E2F4, ETS1, HNRNPA2B1, HTRA1, JUN, MAPK14, PPP1CA, PPP2CA, SPI1, SUMO2, UBC\n",
      "CSNK2B --[anatomy_protein_present | expression present]--> E2F3, ETS1\n",
      "CSNK2B --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "PPP1CA --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PPP1CA --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "PPP1CA --[protein_protein | ppi]--> AURKA, BRCA1, CDK2, CSNK2B, ETS1, SKP2, UBC\n",
      "PPP1CA --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "PCNA --[molfunc_protein | interacts with]--> ITGAM, PPP2CA, enzyme binding\n",
      "PCNA --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, dysraphism-cleft lip/palate-limb reduction defects syndrome\n",
      "PCNA --[protein_protein | ppi]--> BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CDK2, CHEK1, CSTF1, E2F4, EP300, ETS1, SUMO1, SUMO2, UBC\n",
      "PCNA --[pathway_protein | interacts with]--> HDR through Homologous Recombination (HRR)\n",
      "PCNA --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "SUMO2 --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm, RNA binding\n",
      "SUMO2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "SUMO2 --[pathway_protein | interacts with]--> Processing of DNA double-strand break ends, SUMOylation of DNA damage response and repair proteins\n",
      "SUMO2 --[protein_protein | ppi]--> BRCA1, CSNK2B, EP300, ETS1, HNRNPA2B1, JUN, JUND, PCNA, PRPF3, SUMO1, UBC, UBE2I\n",
      "SUMO2 --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "SMAD3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "SMAD3 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNT1, CDK2, E2F4, EGR1, EP300, ETS1, GATA1, HNF4A, JUN, JUND, MYC, PPP2CA, SP1, UBC\n",
      "SMAD3 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "SMAD3 --[molfunc_protein | interacts with]--> ADGRE5, LAGE3, PPP2CA, Pseudoaneurysm\n",
      "E2F4 --[molfunc_protein | interacts with]--> DNA binding, PPP2CA\n",
      "E2F4 --[cellcomp_protein | interacts with]--> HTRA1, PTGFR\n",
      "E2F4 --[protein_protein | ppi]--> AURKA, BARD1, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CHEK1, CSNK2B, CSTF1, E2F1, E2F3, EP300, ETS1, KAT5, MYC, PCNA, PIK3R1, PLK1, SKP2, SMAD3, STAT2, SUMO1, UBC\n",
      "E2F4 --[anatomy_protein_present | expression present]--> AURKA, BARD1, BRAP, BRCA1, CALD1, CCNA2, CCNT1, CDK2, CDKN2A, CSNK2A1, CSTF1, DDT, E2F1, E2F3, EGR1, EIF3B, EP300, ETS1, ETS2, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, NDUFS2, NOS1, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "UBE2I --[molfunc_protein | interacts with]--> PPP2CA, RNA binding, enzyme binding\n",
      "UBE2I --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "UBE2I --[protein_protein | ppi]--> AURKA, BRCA1, CDKN2A, EP300, ETS1, HNF4A, JUN, KAT5, SUMO1, SUMO2, TERF2, UBC\n",
      "UBE2I --[pathway_protein | interacts with]--> Meiotic synapsis, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, SUMOylation of DNA damage response and repair proteins\n",
      "UBE2I --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "E2F3 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "E2F3 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "E2F3 --[protein_protein | ppi]--> BRCA1, CHEK1, E2F1, E2F4, SP1\n",
      "E2F3 --[anatomy_protein_present | expression present]--> ADGRE5, ADRA2B, AURKA, BARD1, BRAP, BRCA1, CALD1, CCNT1, CDK2, CDKN2A, CSNK2A1, CSNK2B, DDT, E2F1, E2F3, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, HNF4A, HNRNPA2B1, HTRA1, INPP1, ITGAM, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NDUFS2, NOS1, PCNA, PIK3R1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, SPI1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBC, UBE2I\n",
      "E2F3 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "SPI1 --[molfunc_protein | interacts with]--> ADGRE5, PPP2CA, RNA binding\n",
      "SPI1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "SPI1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "SPI1 --[protein_protein | ppi]--> BRCA1, CSNK2A1, CSNK2B, ETS1, ETS2, GATA1, ITGAM, JUN, MS4A1\n",
      "SPI1 --[anatomy_protein_present | expression present]--> E2F3, ETS1\n",
      "EP300 --[disease_disease | parent-child]--> PSMB6\n",
      "EP300 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PSMB6\n",
      "EP300 --[protein_protein | ppi]--> AURKA, BRCA1, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, E2F1, E2F4, EGR1, EIF3B, ETS1, ETS2, GATA1, H2AC4, HNF4A, JUN, JUND, KAT5, MAPK14, MYC, PCNA, PIK3R1, PLK1, PPP2CA, RAD23A, SKP2, SMAD3, SP1, STAT2, SUMO2, TERF1, TERF2, UBC, UBE2I\n",
      "EP300 --[pathway_protein | interacts with]--> Metalloprotease DUBs\n",
      "EP300 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "EP300 --[molfunc_protein | interacts with]--> DNA binding, ITGAM, IVL, LAGE3, PPP2CA\n",
      "STAT2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "STAT2 --[cellcomp_protein | interacts with]--> HTRA1, RAD23A\n",
      "STAT2 --[protein_protein | ppi]--> BRCA1, E2F4, EP300, ETS1, UBC\n",
      "STAT2 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CSTF1 --[protein_protein | ppi]--> BARD1, BRCA1, E2F1, E2F4, ETS1, GATA1, HNF4A, MYC, PCNA, UBC\n",
      "CSTF1 --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "CSTF1 --[cellcomp_protein | interacts with]--> HTRA1\n",
      "CSTF1 --[anatomy_protein_present | expression present]--> E2F4, ETS1, ETS2\n",
      "UBC --[molfunc_protein | interacts with]--> PPP2CA, Pseudoaneurysm, RNA binding\n",
      "UBC --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR, RAD23A\n",
      "UBC --[protein_protein | ppi]--> AURKA, BARD1, BRAP, BRCA1, BRCA2, CCNA2, CCNB1, CCNT1, CDK2, CDKN2A, CHEK1, CSNK2A1, CSNK2B, CSTF1, DDT, E2F1, E2F4, EGR1, EIF3B, EP300, ETS1, ETS2, GATA1, H2AC4, HNRNPA2B1, JUN, JUND, KAT5, LAGE3, MAPK14, MYC, NOS1, PCNA, PIK3R1, PLK1, PPP1CA, PPP2CA, PRPF3, PRPS2, PSMB6, RAD23A, SF1, SKP2, SMAD3, SP1, STAT2, SUMO1, SUMO2, TERF1, TERF2, TUBGCP5, UBE2I\n",
      "UBC --[pathway_protein | interacts with]--> HDR through Homologous Recombination (HRR), Metalloprotease DUBs, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation\n",
      "UBC --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "MAPK14 --[molfunc_protein | interacts with]--> PPP2CA, enzyme binding\n",
      "MAPK14 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "MAPK14 --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "MAPK14 --[protein_protein | ppi]--> BRCA1, CDKN2A, CSNK2A1, CSNK2B, EP300, ETS1, HNF4A, JUN, KAT5, MYC, PPP2CA, SKP2, SP1, UBC\n",
      "MAPK14 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CDKN2A --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "CDKN2A --[cellcomp_protein | interacts with]--> PRPS2, PTGFR\n",
      "CDKN2A --[pathway_protein | interacts with]--> SUMOylation of DNA damage response and repair proteins\n",
      "CDKN2A --[protein_protein | ppi]--> BRCA1, E2F1, EGR1, EP300, KAT5, MAPK14, MYC, SP1, UBC, UBE2I\n",
      "CDKN2A --[anatomy_protein_present | expression present]--> E2F3, E2F4, ETS1, ETS2\n",
      "JUND --[cellcomp_protein | interacts with]--> HTRA1\n",
      "JUND --[molfunc_molfunc | parent-child]--> RNA binding\n",
      "JUND --[protein_protein | ppi]--> BRCA1, E2F1, EGR1, EP300, ETS1, H2AC4, HNF4A, JUN, SMAD3, SUMO2, UBC\n",
      "JUND --[molfunc_protein | interacts with]--> ADGRE5, PPP2CA, enzyme binding\n",
      "JUND --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CCNA2 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CCNA2 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "CCNA2 --[protein_protein | ppi]--> BRCA1, BRCA2, CCNB1, CDK2, E2F1, E2F4, EP300, ETS1, PCNA, RAD23A, SKP2, SP1, UBC\n",
      "CCNA2 --[pathway_protein | interacts with]--> Processing of DNA double-strand break ends, Regulation of TP53 Activity through Phosphorylation\n",
      "CCNA2 --[anatomy_protein_present | expression present]--> E2F4, ETS1, ETS2\n",
      "PLK1 --[protein_protein | ppi]--> AURKA, BRCA1, BRCA2, CCNB1, CCNT1, E2F4, EP300, ETS1, GATA1, MYC, PSMB6, TERF1, UBC\n",
      "PLK1 --[anatomy_protein_present | expression present]--> CDK2, ETS2\n",
      "PLK1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "PLK1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "EIF3B --[disease_phenotype_positive | phenotype present]--> BARD1\n",
      "EIF3B --[molfunc_protein | interacts with]--> PPP2CA, RNA binding\n",
      "EIF3B --[protein_protein | ppi]--> BRCA1, EP300, MYC, UBC\n",
      "EIF3B --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "CCNT1 --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA, RNA polymerase binding\n",
      "CCNT1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2\n",
      "CCNT1 --[pathway_protein | interacts with]--> TP53 Regulates Transcription of DNA Repair Genes\n",
      "CCNT1 --[protein_protein | ppi]--> BRCA1, E2F4, EGR1, EP300, ETS1, MYC, PLK1, SMAD3, UBC\n",
      "CCNT1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "HNF4A --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, LAGE3, PPP2CA\n",
      "HNF4A --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, PTGFR\n",
      "HNF4A --[protein_protein | ppi]--> AURKA, BRCA1, CSTF1, EP300, ETS1, JUND, MAPK14, MYC, SMAD3, SP1, UBE2I\n",
      "HNF4A --[anatomy_protein_present | expression present]--> CDK2, E2F3, ETS1, ETS2\n",
      "BRAP --[molfunc_protein | interacts with]--> LAGE3, NOS1, PPP2CA\n",
      "BRAP --[cellcomp_protein | interacts with]--> ADRA2B, HTRA1, PTGFR\n",
      "BRAP --[protein_protein | ppi]--> BRCA1, UBC\n",
      "BRAP --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "BRAP --[disease_protein | associated with]--> AURKA, BRCA1, BRCA2, EGR1, MYC, PIK3R1\n",
      "CSNK2A1 --[molfunc_protein | interacts with]--> PPP2CA\n",
      "CSNK2A1 --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A\n",
      "CSNK2A1 --[pathway_protein | interacts with]--> Regulation of TP53 Activity through Phosphorylation\n",
      "CSNK2A1 --[protein_protein | ppi]--> BRCA1, CHEK1, CSNK2B, ETS1, HNRNPA2B1, JUN, MAPK14, MYC, PIK3R1, PRPF3, SPI1, TERF1, UBC\n",
      "CSNK2A1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "BARD1 --[molfunc_protein | interacts with]--> NOS1, PPP2CA, RNA binding\n",
      "BARD1 --[cellcomp_protein | interacts with]--> ADRA2B, BRCA1-A complex, HTRA1, Increased pitch variability of speech, PRPS2, PTGFR\n",
      "BARD1 --[pathway_protein | interacts with]--> Defective DNA double strand break response due to BARD1 loss of function, Defective DNA double strand break response due to BRCA1 loss of function, G2/M DNA damage checkpoint, HDR through Homologous Recombination (HRR), HDR through Single Strand Annealing (SSA), Homologous DNA Pairing and Strand Exchange, Metalloprotease DUBs, Nonhomologous End-Joining (NHEJ), Presynaptic phase of homologous DNA pairing and strand exchange, Processing of DNA double-strand break ends, Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks, Regulation of TP53 Activity through Phosphorylation, Resolution of D-loop Structures through Holliday Junction Intermediates, Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\n",
      "BARD1 --[anatomy_protein_absent | expression absent]--> NDUFS2\n",
      "BARD1 --[protein_protein | ppi]--> AURKA, BRCA1, BRCA2, CDK2, CSTF1, E2F4, ETS1, KAT5, PCNA, UBC\n",
      "BARD1 --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2\n",
      "BARD1 --[disease_phenotype_positive | phenotype present]--> EIF3B\n",
      "JUN --[disease_disease | parent-child]--> RNA binding\n",
      "JUN --[cellcomp_protein | interacts with]--> HTRA1, PRPS2, RAD23A\n",
      "JUN --[pathway_protein | interacts with]--> TP53 Regulates Transcription of DNA Repair Genes\n",
      "JUN --[molfunc_molfunc | parent-child]--> RNA binding\n",
      "JUN --[protein_protein | ppi]--> BRCA1, CSNK2A1, CSNK2B, EGR1, EP300, ETS1, ETS2, GATA1, H2AC4, JUND, MAPK14, MYC, PPP2CA, SMAD3, SP1, SPI1, SUMO1, SUMO2, UBC, UBE2I\n",
      "JUN --[anatomy_protein_present | expression present]--> CDK2, E2F3, E2F4, ETS1, ETS2, NDUFS2\n",
      "JUN --[molfunc_protein | interacts with]--> ADGRE5, DNA binding, PPP2CA, Pseudoaneurysm, RNA binding, enzyme binding'\n",
      "[Neo4j Output] Aggregated KG Summary:\n",
      "\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Refined Hypothesis:\n",
      "- 'DDT exposure may influence BRCA1 expression through its direct interaction with BRCA1, which is crucial for various cellular processes including DNA damage response and repair mechanisms. This interaction could lead to alterations in BRCA1 expression levels and impair its functionality, contributing to associated phenotypes such as abnormalities in chromosome stability and increased chromosome breakage. Furthermore, disruptions in BRCA1 activity can have downstream effects on critical pathways, including the G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ), ultimately compromising genomic integrity and increasing susceptibility to diseases related to BRCA1 dysfunction.'"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">60412</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">127</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0091</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0229</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0488</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m60412\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m127\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0091\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0229\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0488\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Refine Output]\n",
      "Refined Hypothesis:\n",
      "- 'DDT exposure may influence BRCA1 expression through its direct interaction with BRCA1, which is crucial for various cellular processes including DNA damage response and repair mechanisms. This interaction could lead to alterations in BRCA1 expression levels and impair its functionality, contributing to associated phenotypes such as abnormalities in chromosome stability and increased chromosome breakage. Furthermore, disruptions in BRCA1 activity can have downstream effects on critical pathways, including the G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ), ultimately compromising genomic integrity and increasing susceptibility to diseases related to BRCA1 dysfunction.'\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "**Final Decision: High-Quality Hypotheses and Recommendations**\n",
      "\n",
      "**Refined Hypotheses:**\n",
      "\n",
      "1. **Hypothesis 1: BRCA1 and PPP2CA Interaction**\n",
      "   - \"BRCA1 affects chromosome stability through its interaction with PPP2CA, which is involved in multiple pathways related to DNA damage response, including the G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ). Furthermore, mutations or dysfunctions in BRCA1 can lead to abnormalities in chromosome stability and breakage, thereby implicating a direct relationship between BRCA1, PPP2CA, and chromosome integrity.\"\n",
      "\n",
      "2. **Hypothesis 2: DDT and BRCA1 Interaction**\n",
      "   - \"DDT exposure may influence BRCA1 expression through its direct interaction with BRCA1, which is crucial for various cellular processes, including DNA damage response and repair mechanisms. This interaction could lead to alterations in BRCA1 expression levels and impair its functionality, contributing to associated phenotypes such as abnormalities in chromosome stability and increased chromosome breakage. Furthermore, disruptions in BRCA1 activity can have downstream effects on critical pathways, including the G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ), ultimately compromising genomic integrity and increasing susceptibility to diseases related to BRCA1 dysfunction.\"\n",
      "\n",
      "**Recommendations:**\n",
      "\n",
      "1. **Experimental Validation:**\n",
      "   - Conduct experiments to test the interaction between DDT and BRCA1 using co-immunoprecipitation assays.\n",
      "   - Validate changes in BRCA1 expression levels through quantitative PCR and Western blot analyses in relevant cell lines exposed to DDT.\n",
      "   - Assess the functional consequences of DDT exposure on BRCA1 activity by examining DNA damage response and repair mechanisms, focusing on the G2/M checkpoint and NHEJ.\n",
      "\n",
      "2. **Mechanistic Elucidation:**\n",
      "   - Investigate the specific molecular mechanisms by which DDT alters BRCA1 function and expression. This could involve exploring changes in post-translational modifications of BRCA1 or alterations in its interaction with other cellular proteins.\n",
      "\n",
      "3. **Broader Implications:**\n",
      "   - Explore the implications of DDT exposure on genomic integrity in the context of BRCA1-related malignancies. This research could lead to improved cancer risk assessment and prevention strategies for populations exposed to DDT and similar environmental pollutants.\n",
      "\n",
      "4. **Interdisciplinary Collaboration:**\n",
      "   - Foster collaborations among environmental scientists, molecular biologists, and cancer researchers to enhance the depth and breadth of the research. This interdisciplinary approach could provide a more comprehensive understanding of the environmental impacts on cancer biology.\n",
      "\n",
      "5. **Public Awareness and Policy Recommendations:**\n",
      "   - Based on the findings, advocate for policies aimed at reducing DDT exposure and similar environmental toxins, particularly in vulnerable populations at risk for BRCA1-related cancers.\n",
      "\n",
      "**Conclusion:**\n",
      "The refined hypotheses present a significant opportunity to advance the understanding of how environmental factors like DDT can influence critical tumor suppressor genes such as BRCA1 and their pathways. The recommendations provided will guide future research efforts to validate these hypotheses and assess their broader implications in cancer biology."
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"font-weight: bold\">Stats:</span> <span style=\"color: #800080; text-decoration-color: #800080\">N_MSG</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">2</span><span style=\"color: #800080; text-decoration-color: #800080\">, TOKENS: </span><span style=\"color: #800080; text-decoration-color: #800080\">in</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">801</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">out</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">630</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">max</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">8192</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">ctx</span><span style=\"color: #800080; text-decoration-color: #800080\">=</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">128000</span><span style=\"color: #800080; text-decoration-color: #800080\">, COST: </span><span style=\"color: #800080; text-decoration-color: #800080\">now</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0005</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">cumul</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0005</span><span style=\"color: #800080; text-decoration-color: #800080\">, </span><span style=\"color: #800080; text-decoration-color: #800080\">tot</span><span style=\"color: #800080; text-decoration-color: #800080\">=$</span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">0.0493</span><span style=\"color: #800080; text-decoration-color: #800080\"> </span>\n",
       "<span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold\">(gpt-4o-mini)</span>\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\u001b[1mStats:\u001b[0m \u001b[35mN_MSG\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m2\u001b[0m\u001b[35m, TOKENS: \u001b[0m\u001b[35min\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m801\u001b[0m\u001b[35m, \u001b[0m\u001b[35mout\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m630\u001b[0m\u001b[35m, \u001b[0m\u001b[35mmax\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m8192\u001b[0m\u001b[35m, \u001b[0m\u001b[35mctx\u001b[0m\u001b[35m=\u001b[0m\u001b[1;35m128000\u001b[0m\u001b[35m, COST: \u001b[0m\u001b[35mnow\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0005\u001b[0m\u001b[35m, \u001b[0m\u001b[35mcumul\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0005\u001b[0m\u001b[35m, \u001b[0m\u001b[35mtot\u001b[0m\u001b[35m=$\u001b[0m\u001b[1;35m0.0493\u001b[0m\u001b[35m \u001b[0m\n",
       "\u001b[1;35m(\u001b[0m\u001b[1;35mgpt-4o-mini\u001b[0m\u001b[1;35m)\u001b[0m\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Decision Output]\n",
      "**Final Decision: High-Quality Hypotheses and Recommendations**\n",
      "\n",
      "**Refined Hypotheses:**\n",
      "\n",
      "1. **Hypothesis 1: BRCA1 and PPP2CA Interaction**\n",
      "   - \"BRCA1 affects chromosome stability through its interaction with PPP2CA, which is involved in multiple pathways related to DNA damage response, including the G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ). Furthermore, mutations or dysfunctions in BRCA1 can lead to abnormalities in chromosome stability and breakage, thereby implicating a direct relationship between BRCA1, PPP2CA, and chromosome integrity.\"\n",
      "\n",
      "2. **Hypothesis 2: DDT and BRCA1 Interaction**\n",
      "   - \"DDT exposure may influence BRCA1 expression through its direct interaction with BRCA1, which is crucial for various cellular processes, including DNA damage response and repair mechanisms. This interaction could lead to alterations in BRCA1 expression levels and impair its functionality, contributing to associated phenotypes such as abnormalities in chromosome stability and increased chromosome breakage. Furthermore, disruptions in BRCA1 activity can have downstream effects on critical pathways, including the G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ), ultimately compromising genomic integrity and increasing susceptibility to diseases related to BRCA1 dysfunction.\"\n",
      "\n",
      "**Recommendations:**\n",
      "\n",
      "1. **Experimental Validation:**\n",
      "   - Conduct experiments to test the interaction between DDT and BRCA1 using co-immunoprecipitation assays.\n",
      "   - Validate changes in BRCA1 expression levels through quantitative PCR and Western blot analyses in relevant cell lines exposed to DDT.\n",
      "   - Assess the functional consequences of DDT exposure on BRCA1 activity by examining DNA damage response and repair mechanisms, focusing on the G2/M checkpoint and NHEJ.\n",
      "\n",
      "2. **Mechanistic Elucidation:**\n",
      "   - Investigate the specific molecular mechanisms by which DDT alters BRCA1 function and expression. This could involve exploring changes in post-translational modifications of BRCA1 or alterations in its interaction with other cellular proteins.\n",
      "\n",
      "3. **Broader Implications:**\n",
      "   - Explore the implications of DDT exposure on genomic integrity in the context of BRCA1-related malignancies. This research could lead to improved cancer risk assessment and prevention strategies for populations exposed to DDT and similar environmental pollutants.\n",
      "\n",
      "4. **Interdisciplinary Collaboration:**\n",
      "   - Foster collaborations among environmental scientists, molecular biologists, and cancer researchers to enhance the depth and breadth of the research. This interdisciplinary approach could provide a more comprehensive understanding of the environmental impacts on cancer biology.\n",
      "\n",
      "5. **Public Awareness and Policy Recommendations:**\n",
      "   - Based on the findings, advocate for policies aimed at reducing DDT exposure and similar environmental toxins, particularly in vulnerable populations at risk for BRCA1-related cancers.\n",
      "\n",
      "**Conclusion:**\n",
      "The refined hypotheses present a significant opportunity to advance the understanding of how environmental factors like DDT can influence critical tumor suppressor genes such as BRCA1 and their pathways. The recommendations provided will guide future research efforts to validate these hypotheses and assess their broader implications in cancer biology.\n",
      "\n",
      "**Final Decision: High-Quality Hypotheses and Recommendations**\n",
      "\n",
      "**Refined Hypotheses:**\n",
      "\n",
      "1. **Hypothesis 1: BRCA1 and PPP2CA Interaction**\n",
      "   - \"BRCA1 affects chromosome stability through its interaction with PPP2CA, which is involved in multiple pathways related to DNA damage response, including the G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ). Furthermore, mutations or dysfunctions in BRCA1 can lead to abnormalities in chromosome stability and breakage, thereby implicating a direct relationship between BRCA1, PPP2CA, and chromosome integrity.\"\n",
      "\n",
      "2. **Hypothesis 2: DDT and BRCA1 Interaction**\n",
      "   - \"DDT exposure may influence BRCA1 expression through its direct interaction with BRCA1, which is crucial for various cellular processes, including DNA damage response and repair mechanisms. This interaction could lead to alterations in BRCA1 expression levels and impair its functionality, contributing to associated phenotypes such as abnormalities in chromosome stability and increased chromosome breakage. Furthermore, disruptions in BRCA1 activity can have downstream effects on critical pathways, including the G2/M DNA damage checkpoint and Nonhomologous End-Joining (NHEJ), ultimately compromising genomic integrity and increasing susceptibility to diseases related to BRCA1 dysfunction.\"\n",
      "\n",
      "**Recommendations:**\n",
      "\n",
      "1. **Experimental Validation:**\n",
      "   - Conduct experiments to test the interaction between DDT and BRCA1 using co-immunoprecipitation assays.\n",
      "   - Validate changes in BRCA1 expression levels through quantitative PCR and Western blot analyses in relevant cell lines exposed to DDT.\n",
      "   - Assess the functional consequences of DDT exposure on BRCA1 activity by examining DNA damage response and repair mechanisms, focusing on the G2/M checkpoint and NHEJ.\n",
      "\n",
      "2. **Mechanistic Elucidation:**\n",
      "   - Investigate the specific molecular mechanisms by which DDT alters BRCA1 function and expression. This could involve exploring changes in post-translational modifications of BRCA1 or alterations in its interaction with other cellular proteins.\n",
      "\n",
      "3. **Broader Implications:**\n",
      "   - Explore the implications of DDT exposure on genomic integrity in the context of BRCA1-related malignancies. This research could lead to improved cancer risk assessment and prevention strategies for populations exposed to DDT and similar environmental pollutants.\n",
      "\n",
      "4. **Interdisciplinary Collaboration:**\n",
      "   - Foster collaborations among environmental scientists, molecular biologists, and cancer researchers to enhance the depth and breadth of the research. This interdisciplinary approach could provide a more comprehensive understanding of the environmental impacts on cancer biology.\n",
      "\n",
      "5. **Public Awareness and Policy Recommendations:**\n",
      "   - Based on the findings, advocate for policies aimed at reducing DDT exposure and similar environmental toxins, particularly in vulnerable populations at risk for BRCA1-related cancers.\n",
      "\n",
      "**Conclusion:**\n",
      "The refined hypotheses present a significant opportunity to advance the understanding of how environmental factors like DDT can influence critical tumor suppressor genes such as BRCA1 and their pathways. The recommendations provided will guide future research efforts to validate these hypotheses and assess their broader implications in cancer biology.\n"
     ]
    }
   ],
   "source": [
    "result = run_chat(\"Based on the relationship between TP53, BRCA1 and PARP1, please generate assumptions.\")\n",
    "print(result)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
